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Abstract 
The thymic stroma primarily comprises epithelial, mesenchymal and endothelial 
cells, interspersed with those of haematopoietic orgin.  Thymic epithelial cells 
(TECs) are highly heterogeneous, but can be divided into two broad lineages, cortical 
and medullary, based on phenotype, functionality and location.  A population of 
Plet1+ TEC progenitors have been identified which, when isolated from mouse E12.5 
or E15.5 fetal thymus, reaggregated, and grafted, can produce a functional thymus.  
However, the potential of individual progenitors to form cortex and/or medulla is 
undefined.  The main aim of this thesis was to use retrospective clonal analysis to 
ascertain the point during thymus ontogeny at which the cortical and medullary 
lineages diverge.  To this end, I used transgenic mi e carrying a ubiquitous 
ROSA26laacZ reporter gene (where a duplication within lacZ encodes non-functional 
β-galactosidase).  Here, rare, random laacZ-lacZ genetic recombinations result in 
heritable expression of functional β-gal, producing labelled clones.  As this occurs at 
a known frequency, determination of TEC numbers would enable calculation of the 
expected number of TEC clones present throughout ontoge y.  Due to the lack of 
quantitative data on all thymic cell populations, I determined the size not only of 
TEC (lin-EpCAM+), but also haematopoietic (CD45+), mesenchymal (lin-PDGFRα+ 
and/or lin-PDGFRβ+) and endothelial (lin-CD31+) populations from E12.5 until 
E17.5.  I then showed that the absolute number of Plet1+ TECs remains constant 
during this time, although the proportion of Plet1+ cells in cycle decreases.  From 
these collective data, I propose a model for the rol of the Plet1+ population in 
thymus development, in which Plet1+ cells continually give rise to Plet1- TECs in a 
self-renewing manner.  Finally, I present a ‘dual origin coefficient’ straegy for 
analysis of a library of prospective TEC clones.  I calculated the number of TEC 
lacZ+ clones expected to be present throughout thymus ontoge y, selecting an 
appropriate developmental stage for analysis.  Althoug  I observed several clones of 
apparent mesenchymal origin, supporting a single origin for intrathymic and capsular 
mesenchyme at E15.5, I observed no TEC clones in this extensive analysis.  The 
CpG content of the ROSA26 promoter suggests a possibility of methylation-induced 
silencing brought about by de novo methylation of the lacZ reporter gene.
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Chapter 1. Introduction 
1.1. The mature thymus 
1.1.1. Summary of thymus function 
The thymus is the principal site of T-cell development.  Bone-marrow (BM) derived 
T-cell precursor cells enter the organ from the circulation, in an immature state.  
These are guided through a series of complex maturation nd selection steps to 
ensure the output of an immunologically self-tolerant repertoire of functional T-cells, 
that can recognise and bind to self-major histocompatibility complexes (MHC) with 
the correct degree of avidity. 
1.1.2. Organ structure and composition 
1.1.2.1. Overview 
The mature mouse thymus consists of two conjoined lobes, situated on the midline, 
just above the heart.  These lobes are covered in a thick capsule of connective tissue, 
from which trabeculae penetrate inward on a regular basis and further divide the 
thymus into a series of lobulations (Figure 1.1A).  Within these lobules, the organ 
can be said to consist of two zones  – an inner medulla, surrounded by an outer 
cortex.  These areas can be designated on a histological basis; staining with 
hematoxylin and eosin (H&E) results in a darker cortex, due to a higher cell density 
(Figure 1.1A). 
Thymic epithelial cells (TECs) comprise the major functional component of the 
thymic stroma, and form a complex, strictly regulated 3-dimensional network.  
Amongst this epithelial network reside many tightly packed thymocytes, at various 
stages of development (Figure 1.1B).  Other stromal components include cells of 
mesenchymal origin such as fibroblasts and pericytes, and BM derived cells such as 
macrophages and dendritic cells (DCs).  The interior of the thymus is heavily 
vascularised and innervated. 
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Figure 1.1 Thymus structure and cellular organisati on 
A) H&E stain of thymus, showing histologically distinct dark cortex (C) and lighter 
medulla (M).  Cortex appears darker owing to a higher density of thymocytes than in 
the medulla.  The connective tissue of the surrounding capsule and dividing 
trabeculae (tr) are also indicated. 
Picture adapted from http://www.lab.anhb.uwa.edu.au/mb140/ 
B) Cartoon showing cellular organisation in the mature thymus.  Bounded by 
subcapsular epithelium, the thymic parenchyma consists of an outer cortex and an 
inner medulla.  Distinct cortical and medullary epithelial cells inhabit these regions, 
with the cortex being particularly tightly packed with thymocytes.  Picture taken 
from Janeway et al., 2001. 
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1.1.2.2. Thymic epithelium 
Although generally designated into three broad types (subcapsular, cortical and 
medullary), thymic epithelial cells are highly heterogeneous and have been subject to 
various methods of classification.  Firstly an ultrast uctural study of human thymus 
classified TECs into 6 different types – “subcapsular-perivascular” (type 1); “pale” 
(type 2); “intermediate” (type 3); “dark” (type 4); “undifferentiated” (type 5); and 
“large-medullary” (type 6) (van de Wijngaert et al., 1984).  A second means of TEC 
classification has been according to profiles of staining with monoclonal antibodies 
(MAbs), in chicken, human, mouse and rat, assigning them to ‘clusters of thymic 
epithelial staining’ (CTES) groups, summarised in Table 1.1 (Kampinga et al., 1989, 
Brekelmans and van Ewijk, 1990, Van Vliet et al., 1984, Godfrey et al., 1990, Boyd 
et al., 1992). 
If one were to move inward from the outer capsule toward the medulla, different 
TEC types would be sequentially encountered (Figure 1.1B).  Firstly, a flattened 
epithelial cell type lines the thymic parenchyma, separating it from the thymic 
structural elements of the capsule and trabeculae (v n de Wijngaert et al., 1984).  
This ‘subcapsular’ (or ‘type 1’) epithelium is supported on a basement membrane, 
creating a barrier between the internal and external thymic microenvironments.  Type 
1 epithelium is also continuous in surrounding large thymic blood vessels and 
cortical capillaries, creating perivascular spaces (PVS) and maintaining the ‘blood-
thymus barrier’ in the cortex and at the cortico-medullary junction (CMJ) (Kendall, 
1989).  These cells are stained by CTES II MAbs, and re MHC class II negative 
(Boyd et al., 1992, Kampinga et al., 1989). 
Type 1 epithelium apart, the most striking feature of pithelial cells in the thymus is 
their 3-dimensional arrangement.  In contrast to the classical 2-dimensional sheets or 
stratified arrangements found in the majority of epithelial structures, TECs form an 
organised open network. 
Immediately beneath the subcapsular epithelium lies th  cortex.  Cortical epithelial 
cells (cTECs) typically form an inter-connected meshwork, extending out long 
finger-like processes that join to their neighbouring cTECs by way of desmosomes.  
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TECs in the outermost cortex are ‘type 2’, appearing as “pale” on electron-
micrographs (van de Wijngaert et al., 1984).  Directly beneath these lie ‘type 3’ 
cTECs, characterised by an “intermediate” electron lucency, followed by ‘type 4’ 
cTECs that appear as “dark” on electron-micrographs (van de Wijngaert et al., 1984). 
Type 2, 3 and 4 cTECs are seen to stain with the CTES III group of antibodies and 
are also MHC class II positive, to a varying degree (Boyd et al., 1993, Kampinga et 
al., 1989, Gray et al., 2006).  In the ultrastructural TEC analysis it was considered 
that TEC types 2 and 3 were very metabolically active, and presumed that cytokine 
production was occurring.  Conversely, type 4 TECs have “features of dying cells” 
and may represent a terminal cTEC stage (Boyd et al., 1993, van de Wijngaert et al., 
1984).  On the basis of staining with MAbs to different species of keratin (K), two 
distinct cTEC subsets have been observed: a predominating K8+K18+K5-K14- subset, 
and an infrequent K8+K18+K5+K14- subset concentrated at the CMJ (Klug et al., 
1998, Savino and Dardenne, 1988b, Savino and Dardenne, 1988a). 
Some cTECs are known to form multicellular complexes, termed ‘thymic nurse 
cells’ (TNC).  These are of enormous size, having appe red to engulf as many as 50-
200 thymocytes (Wekerle and Ketelsen, 1980, Wekerle et al., 1980).  Although little 
is known about the function of TNC, there is little evidence for phagocytic 
degradation of internalised thymocytes (Wekerle et al., 1980).  Instead, these are 
completely sequestered within caveolae, and are often seen to be mitotically active 
(Wekerle et al., 1980).  It has been postulated that t ese structures are involved in 
thymocyte maturation.  In hanging drop culture experim nts, an isolated cell line of 
rat ‘TNC’ was indicated to have the ability to internalise, and induce maturation of, 
immature CD4-CD8+ thymocytes to the CD4+CD8+ stage (Li et al., 2005).  However, 
other studies have implied that it is in fact the CD4+CD8+ subset which are 
internalised and that TNC are involved in the process of MHC restriction (Martinez 
et al., 2007, Li et al., 1992). 
In the innermost portion of the thymus lies the medulla.  Medullary epithelial cells 
(mTEC) occur at a higher density than cTEC, are more c mpact in appearance, and 
are interspersed by fewer, less tightly packed thymocytes.  Nearly all mTECs stain 
with CTES II or IV MAbs.  By ultrastructural analysis, ‘type 5’ (“undifferentiated”) 
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mTECs can be identified in small clusters at the CMJ (van de Wijngaert et al., 1984).  
Type 3 cells comprise the major proportion of mTECs within the main body of the 
medulla, interspersed with isolated type 6 “large mdullary” cells – secretory cells 
with extensive endoplasmic reticulum (van de Wijngaert et al., 1984).  All mTECs 
express MHC class I, and MHC class II expression is seen to vary between high and 
low expression (Farr and Nakane, 1983, Surh et al., 1992, Van Ewijk et al., 1980, 
Gray et al., 2006).  As in the cortex, mTEC subpopulations have been identified on 
the basis of anti-keratin antibody staining.  A major, centrally located K8-K18-
K5+K14+ population of cells exhibits a stellate morphology and reacts with the MAb 
MTS10, whereas a smaller, globular K8+ 18+K5-K14- population is localised in the 
outer medulla and is seen to bind the lectin UEA-1 with high affinity whilst being 
MHC class IIhi (Klug et al., 1998, Yang et al., 2006).  Within the UEA-1+ population, 
another scattered mTEC subpopulation expresses specific tight-junction components 
(the claudins Cld3 and Cld4 and occludin) (Hamazaki et al., 2007).  This mTEC 
subset is predominantly MHC class IIhiCD80+MTS10- and is known to also express 
the autoimmune regulator (Aire) transcription factor - involved in the expression of 
tissue-restricted antigens (TRAs) to facilitate negative selection (see section 1.1.3.3). 
Multicellular complexes, Hassall’s Corpuscles (HC), also occur in the medulla 
(Hassall, 1849).  More commonly observed and well-dveloped in the human and 
guinea-pig thymus than in the mouse or rat, the rolof these whorl-like groups of 
epithelial cells is still debated (Farr et al., 200).  HC have been proposed to be 
involved in the removal of apoptotic thymocytes, or in their maturation (Blau, 1973, 
Senelar et al., 1976).  They have been shown to be active cytokine-producers; 
expressing interleukin (IL)-7, transforming growth factor (TGF)-α, CD30 ligand, 
stromal-cell-derived factor (SDF)-1 and macrophage-derived chemokine (MDC) 
(Annunziato et al., 2000, He et al., 1995, Le et al., 1991, Romagnani et al., 1998, 
Zaitseva et al., 2002).  Expression of various elemnts of the mitogen-activated 
protein kinase (MAPK) signalling pathway suggest that the mTECs within HC may 
be in varying states of maturity (Nishio et al., 2001).  Recently, it has been indicated 
that HC may play an indirect role, in inducing CD4+CD25+ regulatory T cells in 
human thymus.  HC were shown to produce thymic stromal lymphopoietin (TSLP), 
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which activated CD11c+ DCs to express CD80 and CD86.  These ligands in tur  
activated CD4+CD8-CD25- thymocytes to proliferate and differentiate along the 




Table 1.1 CTES phenotypic classification in respons e to monoclonal 
antibody staining 
CTES Group Specificity 
I All TEC 
II Subcapsular/perivascular/medullary TEC 
III.A Cortical TEC 
III.B Cortical TEC, isolated medullary TEC 
III.C.1 Cortical TEC, macrophages 
III.C.2 Cortical TEC, thymocytes 
IV Medullary TEC, Hassal's corpuscles 
V.A Hassal's corpuscles 
V.B Hassal's corpuscles, myeloid cells 
V.C Hassal's corpuscles, associated medullary TECs 
V.D Hassal's corpuscles, associated medullary TECs, some leukocytes 
V.E Hassal's corpuscles, associated medullary TECs, subcapsular TEC 
VI Type 1 epithelium 
XX.A Most corticall and medullary TEC, isolated subcapsular TECs 
XX.B Minority of cortical and medullary TEC 
XX.C Minority of medullary TEC, cortical thymocytes 
Summary of ‘clusters of thymic epithelial staining’ (CTES), where TEC 
subpopulations were assigned in response to monocloal antibody staining patterns. 
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1.1.2.3. Thymic vasculature and innervation 
Major blood vessels and lymphatics from the thymic exterior arrive at the cortico- 
CMJ from within trabecular connective tissue.  These subsequently diverge into the 
thymic parenchyma, connecting to a fine network of capillaries that lead into the 
cortex and medulla (Kato, 1997, Kato and Schoefl, 1989).  Cortical capillaries extend 
out toward the subcapsule, whereupon the vasculature loops back toward the CMJ 
and drains into postcapillary venules (Kato and Schoefl, 1989).  Around large blood 
vessels of the thymic parenchyma, in the medulla and t the CMJ, an additional 
sheath of perivascular cells is present which form close contact to type 1 simple 
epithelium.  The gap formed between the inner and outer perivascular cells is known 
as the perivascular space, and is involved in the selective transport of haematopoietic 
precursors and mature thymocytes between the circulation and the thymic stroma 
(Mori et al., 2007, Kato and Schoefl, 1989). 
Dense nerve plexuses from the sympathetic nervous system enter the thymus 
associated with large blood vessels, with which they reach the inner cortex and 
medulla.  Nerve fibres also enter the outer cortex from the capsule and interlobular 
septae.  Innervation is particularly dense at the CMJ (Kendall, 1991, Kendall and al-
Shawaf, 1991, Mignini et al., 2003). 
1.1.2.4. Other stromal components 
In the mature organ, mesenchyme-derived cells are present in a number of structural 
components such as the outer capsule, inner connective tissue and trabeculae, 
intrathymic fibroblasts, and the pericytes and smooth muscle cells that surround 
many blood vessels.  Extra-cellular matrix (ESM) produced by fibroblasts is an 
important contributor to thymus structure, and is involved in signalling with 
epithelial, endothelial and haematopoietic cells.  Thymic mesenchyme is 
heterogeneous - for example, sub-populations showing staining with the monoclonal 
antibody MTS15 have been identified, lining the subcapsule and large blood vessels 
(Gray et al., 2007b, Gray et al., 2002). 
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1.1.3. Intrathymic T-cell development in the mature thymus 
1.1.3.1. Initial stages 
Because of the need to establish a self-tolerant repertoire with a propensity to 
recognise self-MHC, via combinational gene rearrangement, a number of gating or 
“selection” steps are imposed during T cell development.   As a result, only 3-5% of 
candidates pass all these stringent selection criteria (Scollay et al., 1984, 
Merkenschlager et al., 1997).  In the steady-state adult thymus, T-cell precursors 
enter from the circulation at the CMJ (Figure 1.2).  These then move outward 
through the cortex toward the subcapsular area, passing through defined zones 
(region 1-4, see Figure 1.2) that are inhabited by thymocytes of increasing maturity 
(Lind et al., 2001).  Thymocyte migration between different zones of the thymus is 
largely induced by a range of chemokines (for a recent review see (Takahama, 
2006)). 
Upon entering the thymus, prospective thymocytes ar CD4-CD8- double negative  
(DN) (Petrie et al., 1990).  These are heterogeneous in their potential to generate T 
cells or other BM-derived cells such as natural killer (NK) cells, DCs and 
macrophages (Porritt et al., 2004, Balciunaite et al., 2005).  These DN cells can be 
further subdivided into subsets of progressive maturation, based on expression of 
CD44 and CD25 (Godfrey et al., 1993).  Initially CD44+CD25- (DN1) thymic 
immigrants move from region 1 to region 2 (Figure 1.2) – undergoing proliferative 
expansion, and adopting a CD44+CD25+ (DN2) phenotype (Godfrey et al., 1993, 
Penit et al., 1995). 
Transition to the CD44-CD25+ (DN3) stage in region 3 is followed by rearrangement 
of the T-cell receptor (TCR) gene segments.  Supported by IL7 signalling from 
stromal cells, and under the control of recombination activating gene (RAG) 1 and 
RAG 2, the β-, γ- and δ-TCR genes begin rearrangement virtually simultaneously 
(Wilson et al., 1994a, Hofmeister et al., 1999, Muegg  et al., 1993).  The choice 
between α:β or γ:δ T-cell lineage is regulated by whichever TCR genes are 
productively rearranged first (known as the β-selection checkpoint).  Signalling 
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occurs via expression of the corresponding TCR chains on the cell surface, leading to 
shutdown of further TCR gene rearrangement.  This process, termed allelic 
exclusion, thus blocks productive recombination of gene segments for the alternate 
lineage in that cell.  The γ:δ lineage requires expression of both functional γ- and δ-
chains; the α:β lineage initially requires only a functional β-chain (which pairs with a 
surrogate α-chain to form the β:pTα pre T-cell receptor), hence 95% of thymocytes 
are of the α:β lineage (Godfrey and Zlotnik, 1993, Groettrup and von Boehmer, 
1993).  The γ:δ T-cells remain DN and show little proliferation.  β:pTα cells are 
stimulated to proliferate and subsequently undergo α-TCR rearrangement to become 
α:β T-cells (Dudley et al., 1994).  The α-TCR gene segments continuously rearrange 
until a functional α-TCR chain is produced, maximizing the production of useful 
thymocytes (Petrie et al., 1993). 
Thymocytes subsequently migrate to the outermost subcapsular region (region 4, 
Figure 1.1) thymocytes become CD44-CD25- (DN4/preDP) and undergo further 
proliferation followed by a switch to the CD4+CD8+ double-positive (DP) phenotype 
(Godfrey et al., 1993). 
1.1.3.2. Positive selection 
DP thymocytes migrate back toward the CMJ, on the way undergoing positive 
selection – a process mediated by cortical TECs (Anderson et al., 1994, Laufer et al., 
1996).  Positive selection ensures that the TCR gene rearrangement step has 
produced a TCR that is able to recognise self-MHC with the correct avidity.  Any 
thymocyte that is not MHC-restricted will subsequently undergo apoptosis. 
Upon completing positive selection, thymocytes become either CD4+CD8- or CD4-
CD8+ single-positive (SP) (also known as helper and cytotoxic T-cells respectively).  
This fate choice is based on the strength and duration of MHC-induced signalling 
through the TCR during positive selection.  Initial MHC recognition by the TCR 
leads to uniform downregulation of CD8, the MHC class-I-specific co-receptor.  It 
therefore follows that thymocytes interacting with MHC class-I molecules will 
experience disrupted, transient signalling.  Conversely, MHC class-II interaction will 
produce strong, sustained TCR signalling since expression of the MHC class-II-
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specific CD4 co-receptor is maintained (Singer, 2002).  These MHC-TCR signals are 
mediated by the src-family kinase p56lck (Lck) (Liu and Bosselut, 2004, Salmond et 
al., 2009, Brugnera et al., 2000).  Strong, sustained signalling from MHC-II-specific 
TCRs activates initial CD4+ thymocyte differentiation via the transcription factor 
GATA-3 (Pai et al., 2003).  ThPOK, another transcription factor, acts downstream to 
commit these cells to the CD4+ fate (Egawa and Littman, 2008, Muroi et al., 2008, 
Wang et al., 2008).  In contrast, transient signalli g by MHC-I specific TCRs 
activates Runx3, which supports CD8+ thymocyte differentiation (Kohu et al., 2005).  
1.1.3.3. Negative selection  
Upon crossing the CMJ, SP thymocytes undergo the process of negative selection to 
create a self-tolerant repertoire.  This serves to identify and neutralise any T-cells 
that may have an affinity toward self-antigens through clonal deletion – thereby 
preventing autoimmune attack.  Negative selection is mediated by contact with 
various antigen-presenting cells (APCs) in the medulla.  Dendritic cells are able to 
ingest and present extracellular self-antigens from dead cells, in addition to 
presenting antigens of self-haematopoietic origin, via surface MHC complexes.  
MTECs also present self-antigens to T-cells.  MTECs express one of the highest 
levels of different genes in any cell – organ-specific antigens from peripheral areas, 
e.g. liver, stomach, are found to be expressed (often as thymic splice variants) by 
mTECs, each usually by only a small number of cells per individual mouse 
(Derbinski et al., 2001, Kyewski et al., 2002).  This elevated expression of peripheral 
tissue-restricted antigens (TRAs) aids in identification of self-reactive thymocytes 
during negative selection. 
Mature T cells can remain in the thymus for up to 2 weeks before emigrating from 
the thymus via blood vessels to the circulation.  
1.1.3.4. Aire+ mTECs 
The promiscuous expression of TRAs in the thymus is regulated, at least in part, by 
expression of the autoimmune regulator protein (Aire) (Anderson et al., 2002, 
Kuroda et al., 2005, Liston et al., 2003).  AIRE was originally identified in humans, 
as the gene responsible for a multiorgan autoimmune disease, autoimmune 
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polyendocrinopathy candidiases ectodermal dystrophy (APECED) (Aaltonen et al., 
1997).  Mouse studies have shown that Aire, now known to be a transcriptional 
regulator, is expressed by a specific subset of mTECs (Derbinski et al., 2001, Hubert 
et al., 2008).   
It has also recently been suggested that the Aire protein itself may play a role in 
inducing apoptosis of mTECs that express TRAs and that are becoming terminally 
differentiated, possibly to facilitate cross-presentation of ectopically expressed 
antigens within the thymus (Dooley et al., 2008).  In support of this, Aire-/- mice 
display a large number of K8+K14-/lo ‘globular’ mTECs.  These are found as a minor 
subset in WT mice, perhaps indicating that in the Aire-/- thymus they are able to 
terminally differentiate and persist instead of being nduced to die.  Thus, it may be 
that K14+K8-p63+Aire- cells give rise to K14+K8+p63-Aire+ cells, and that these – if 
not eliminated by apoptosis – may terminally differentiate into K8+K14-/lo mTECs. 
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Figure 1.2 Intrathymic T-cell development 
Developing thymocytes migrate through defined zones of the thymus in a stepwise 
manner, progressing through a highly ordered differentiation programme.  
Uncommitted DN1 precursors enter at the CMJ and migrate out toward the 
subcapsule.  During this time they undergo proliferative expansion and lose NK- and 
B-cell potential (DN2), and begin TCR gene rearrangement (DN3).  In the 
subcapsular region thymocytes become DP.  They then migrate back through the 
cortex, becoming either CD4+ or CD8+ SP, and finally into the medulla prior to 
export to the periphery (subject to surviving positive and negative selection). 
(Figure adapted from Blackburn and Manley, 2004) 
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1.2. The developing thymus 
1.2.1. Overview of early organogenesis 
Developing separately and bilaterally on opposite sid s of the embryo, the murine 
thymus lobes originate in the pharyngeal region of the embryonic foregut (Figure 
1.3A).  This region consists of a series of mesodermal bulges, known as the 
pharyngeal arches.  These arches (of which there ar 5 in the mouse) form by day 9 
of embryonic development (E9), in a rostral to caudal manner.  The arches are 
separated by bilateral out-pocketings of endoderm, termed the pharyngeal pouches, 
and invaginations of ectoderm immediately opposite, termed the pharyngeal clefts 
(Figure 1.3B).  The pharyngeal endoderm and ectoderm are at this stage composed of 
single layers of simple epithelium.  Between E9.5 and E10 third pouch endoderm and 
third cleft ectoderm are in close contact, but separation subsequently occurs. 
By E11, following proliferation of the endodermal epithelium, the thymus has begun 
to form an outgrowing bud and is morphologically visible (Manley, 2000).  This 
anlage contains the primordia of both the thymus (di tal region) and parathyroid, and 
is surrounded by a neural-crest-derived mesenchymal capsule (Figure 1.3C).  
Lymphocyte precursors arrive in the capsule from E11 (Itoi et al., 2001).  At this 
early stage, thymic epithelium exists as a bilayered epithelial sheet with an inner 
lumen.  At E11.5 this epithelium is K5+K8+, with the apical layer expressing claudin-
3 and claudin-4 (Hamazaki et al., 2007, Bennett et al., 2002). 
By E12, the thymus/parathyroid primordia have completely separated from the 
pharynx (Figure 1.3E), following apoptosis on opposing sides of surface ectoderm 
and connective endoderm (Gordon et al., 2004).  Thymus structure has now changed 
from a two-dimensional sheet to a three-dimensional clustered formation, and 
lymphocytes begin to invade the thymic epithelium from the capsule (Itoi et al., 
2001).  By E12.5, patterning and differentiation within the thymus has begun.  
Epithelial cells are predominantly K5+K8+, with a minor subset of K5-K8+ appearing 
around the periphery (Klug et al., 2002).  TEC are negative for MHC class II (a 
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marker of mature thymic epithelium) at this stage (B nnett et al., 2002, Jenkinson et 
al., 1981). 
The thymus and parathyroid begin physical separation by E13, with the thymic 
rudiment beginning to migrate in a ventro-medial and caudal manner toward its final 
location (Figure 1.3E), in a central position just above the heart (Manley and 
Blackburn, 2003).  The centre of the E13.5 thymus remains predominantly K5+K8+, 
with an increasing K5-K8+ population around the outside.  The central region of the 
K5+K8+ clusters stains brightly with MTS10, a marker of the predominant mature 
medullary subset (Klug et al., 2002). 
By E15.5 K5+K8+ TECs persist as small clusters (~13% of total TECs) within the 
predominant (~60% of TECs) K5-K8+ subset, emanating out from the central area of 
the thymus.  Cells in the centre of these clusters g nerally express the highest levels 
of K5, and some of those on the outer boundaries of the clusters are K5+K8lo (~27% 
of all TECs) (Klug et al., 2002, Jenkinson et al., 2005).   
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Figure 1.3 Early thymus organogenesis 
A) Embryo showing location of pharyngeal region (green box).  The blue line depicts 
a coronal section through the pharyngeal region.  (Modified from Manley, 2000) 
B) Cartoon representing the coronal section from A, at E9.5.  Right side of figure 
indicates positioning of endodermal pharyngeal pouches (pp1-pp4); this side also 
depicts mesenchymal/mesodermal pharyngeal arches (purple, I-V) and pharyngeal 
ectoderm (shown in blue).  Left side of figure shows pharyngeal pouches only, 
indicating expression patterns of Pax1, Pax9 and Fgf8 (required for pharyngeal 
pouch formation) and Hoxa3 (required for pp3 axial identity). 
C) Rudiment outgrowth begins.  Continued development is dependent on activity of 
the transcription factors Hoxa3, Pax1, Pax9, Eya1 and Six1.  These are all expressed 
in the endoderm, with Hoxa3, Eya1 and Six1 also expressed in NCC and ectoderm. 
D) Outgrowth and patterning of rudiment.  This begins at E10 with the onset of 
Gcm2 expression, indicating the parathyroid domain of pp3 (red).  Foxn1 is 
expressed in the thymus domain of pp3 at high levels from E11.25 (blue). 
E) Separation from the pharynx and migration of the t ymic rudiment.  Separation 
requires Pax9.  Production of Fgf7/Fgf10 by NCC stimulates epithelial proliferation 
via the Fgfr2-IIIb receptor. 
(B, C, D & E modified from Blackburn and Manley, 2004) 
Chapter 1: Introduction 
  16 
1.2.2. Genetic factors influencing thymus development 
1.2.2.1. Tbx1 
One of the first genes to act in the process of thymus organogenesis is the T-box 
transcription factor Tbx1.  Expressed during development from E7.5 until E12.5, 
Tbx1 is active in a variety of structures including pharyngeal endoderm and 
pharyngeal mesoderm (Chapman et al., 1996). Tbx1 plays a role in pharyngeal 
segmentation, with loss of its expression resulting in severe hypoplasia or aplasia of 
most pharyngeal arches and pouches, and also severe hypoplasia of the pharynx 
(Jerome and Papaioannou, 2001, Vitelli et al., 2002). 
Findings from the lab of Baldini and colleagues have revealed a crucial time window 
for Tbx1 function in thymus formation.  Tamoxifen-inducible cre recombinase was 
used to produce timed Tbx1-null mutant mouse embryos.  Cre-induction at E8.5 or 
earlier resulted in athymic embryos when examined at E18.5 (Xu et al., 2005).  In 
further experiments, tamoxifen-inducible cre was knocked into the Tbx1 allele and 
used to activate permanent β-galactosidase expression.  Here, E12.5 lobes were 
heavily labelled when β-gal was activated at E8.5, but not at E9.5 – indicating Tbx1 
is not active in TECs at E9.5 (Xu et al., 2005).  These results indicate the importance 
of Tbx1 function during the E8.5-9.5 time interval – coinciding with the formation of 
the third pharyngeal pouch.  Tbx1 appears to also play a role in subsequent thymus 
organogenesis, with Tbx1-null mice induced at E10.5 exhibiting a slightly 
hypoplastic thymus at E18.5 (Xu et al., 2005). 
1.2.2.2. Hoxa3 
The homeobox transcription factor Hoxa3 is also known to play a role in pharyngeal 
development.  The Hox family are known to regulate the anterior/posterior axis in 
embryogenesis (Krumlauf, 1994).  Hoxa3 is expressed in the pharyngeal endoderm 
and surrounding mesenchyme from E9.5, with its anterior boundary of expression 
being the third pouch (Figure 1.3B) (Manley and Capecchi, 1995).  Hoxa3 
homozygous mutations are lethal, showing deletions of both parathyroid and thymus, 
and thyroid hypoplasia (Manley and Capecchi, 1998). 
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1.2.2.3. Pax1 and Pax9 
The paired box transcription factor genes Pax1 and Pax9, both of which are 
expressed in the third pharyngeal pouch from E9.5 (Figure 1.3), are affected by 
Hoxa3 expression (Manley and Capecchi, 1995, Neubuser et al., 1995).  Pax1 
inactivation results in a hypoplastic parathyroid and thymus, with disturbed 
thymocyte maturation (Wallin et al., 1996).  Pax9 null mutants result in the ectopic 
location of the early thymus rudiment; this is followed by failure of thymopoiesis, 
and subsequently by atrophy (Hetzer-Egger et al., 2002). 
1.2.2.4. Eya1 and Six1 
A homologue of the drosophila transcription factor gene eyes absent (Eya1) is 
present in second, third and fourth pouch endoderm and adjacent NC-derived 
mesenchyme (Figure 1.3), expressed form E9.5 until E10.5 (Xu et al., 2002).  In 
Eya1 deficient mice, thymus and parathyroid organ primodia fail to form.  
Expression of the sine oculis (Six1) transcription factor gene, also expressed in the 
above tissues, is also markedly reduced in Eya1 null mice, suggesting dependence on 
Eya1 (Xu et al., 2002).  Six1-/+ mutants lack a thymus (Laclef et al., 2003).  In 
drosophila, the homologues of Pax, Eya and Six form a pathway, which appears to be 
conserved to some degree in mammalian development.  A more recent study, 
however, has placed Pax1 downstream of Eya1 and Six1 (Zou et al., 2006). 
1.2.2.5. Gcm2 and Rhox4 
A further transcription factor, glial cells missing 2 (Gcm2), is thought to be regulated 
by the Hox-Pax-Eya-Six cascade – its expression is reduced in Pax1-/- single mutants, 
and further reduced in Hoxa3+/-Pax1-/- mutants (Su et al., 2001).  Gcm2 expression 
has also been shown to be Eya1 dependent (Xu et al., 2002).  Expressed after E9.5in 
the anterior part of the third pouch, Gcm2 marks the parathyroid-specific area 
(Gordon et al., 2001).  Gcm2 null mice lack parathyroid glands (Gunther et al.,
2000). 
Recently, the reproductive homeobox 4 (Rhox4) gene was found to be expressed in 
the third pharyngeal pouch, in a pattern complementary o Gcm2 from E9.5 until 
E11.0.  In Gcm2 null mice, Rhox4 continues to be limited to the ventral third pouch.  
Chapter 1: Introduction 
  18 
Rhox4 expression remains unaltered in Hoxa3 null mice indicating that, unlike 
Gcm2, its regulation is controlled by a means other than Hoxa3 (Morris et al., 2006). 
1.2.2.6. Foxn1 
Formerly known as winged-helix nude (Whn), the forkhead box transcription factor 
Foxn1 is present in a mutant form in Nude (nu) mice (Nehls et al., 1996).  In the nu
mouse only a rudimentary, non-functional thymus is present, with its epithelial 
compartment composed of cells seemingly in an undifferentiated state.  These cells 
appear phenotypically similar to the thymic epithelial progenitor population 
discussed in section 1.2.4.1, expressing the marker MTS24.  During normal thymus 
development, Foxn1 complements Gcm2 expression in the third pharyngeal pouch at 
E11.25 (Figure 1.3D) (Gordon et al., 2001).  Heterozyg us, nu+/- thymus lobes show 
reduced colonisation by lymphoid progenitors (Scheiff et al., 1978). 
A study by Blackburn et al demonstrated that Foxn1 acts in a cell autonomous 
manner.  Here, nu/WT chimeras were created by blastocyst complementatio  and 
some nu-derived cells were seen to contribute to the thymus.  However, these cells 
remained clustered in the medulla, in an apparently undifferentiated state, and were 
not incorporated into the WT-derived normal thymic epithelial architecture 
(Blackburn et al., 1996).  Studies involving the targeting of Foxn1 to express reporter 
genes reveal continued expression of F xn1 by TECs throughout thymus ontogeny 
(Gordon et al., 2007, Nehls et al., 1996).  It has recently been shown, by the absence 
of the cortical cell-surface marker CD205 and the cTEC-specific proteasome subunit 
β5t in the nude thymus, that the appearance of cellsexpressing cTEC markers at E12 
occurs via a Foxn1-dependent mechanism (Shakib et al., 2009).  Within the postnatal 
thymus, it appears that Foxn1 expression is necessary to maintain the thymic 
microenvironment, and its artificial down-regulation reveals a dosage-dependent 
effect on the loss of specific TEC subsets (Chen et al., 2009).   
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1.2.3. Cellular origin and interaction during thymus ontogeny 
1.2.3.1. Thymic epithelial origin 
Derivation of the thymic epithelium had, until relatively recently, been subject to a 
degree of controversy.  It was generally agreed that e medullary epithelium 
originates from the endoderm of the third pharyngeal pouch.  However, it was a 
matter of dispute whether the cortex also originated from this structure, or whether it 
in fact had an ectodermal origin in the third pharyngeal cleft, as was the traditionally 
held view. 
The dual-origin model was based primarily on a study in nude mice, in which thymus 
development is halted at the primordial stage betwen E11.5 and E12.0.  Here, in 
homozygous nu/nu embryos, proliferation of the pharyngeal ectoderm was reported 
as being greatly reduced. The authors concluded that the nude phenotype rendered 
the ectoderm unable to fulfil its role in thymus development (Cordier and Haumont, 
1980, Cordier and Heremans, 1975). 
More recent studies, however, have verified the single origin model, initially 
demonstrated by the sufficiency of pharyngeal endoderm alone to develop into a 
thymus in chick/quail chimera studies (Le Douarin and Jotereau, 1973).  In a study 
on whole mouse embryos, E10.5 pharyngeal ectoderm was labelled with tracking dye 
(Gordon et al., 2004).  Following 30 hours in whole-embryo culture, the labelled 
cells showed no sign of contribution to the resultant thymus lobes.  In the same 
study, E8.5-E9.0 second and third pharyngeal pouch endoderm was isolated and 
grafted under the kidney capsule of athymic nude mice.  This resulted in thymus-like 
structures that contained distinct cortical and medullary areas, thus verifying the 
single origin model (Gordon et al., 2004). 
1.2.3.2. Thymic mesenchymal origin 
Mesenchymal cells migrate into the pharyngeal arches from E9.0, encapsulating the 
thymus during early organogenesis.  These are neural crest (NC) derived, as shown 
in chick/quail chimera experiments (Le Douarin and Jotereau, 1975, Le Lievre and 
Le Douarin, 1975).  The requirement for NC mesenchyme in the proliferation of 
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thymic epithelium has been demonstrated, with extirpa on of cephalic NC areas in 
chick embryos resulting in thymus hypoplasia or absence (Bockman and Kirby, 
1984).  Culture of the mouse thymic rudiment minus the surrounding mesenchyme 
also results in failure of normal thymus development (Anderson et al., 1993, 
Auerbach, 1960, Suniara et al., 2000, Jenkinson et al., 2007). 
To assess NC contribution to mature thymus, lineage-tracing experiments using a 
silent ROSA26R lacZ reporter activated by myelin protein zero-Cre (Yamazaki et al., 
2005) and Wnt1-Cre (Jiang et al., 2000) reporter mice have been performed, 
labelling NC-derived mesenchyme.  Results from these studies appeared to suggest 
that, although present in large numbers in earlier organogenesis, NC contribution to 
mesenchymal structures in the mature thymus is trivial or absent. 
However, more recent studies - using Cre under the control of Wnt1 and Sox10 
promoters to reactivate silent ROSA26R-eYFP in the embryonic NC - have 
demonstrated the persistence of NC-derived cells in the adult thymus, as perivascular 
cells and in the thymic capsule (Foster et al., 2008, Muller et al., 2008).  The 
difference between these and the earlier studies using lacZ may be a result of poor 
sensitivity in the lacZ system, or perhaps age-related silencing of the lacZ gene 
(Chevalier-Mariette et al., 2003).  It remains to be confirmed as to whether or not a 
mesodermally derived mesenchyme population also contributes to thymus 
development. 
1.2.3.3. Role of mesenchyme in thymus ontogeny 
From around E11, the outer mesenchymal layer attracts haematopoietic progenitors 
as the first part of a two-step thymus seeding process, preceding their movement 
from the mesenchyme into the epithelial core (Itoi et al., 2001).  Mesenchymal cells 
penetrate the epithelial core of the thymus from the outer capsule at around E13 or 
earlier. 
The mechanisms by which mesenchymal cells affect thymus development are poorly 
understood.  Fibroblast growth factors (FGF) 7 and FGF10, produced by thymic 
mesenchyme, and their receptor FGFR2-IIb, expressed on the epithelial component, 
are thought to be involved in epithelial expansion at around E14.  FGF10 has also 
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been reported to maintain the proliferative capacity of epithelial progenitor cells in 
the pancreas (Bhushan et al., 2001).  Addition of these factors in place of 
mesenchyme in vitro can induce thymic epithelial proliferation (Jenkinson et al., 
2003, Revest et al., 2001), as can the addition of epidermal growth factor (EGF) 
(Shinohara and Honjo, 1996).  It also has been report d that, at E12, Insulin-like 
growth factors (IGF) 1 and IGF2 are expressed by thymic mesenchyme, with the 
receptor IGF1R being expressed on epithelial cells - correlating with an absence of 
FGF7 and FGF10 at this stage (Jenkinson et al., 2007).  Implication of a role for 
IGF/IGFR signalling in thymus growth would seem to agree with a study where 
over-expression of human IGF2 in mice resulted in an enlarged thymus (van Buul-
Offers et al., 1995).  Mesenchyme may also be requid in maturation of thymic 
epithelial cells, for example in inducing the expression of MHC class II (Itoi et al., 
2007, Shinohara and Honjo, 1997, Itoi and Amagai, 1998). 
1.2.3.4. Thymic vascular development 
During the early stages of thymus development, endothelial cells migrate into the 
thymus and proliferate, probably driven by angiogenic stimuli such as vascular 
endothelial growth factor (VEGF) (Leung et al., 1989).  VEGF is a permeability-
enhancing factor and an endothelial cell mitogen, and is expressed by both the TEC 
and mesenchymal cells of the developing thymus (Brooks et al., 1998, Muller et al., 
2005).  Since pericytes have been demonstrated to be a source of VEGF, it is 
possible that these migrate into the thymus ahead of endothelial cells and guide the 
sprouting process (Ozerdem and Stallcup, 2003). 
Endothelial cells are known to express platelet derived growth factor (PDGF) β, 
which attract PDGF receptor (PDGFR) β+ perivascular mesenchyme (Lindahl et al., 
1997).  These cells – pericytes and smooth muscle cel s – then proceed to wrap 
around certain blood vessels, providing support and participating in the regulation of 
endothelial cell function.  Perivascular mesenchyme has been shown to be of NC 
origin, even in adult thymus (Muller et al., 2008, Foster et al., 2008).  
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1.2.3.5. Lympho-epithelial crosstalk in epithelial development and 
differentiation 
The influence of thymocytes on the development of epith lium in the thymus has 
been termed thymic crosstalk (van Ewijk et al., 1994).  Haematopoietic progenitors 
(HPs) first invade the thymic rudiment at E11 – E11.5.  Shortly after this, the thymus 
changes from a two-dimensional to a three-dimensional structure and differences in 
expression of certain keratin molecules (described n section 1.2.1) are observed (Itoi 
et al., 2001, Klug et al., 2002). 
Observations using both RAG2/γc deficient mice (where a lack of RAG2 prevents 
TCR rearrangement, whilst a deficient γc gene precludes IL-7/IL7-R interaction) and 
Ikaros (a transcription factor required by HPs to commit to the lymphoid lineage) 
null mice showed that thymic epithelium was still able to adopt a 3-D morphology 
and also K8+K5+ and K8+K5- TEC subsets seen in the wild-type at E13.5 and E15.5 
(Klug et al., 2002).  However, when these mice were analysed at the newborn stage, 
a hypoplastic thymus was observed.  This showed similar TEC architecture to E13.5-
15.5, with prominent central K5+K8+ clusters, and absence of organised medullary 
areas (Klug et al., 2002).  Furthermore, when adult examples of these transgenic 
models were examined the thymi were seen to be severely hypoplastic, with a 
disorganised two-dimensional TEC compartment consisti g of K8+K5+ TECs only.  
Similar results were observed in adult hCD3εtg26 mice (which overexpress a human 
CD3ε transgene), where T cell development was arrested at the CD4-CD8-
CD44+CD25-, or DN1, immature stage (Klug et al., 2002, Wang et al., 1994).  
Further observations in CD3εtg26 mice showed that functional thymic epithelial 
differentiation could proceed in the absence of developing thymocytes until at least 
E15 (Jenkinson et al., 2005).  Taken together, these data indicate that TEC 
development proceeds independently of thymocyte-derived signals until E15 - 
coinciding with the appearance of CD25+ immature thymocytes. 
Observations using a range of transgenic mice have, however, illuminated the roles 
of different thymocyte developmental stages in regulating a number of subsequent 
steps in the differentiation, maturation and maintenance of various TEC types.  The 
transplantation of RAG-/- bone marrow into CD3εtg26 neonatal mice restores cortical 
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but not medullary development, with transplantation of WT BM leading to full 
restoration of the medulla also (Hollander et al., 1995, van Ewijk et al., 2000).  It has 
subsequently been shown that, in E15 CD3εtg26 mice, cTECs cannot progress 
further than the immature CD205+CD40-MHC class II- stage; RAG-/- mice, however, 
allow the appearance of CD205+CD40+MHC class II+ cTEC, demonstrating that 
thymocytes blocked in DN3 but not in DN1 are sufficient at this stage for normal 
cortex development (Shakib et al., 2009). 
In medullary development, a defective phenotype lacking discrete medullary areas is 
observed in mice lacking TCR genes (TCRα null mouse, or the TCR-/- severe 
combined immunodeficiency (SCID) mouse) (Palmer et al., 1993, Shores et al., 
1991).  However, this can be rescued following addition of TCR+ haematopoietic 
cells to SCID mice (Shores et al., 1991).  In furthe  BM-reconstitution work using 
SCID mice, medullary foci (MTS10+) were seen to develop in parallel with 
CD4+CD8- thymocytes (Penit et al., 1996).  Expansion of these initially small 
medullary islands at E18.5 and their maturation and maintenance is strongly 
correlated with the appearance of mature SP thymocytes (Irla et al., 2008). In 
addition, when RFTOC from E16.5 fetal thymi were grafted into RAG2-/-/MHC class 
II -/- mice, normal thymus architecture was obtained, indicating the sufficiency of 
host-derived CD3-CD4-CD8- TN immature thymocytes to drive medullary formation 
(Rodewald et al., 2001).  Further analysis of lympho-epithelial crosstalk in the 
medulla has revealed that initial induction of CD80-Aire- mTECs to produce 
CD80+Aire+ cells may be mediated by RANK signalling from CD4+CD3- lymphoid 
tissue inducer cells (Rossi et al., 2007b).  
One means through which lympho-epithelial crosstalk is mediated is that of 
lymphotoxin β receptor (LTβR, a member of the TNF receptor family) signalling 
(Boehm et al., 2003).  In LTβR-/- mice or aly/aly mice (which posses a mutant 
nuclear factor-κB-inducing kinase (Nik) that acts downstream of LTβR), 
components of this pathway are removed - leading to aberrant, disorganised 
medullary morphology.  A similar pattern is acquired when LTβR ligands are 
blocked from interacting with their receptor following injection of WT mice with 
soluble LTβR (Boehm et al., 2003).  Transplantation of WT BM into these 
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transgenic mice failed to restore normal medullary rchitecture, mapping the defect 
in signalling to the epithelial compartment.  Numbers of mTEC in these altered 
thymi were significantly reduced when compared to WT, and accompanied by a 
proportional increase in CD4+ and CD8+ SP thymocytes (Boehm et al., 2003).  
Additional studies investigating other components of the lymphotoxin pathway such 
as RelB or NF-κB have observed decreased TRA expression in the medulla and 
autoimmune phenotypes (Fletcher et al., 2009, Gray et al., 2006, Seach et al., 2008, 
Valero et al., 2002).  Together, these data show that LTβR signalling is critical for 
normal medullary differentiation and function. 
1.2.4. Thymic epithelial lineage 
1.2.4.1. Identification of thymic epithelial progenitors 
Evidence suggests that epithelial cells are already specified to the thymus lineage 
prior to formation of the thymic rudiment, due to the ability of isolated and 
transplanted pharyngeal pouch endoderm to develop int  a thymus, both in mammals 
and birds, as mentioned earlier (Gordon et al., 2004, Le Douarin and Jotereau, 1973).  
Various studies have investigated the nature and identity of the epithelial progenitors 
involved in the development of the thymus from this early stage through ontogeny. 
The existence of a bipotent thymic epithelial cell (TEPC) was initially proposed on 
the basis of the existence of TEC expressing cTEC and mTEC markers.  The markers 
4F1 and IVC4, markers of cortex and medulla respectiv ly, are co-expressed in 
E10.5 third pouch endoderm (Kanariou et al., 1989).  Furthermore, in vitro culture of 
harvested embryonic TECs has shown consistent, small populations of cells 
expressing both cTEC and mTEC markers; however, these are not followed up by 
functional studies (Cirne-Lima et al., 1993, Ropke et al., 1995).  Observations from 
thymic epithelial tumours (both in the mouse and the human) also lent some support 
to the common TEPC hypothesis, as many contain cells that predominantly co-
express markers of cortical and medullary TECs in addition to containing 
differentiated subpopulations of each (Schluep et al., 1988, Von Gaudecker et al., 
1997). 
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Subsequently, a rare population of K5+ 8+ cells were observed in WT adult thymus 
(Klug et al., 1998).  All TEC were K5+K8+ in the hypoplastic thymus of newborn 
hCD3εtg26 mice, but were able to give rise to K5- 8+ cTEC upon ectopic 
transplantation into RAG-/- mice, identifying K5+K8+ cells as a potential progenitor 
population, at least for cTEC (Klug et al., 1998).  It was speculated that, since they 
co-expressed markers for the predominantly single-positive K5+K8- mTEC and K5-
K8+ cTEC compartments seen in the mature organ, K5+K8+ TECs may represent an 
unrestricted bipotent progenitor (Klug et al., 1998). 
In the nude thymus rudiment, developmentally arrested TECs in a seemingly 
undifferentiated, progenitor state were found to stain with the monoclonal antibodies 
MTS20 and MTS24 (Blackburn et al., 1996).  It was proposed, and subsequently 
shown, that these antibodies (both of which have rec ntly been shown to recognise 
the same antigen – Plet-1 (Depreter et al., 2008)) identify a population of progenitor 
cells in the WT fetal thymus.  This TEPC population is sufficient to form a fully 
functional thymus upon ectopic transplantation (Bennett et al., 2002, Gill et al., 
2002).  In the two studies that demonstrated this, dissociated Plet1+ cells from either 
E12.5 or E15.5 thymus were isolated by flow cytometric sorting, reaggregated in 
vitro, and grafted under the kidney capsule of nude or congenic recipient mice 
respectively (Bennett et al., 2002, Gill et al., 200 ).  These were able to generate a 
functional thymus displaying normal cortical and medullary architecture and, as 
demonstrated in the immuno-compromised nude mouse transplants, support 
development of a full complement of T cells, both in the periphery and the thymus 
itself (Bennett et al., 2002).  In both these studies, reaggregates made using 
comparable numbers of Plet1- cells were unable to reconstitute a functional thymus 
when subjected to identical transplantations in these studies (Bennett et al., 2002, 
Gill et al., 2002).  Unfortunately, neither of these tudies confirmed the epithelial 
percentage of their sorted Plet1- ‘TEC’ populations by using a definitive epithelial 
marker.  Indeed, it is now realised that the majority of the sorted Plet1- cells used in 
the E12.5 grafting study were mesenchymal.  Importantly, however, grafted Plet1+ 
cells showed improved ability to generate functional thymus over dissociated and 
reaggregated whole thymus (Bennett et al., 2002).  In the E15.5 study, ‘TECs’ were 
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selected on the basis of MHC class II expression, which would exclude mesenchymal 
cells but also a proportion of TECs (Gill et al., 200 ). 
Differences in the expression of certain markers suggest a phenotypic progression of 
the Plet1+ population between E12.5 and E15.5.  Lack of MHC class II expression 
and co-expression of K5 and K8 in TEPCs at E12.5 suggests an undifferentiated, 
unrestricted progenitor cell type (Bennett et al., 2002).  By E15.5, most Plet1+ cells 
are MHC class II+, and co-express K5 and K8 more rarely, indicating a more mature 
TEPC population (Gill et al., 2002).  Also at E15.5, a small subset (~5%) expressing 
UEA-1– a marker of a distinct mature mTEC group – is identifiable, suggesting a 
lineage restriction or change in potency in at least p rt of the TEPC population (Gill 
et al., 2002). 
1.2.4.2. Does a common TEPC exist? 
Although the above studies demonstrated the existence of a pool of thymic epithelial 
progenitors, it is not yet clear to what extent during fetal development these represent 
a homogenous population retaining the capacity to each generate cortex and medulla, 
or whether a mixed population is present with pre-restricted potential for cTEC and 
mTEC (Figure 1.4).  The studies above were performed at population level, showing 
the potential of a group of cells, rather than at the clonal level where the potential of 
a single cell is examined, and co-expression of comm n markers cannot alone be 
used as evidence to support the existence of a common TEPC.  
Evidence pointing toward divergence to a lineage specific progenitor, at least in the 
medulla, has been shown in studies using MHC-mismatched blastocyst/embryonic 
stem (ES) cell chimeras (Rodewald et al., 2001).  At two weeks postnatally, it was 
observed that MTS10+ medullary areas arose consisting of one or more ‘clonal’ islets 
- exhibiting either blastocyst or ES cell, but not mixed, origin.  The identity of 
surrounding cortex was shown not to correlate with the origin of these medullary 
islets (Rodewald et al., 2001).  The nature of fetal medullary development was also 
investigated, with similar results.  E16.5 thymus lobes from MHC-mismatched 
mouse embryos were dissociated, CD45+ haematopoietic cells were removed by flow 
cytometry and the remainder reaggregated.  In contrast o reaggregated fetal thymic 
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organ culture (RFTOC) allowed to develop in vitro, grafted RFTOCs demonstrated 
organised medullary areas.  Once again, these occurred as islets of uniform MHC 
class II identity, implying the ability of some E16.5 TECs to function as medullary 
progenitors (Rodewald et al., 2001).  These experiments appear to demonstrate that, 
from at least E16.5, a population of medullary thymic epithelial progenitors 
(mTEPCs) exists with the ability to locally expand and generate areas of MTS10+ 
medullary epithelium.  However, these data do not rule out the continued existence 
of a common TEPC, and furthermore do not address mechanisms of generation of 
cortex, or of maintenance of cortex or medulla postnatally. 
Recent work has shown that a discrete subset of fetal progenitor cells gives rise to 
Aire-expressing mTECs.  These progenitors were identifi d as claudin (cld) 3,4hi 
UEA-1+ in E13.5 thymus (Hamazaki et al., 2007).  Initially located at the apical layer 
of the E10.5 bilayered thymic rudiment, Cld3,4hi cells form a predominantly MTS10+ 
central cluster by E12.5.  By E13.5, expression of Cld3,4 occurs in small clusters 
throughout the thymus; and it is within a subpopulation of these cells that UEA-1 is 
first expressed.  At later fetal stages, Cld3,4+MTS10+ clusters were surrounded by 
CLd3,4-MTS10+ TECs; and by the newborn stage, Cld3,4+ TECs were MTS10-, and 
were scattered throughout the medulla (Hamazaki et al., 2007).  Reaggregation and 
grafting of E13.5 Cld3,4hi TECs has revealed a medullary-only potential, with those 
also expressing UEA-1 showing an ability to give rise to Aire+ TECs.  In contrast, 
the Cld3,4loUEA-1- TEC population showed bi-potential ability for cortex and for 
medulla, some of which were also Aire+ (Hamazaki et al., 2007).  It has been shown, 
from BrdU incorporation studies, that Aire+ mTECs (mostly K14+K8+) are a post-
mitotic population in the steady-state adult thymus, with a high rate of turnover 
(Gray et al., 2007a).  Expression of p63 (required n maintaining a high proliferative 
potential in epithelial cells of both epidermis and thymus) and Aire have been found 
to be mutually exclusive in mTECs (Candi et al., 2007, Dooley et al., 2008, Senoo et 
al., 2007).  This evidence, in conjunction with theappearance x vivo of MHC class 
IIhi Aire+ cells from isolated MHC class IIlo Aire- mTECs suggest a precursor/product 
relationship (Gray et al., 2007a).  
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A very recent study suggests that thymic cortex develop in a stepwise fashion, with a 
proliferating CD205+CD40-MHC class II- population producing non-proliferating, 
CD205+CD40+MHC class II+ fully differentiated cells.  CD205 expression was 
detected as early as E12, with CD40 expression acquired at around E14-15 (Shakib 
et al., 2009). 
Whilst the work in this thesis was in progress, two studies were published that have 
used lineage-tracing analysis to address the question of whether a common thymic 
progenitor exists.  The first of these examined thepotential of TEPCs from 
embryonic thymus (Rossi et al., 2006).  E12.5 thymus lobes from mice constitutively 
expressing yellow fluorescent protein (eYFP) were dissociated, and TECs were 
isolated by flow cytometric sorting on the basis of EpCAM (a pan-epithelial marker 
in fetal thymus) expression.  Cells from this EpCAM+, eYFP+ population were 
shown to be predominantly Plet1+.  Single eYFP+ cells were then microinjected into 
E12.5 thymus primordia removed from wild-type mice, and subsequently allowed to 
develop for 4 weeks following kidney capsule transplantation.  Of 13 transplants, 4 
were recovered that showed surviving eYFP+ cells.  Each of these displayed eYFP+ 
mTEC (MTS10+K5+) and eYFP+ cTEC (Ly51+K18+) (Rossi et al., 2006).  This 
would appear to be the best evidence yet for the existence of a bipotent TEPC at 
E12.5, however attempts in our lab to repeat this have been unsuccessful and have 
only produced eYFP+ cTECs (A. Farley, unpublished).  
The second of these recent works used non-invasive lineage tracing to follow the fate 
of genetically marked TECs (Bleul et al., 2006).  As a cellular marker, a mouse 
harbouring a silent eYFP gene under the control of the ubiquitous ROSA26 locus 
(Rosa26R-eYFP) was used.  To achieve Cre-mediated deletion and eYFP expression, 
the Rosa26R-eYFP line was mated with hK14::Cre-ERT2 mice.  The latter enables 
the production of Cre-recombinase, by tamoxifen induction, in cells expressing the 
human keratin 14 (hK14) promoter.  However, in these xperiments the ‘leaky’ 
nature of Cre-ERT2 was exploited to generate a very low level of non-induced 
expression.  Therefore, in rare cells in the neonatal thymus, eYFP was activated as a 
heritable marker (Bleul et al., 2006).  In 58 thymus lobes taken 14 days postnatally 
(P14) from 29 pups, 21 clusters of eYFP+ cells were observed.  Of these, 1 was 
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cortex-only, 4 were medulla-only, and 16 were comprised of mTECs and cTECs 
spanning the CMJ.  9 singly occurring cTECs were also found.  10 newborn mice 
(P0) displayed no eYFP+ cells, indicating that the majority of these seen in P14 mice 
originated in postnatal TEPC (Bleul et al., 2006).  These data strongly suggest that in 
the postnatal thymus, active progenitor cells with bi-potent and medulla-only ability 
are present.  It is not known, however, whether the mTEC- or cTEC-only clusters 
seen occurred downstream of the common TEPC, or whether they derive from a 
separate cell type.  The sample-size of this analysis was small, and since the activity 
of the hK14 promoter has not been fully characterised in developing thymus and 
third-pouch endoderm, it is impossible to say whether recombination could have 
occurred in all TECs. 
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Figure 1.4 Models of thymus cortical and medullary lineage divergence 
Two prospective modes of TEC lineage divergence are shown.  At one extreme (A), 
thymic epithelial progenitor cell (TEPC) diverge shortly after thymic identity is 
assigned to cells in the early endoderm, into separate medullary (mTEPC) and 
cortical (cTEPC) lineages.  At the other extreme (B), a population of common 
TEPCs is maintained until shortly before terminal differentiation.  A likely scenario 
would be somewhere in between these two models - a common progenitor persists 
from thymus specification in the early endoderm through to early organogenesis, and 
subsequently gives rise to distinct mTEC and cTEC lineages. 
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1.3. Thymic involution and regeneration 
The process of thymic involution, or atrophy, is a consequence of an ageing immune 
system, where profound changes in thymus anatomy lead to a progressive reduction 
in its size.  This is due to loss of epithelial cells, and an accompanying decrease in 
thymopoiesis – the thymus of a 24-month-old mouse contains less than 1% of the 
number of thymocytes found in the newborn thymus (Taub and Longo, 2005).  The 
aged thymus is, however, able to continue T-cell differentiation, but at a heavily 
reduced capacity (Sempowski et al., 2002).  Thymic involution involves an 
organisational collapse of the cortical epithelium, loss of a distinct cortico-medullary 
junction, and a decline in the number and proportion of mTECs (Sutherland et al., 
2005, Gray et al., 2006).  This is accompanied by an increase in adipose tissue within 
the thymus, even though the overall size of the organ reduces (Taub and Longo, 
2005).  The mechanisms responsible for age-related thymic involution are poorly 
understood, although several reasons have been hypothesised, including: a decline in 
HP cells migrating into the thymus from the bone marrow; loss of certain thymic 
stromal cells; changes in levels of cytokines, hormones or growth factors; or 
alterations in productive TCR rearrangement (Taub and Longo, 2005).   
It has been seen that regeneration of both structure and function can occur in the aged 
(18-24 month old) thymus of mice following ablation of sex steroids, either by 
castration or by chemical means (Gray et al., 2006, Sutherland et al., 2005).  An 
increase in firstly MHC class IIhi mTECs followed by MHC class IIlo mTECs is 
observed in response to castration (Gray et al., 2006). 
A recent study has demonstrated the ability of a single cell to give rise to a functional 
thymic microenvironment postnatally (Bleul et al., 2006).  Here, a Cre-mediated re-
activateable Foxn1 null allele was created (Foxn1SA2); exhibiting a hypoplastic 
thymus comprised of developmentally arrested TECs (see section 1.2.2.6).  This was 
paired with the hK14::Cre-ERT2 allele which, as described earlier in section 1.2.4.1, 
can express Cre-recombinase in epithelial cells.  This strain causes a low level of 
deletion in the absence of tamoxifen induction of Cre.  In some resultant 
Foxn1SA2/Foxn1SA2; hK14::Cre-ERT2 mice, single infrequent TECs were shown to 
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spontaneously regain Foxn1 expression and give rise to a functional thymic 
microenvironment with distinct cortical and medullary areas (Bleul et al., 2006).  
However, these cells cannot be equated with WT postnatal/adult TECs, due to the 
abnormal thymus development in these transgenic mice.  Nor can it be conclusively 
proved that the TECs reactivated here in the Foxn1SA2 thymus are equivalent to those 
found in the embryo, prior to developmental arrest ulting from Foxn1 absence. 
It may be that a thymic stem cell population, persisting even after thymic involution, 
occurs.  A comparatively high proportion of Plet1+ TECs are observed in aged mice - 
this is seen to decrease as the number of TECs in the thymus grows following sex 
steroid ablation (Sutherland et al., 2005).  However, these have not been functionally 
studied and it may be that thymic regeneration occurs via replication of differentiated 
cells (as has been observed in the pancreas (Dor et al., 2004)). 
Confirmation and identification of a postnatal thymic stem cell population would be 
of great interest to medical science.  If it proved possible to (re)activate these cells, 
either in vivo or after isolation, it may lead to the ability to regenerate a fully 
functional thymus.  This would be of particular use to immuno-compromised 
individuals (such as the elderly, AIDS patients, or those on immunosuppressant 
medication) where the functional T cell repertoire would be reduced.  
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1.4. Aims 
The primary aim of this project was to address the debate on the point of divergence 
of the cortical and medullary epithelial lineages, and to assess the longevity and 
contribution of a putative bipotent TEPC, as discused in section 1.2.4.2.  To answer 
these questions, various methods of developmental aalysis were considered. 
1.4.1. Methods of developmental analysis 
A key area of study involves resolving the origins of given tissues with regard to the 
position and phenotype of the progenitor cells from which they are derived.  
Conversely, the developmental potential, proliferative capacity, and migrational 
abilities of an identified group of cells are also of interest.  A variety of methods exist 
by which answers to these questions can be found experimentally.   
To answer questions involving the potential of a particular area in the early embryo, 
such as the neural crest, somites, or central nervous system, chick/quail chimera 
experiments have proved successful.  Sections of quail tissue can be surgically 
removed, grafted into the corresponding location in a chick embryo, and allowed to 
develop.  The position of quail-derived cells can then be ascertained due to 
differences in staining properties in the nuclei when compared to chick cells (Le 
Douarin, 1974).  This method has several drawbacks, however, with issues of 
concern including effects of wound healing following surgical intervention, and 
inter-species differences. 
Fluorescent dyes have also been widely used to identify the contribution of different 
regions of cells, with a variety of applications.  In the most basic approach, dye can 
be spotted onto a particular area of cells, whose progress during development can be 
followed.  This method has been previously employed in thymus studies, to 
determine that labelled pharyngeal ectoderm did not con ribute cells to the formation 
of thymic cortex (Gordon et al., 2004).  Dye-labelling has a number of limitations.  
Firstly, the required embryo manipulation may disturb normal development.  This 
particularly applies to mammals, as embryos usually must be subsequently cultured 
ex utero, limited to 48h or less after E6 in the mouse (Petit et al., 2005).  Another 
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limitation of the dye-labelling method is the effect of dilution, resulting in decreased 
detection of labelled cells after only a small number of cell divisions. 
If the population of cells being studied exhibits expression of a known unique gene, 
then the Cre/LoxP recombination technique can be used.  A tissue-specific promoter 
can drive Cre recombinase production, initiating permanent heritable expression of a 
reporter gene such as GFP or LacZ via genetic recombination (Sauer, 1998).  This 
method has been widely used in a variety of tissues, but has the difficulty of 
requiring transgenic animals to be generated.  Another issue is that an identified gene 
expressed under a defined promoter region, and restrict d to the tissue of study, is 
needed.  Such candidates are known at the appropriate stage of development in many 
tissues.  It is possible to temporally regulate Creexpression if the promoter of choice 
is expressed in different tissues at different times, enabling the investigator to have 
some control as to both where and when any genetic r combination occurs 
(Danielian et al., 1998).  The Cre/LoxP system has t e advantage of not requiring 
surgical intervention or embryo manipulation.   
To unambiguously determine the properties and fate choices of individual cells 
within populations labelled using any of the above m thods, analysis at clonal 
resolution is required, i.e. labelling or functional testing of a single cell.  Clonal 
progeny can be tracked either by the injection of cellular markers, such as dye, or by 
genetic modification to induce expression of a repoter gene in the descendants of 
that cell.  These methods of labelling, where the experimenter selects the initial cell, 
are known as prospective clonal analysis.  Aside from the drawbacks of ex utero 
embryo manipulation mentioned above, prospective clonal analysis has the limitation 
of not being objective.  Since the investigator selects the initial labelled cell, there is 
the distinct possibility that not all cells within the population being investigated will 
be labelled.  Even if the experiment is carried outmany times, certain cells may 
never undergo labelling due to small size, awkward position or human error. 
To overcome these caveats, retrospective clonal analysis can be undertaken.  This 
involves any single cell within the embryo or tissue being genetically labelled at 
random.  The label is passed on to all clonal progeny from this cell, to be observed at 
a later stage in development.  One technique uses recombinant retroviruses (RRV) to 
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infect embryonic cells, introducing a reporter gene that randomly integrates into the 
host genome (Cepko et al., 1998, Sanes et al., 1986).  Due to this random integration, 
only a tiny number of infected cells are able to expr ss the reporter gene – an ability 
that is stably transmitted to their descendants.  The RRV lacks the proper machinery 
to enable formation of new viruses, hence does not posses the ability to cause 
secondary infection.  This means the investigator has temporal control over any 
initial labelling events, for example with the timing of the intra-uterine injection of 
the RRV in the mouse.  There is, however, potential for this injection to damage 
embryos.  Problems involving non-uniform accessibility of all cells to the RRV, 
combined with an inability to infect cells that are not currently replicating, do not 
make this an ideal technique. 
Retrospective clonal analysis can also be performed using the laacZ system, as 
described below. 
1.4.2.  The laacZ system 
The laacZ system is based on expression of the lacZ gene from Escherichia coli, 
which encodes the β-galactosidase enzyme.  Cells expressing lacZ can be identified 
histologically by addition of X-gal substrate, resulting in generation of an 
intracellular blue precipitate (Figure 1.5).  In the laacZ system, this gene has been 
modified by duplicating an internal section of the coding sequence, resulting in the 
appearance of premature stop codons as shown in Figure 1.5.  LaacZ produces a non-
functional, truncated version of β-galactosidase (Bonnerot and Nicolas, 1993). 
However, the ability to generate functional β-galactosidase can be regained.  The 
DNA double stranded break repair mechanism in cells can result in intragenic 
homologous recombination.  If a double stranded break occurs within the DNA of 
the duplicated region of laacZ, the correct open reading frame required for 
functional, full-length β-galactosidase production can be re-established.  This 
recombined sequence is subsequently inherited by all descendants of the cell in 
which it occurred, enabling them to be traced retrospectively (Figure 1.6). 
The spontaneous recombination of laacZ is an extremely rare event, with a constant 
rate of occurrence, and proportional to the size of the duplication.  Ideally this will 
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result in a frequency where, if any LacZ+ cells are observed, they can be reasonably 
assumed to be clonal, i.e. to originate from a single recombination event. 
LaacZ retrospective clonal analysis has been successfully employed to study the 
development of a number of tissues, usually in combination with tissue-specific 
promoters.  Hence, although laacZ recombination can happen elsewhere in the 
embryo, β-galactosidase expression and therefore clone visualisation occurs only in 
the tissue of interest.  Such studies have taken place in myotome, under control of the 
promoter of the α subunit of the acetylcholine receptor (αAChR) (Nicolas et al., 
1996), the central nervous system using a neuron-specific enolase (NSE) promoter 
(Mathis et al., 1997), and myocardium with the α-cardiac actin promoter (Meilhac et 
al., 2003).  A mouse model where laacZ is under the control of the ROSA26 
promoter has also been engineered (Tzouanacou et al., 2009).  ROSA26 is 
constitutively expressed, therefore giving the potential for clones to be detected in 
any possible cell lineage during development (Friedrich and Soriano, 1991, 
Zambrowicz et al., 1997, Soriano, 1999).  The laacZ gene used in these systems is 
preceded by a nuclear localisation sequence (NLS), allowing specific labelling of the 
nucleus and making resolution of individual cells ea i r.  
Information regarding phases of cell growth can be deduced upon examination of the 
arrangement of cells in a clone (Figure 1.7).  For example, a clone where all cells are 
grouped in a tight cluster points to a coherent mode f growth, whereas cells that are 
widely separated would indicate a phase of dispersiv  growth.  Sometimes 
observation of larger clones may point to more than one distinct growth phase; for 
example a clone with several separated clusters could mark an initial dispersive 
growth phase involving older progenitors, followed by a more recent coherent 
growth phase.  This has been observed previously, for example in myocardial cells of 
the embryonic mouse heart (Meilhac et al., 2003).  Data on orientation of clones can 
reveal other characteristics of cell growth, for example isotropic growth versus 
orientated growth along/perpendicular to an axis. 
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Figure 1.5 Generation and operation of the laacZ gene 
The lacZ gene expresses β-galactosidase, reacting with X-gal substrate to produce a 
blue colour within the cell (A).  To create the laacZ gene, a duplication of part of the 
open reading frame was created (B).  This results in a premature stop codon, and a 
truncated, non-functional version of β-galactosidase that cannot process X-gal (C).  
A rare homologous recombination event can excise the duplicated segment, restoring 
functional activity of lacZ (D).  (Picture from Sanes, 1994). 
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Figure 1.6 Inheritance in the laacZ labelling system 
All cells in all lineages harbour the silent laacZ reporter gene.  Spontaneous 
homologous recombination can occur at any stage during development, with those 
occurring earlier in development having the potential to label a larger population 
(long clone) than those occurring later (short clone).  Upon examination of the 
embryo, histological staining determines the size and location of the clone, enabling 
information on lineage to be deduced. (Picture modifie  from Petit et al., 2005). 
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Figure 1.7 Clonal modes of growth 
The growth of a structure generally combines several g owth behaviours (clonal 
modes).  Top line: Elementary clonal modes.  A) Isotropic-coherent growth.  B) 
Oriented-coherent growth.  C) Isotropic-dispersive growth.  D) Oriented-dispersive 
growth.  Bottom line: Examples of growth patterns where different clonal modes 
occur in succession.  Adapted from Petit et al, 2005. 
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1.4.3. Project strategy 
In this project, it was decided to use laacZ retrospective clonal analysis to gain 
information on fate decision, during thymic epithelial lineage development.  As 
stated above, laacZ-lacZ recombination, and thus clone generation, occurs at a 
known frequency.  Two variants of the laacZ gene have been constructed, containing 
different intragenic duplication sizes and therefor different recombination 
frequencies.  Ideally, the laacZ system should be optimised such that there is a low 
likelihood of multiple clones occurring in a single tissue sample and thus confusing 
cellular relationships.  This likelihood can be calculated if the number of cells in the 
tissue of study is known, along with the laacZ recombination frequency. 
Thus, determination of TEC numbers throughout ontogeny would enable calculation 
of the number of TEC clones likely to occur in a single thymus lobe, enabling me to 
choose an appropriate combination of laacZ duplication size and thymic 
developmental stage.   
In Chapter Three, therefore, I determined the size of the TEC (lin-EpCAM+) 
population from E12.5 until E17.5.  Due to the lack of quantitative data on all thymic 
cell populations, I also determined the absolute number of haematopoietic (CD45+), 
mesenchymal (lin-PDGFRα+ and/or lin-PDGFRβ+) and endothelial (lin-CD31+) cells 
present.   
In Chapter Four, I went on to examine the TEC population in more detail, focussing 
on the developmental kinetics of the Plet1+ population.  I determined the absolute 
number of Plet1+ TECs from E12.5 to E17.5, and examine modes of prolife ation in 
these cells.  From these collective data, I proposed a model for the role of the Plet1+ 
population in thymus development. 
In Chapter Five, I outline strategies to analyse and interpret the library of prospective 
TEC clones.  I calculated the number of TEC lacZ+ clones expected to be present 
throughout thymus ontogeny for each laacZ mouse genotype, selecting an 
appropriate developmental stage/duplication size combination for analysis.  I 
attempted to compile a library of thymus epithelial clones, from an extensive analysis 
of fetal thymic lobes.  However, although I observed several clones of apparent 
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mesenchymal origin, supporting a single origin for intrathymic and capsular 
mesenchyme at E15.5, I observed no TEC clones.  I describe my extensive attempts 
to optimise the sensitivity of detection of lacZ+ cells, and conclude that the 
ROSA26laacZ system is unsuited to clonal analysis of the thymic epithelium, at least 
in the stages of development under examination.  The CpG content of the ROSA26 
promoter suggests a possibility of methylation-induced silencing brought about by de
novo methylation of the lacZ reporter gene. 
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Chapter 2. Materials and Methods 
2.1. Materials and solutions 
Unless stated otherwise, all materials used in this the is were obtained from Sigma, 
Invitrogen, Gibco or BDH. 
Thymus dissociation mixture: 
 1.4 mg/ml hyaluronidase 
 0.7 mg/ml collagenase 
 0.05 mg/ml deoxyribonuclease I 
 Made up in PBS 
FACS wash (100 ml): 
 5 ml foetal calf serum 
 95 ml PBS 
1xDPBS (1 L): 
 0.2 g KCl 
 0.2 g KH2PO4 
 8.0 g NaCl 
 2.16 g Na2HPO4•7H2O (pH 7.2 - 7.4) 
X-gal-wash: 
 0.1 M phosphate buffer (pH 7.3) 
 2 mM MgCl2 
 0.1% sodium desoxycholate 
 0.02% NP-40 
 0.05% BSA 
X-gal-stain: 
 Made up in X-gal wash mixed with: 
 0.024% spermidine 
 5 mM K3FE(CN)6 
 5 mM K4FE(CN)6 
 0.0014% NaCl 
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 2.5 mM X-gal 
 0.1% DMF 
X-gal-fix: 
 0.1 M phosphate buffer (pH 7.3) 
 0.2% glutaraldehyde 
 2 mM MgCl2 
 5 mM EGTA 
2.2. Mice 
Animals were housed within the Division of Biological Sciences Animal Facility at 
the University of Edinburgh under conditions outlined in the Animals (Scientific 
Procedures) Act 1986.  Mice were housed in a stabilised environment with a 12-hour 
light/dark cycle and supplied with food and water ad libitum.  Adult mice were 
sacrificed by the schedule 1 method of cervical dislocation. 
2.2.1. Embryonic thymus collection 
For timed matings, male and female mice were placed together overnight, and 
females were examined the following morning for thepr sence of a vaginal plug.  
This was taken as time point E0.5.  Females were sacrificed at the desired stage of 
pregnancy, whereupon the uterine horns were removed and placed in PBS.  Embryos 
were subsequently removed from the uterus and transferred to clean PBS, where they 
were sacrificed by decapitation.  Thymus lobes were then removed from embryos 
and dissected of excess extrathymic tissue with the aid of a microscope.  
In results Chapter Three, wild-type embryos were from crosses between males of the 
CBA strain and females of the C57BL/6 strain.   
In results Chapter Five, all mice were kindly supplied by the lab of Val Wilson 
(Institute for Stem Cell Research, University of Edinburgh).  R26laacZ0.3 and 
R26lacZ mice were created by Elena Tzounacou at this location.  R26laacZ1.1 mice 
were also created by Elena Tzounacou, in the lab of Jean-François Nicolas (Pasteur 
Institute, Paris). 
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2.3. Flow cytometry 
2.3.1. Cell Preparation 
Embryonic thymus lobes were completely dissociated by incubation in dissociation 
mixture (DM) (see section 2.1) at 37°C, followed by 0.025% trypsin at37°C, for the 
minimum time required to produce a single cell suspen ion.  Lobes in DM were 
gently pipetted up and down using a 1 ml tip every 5 minutes.  E15.5 - E17.5 lobes 
were incubated for 15 minutes in DM, followed by 5 minutes in 0.025% trypsin.  
E13.5 & E14.5 lobes were incubated in DM for 10 mins i  DM & 3 mins in trypsin.  
E12.5 lobes were incubated in DM for 10 mins and trypsin for 1 minute.  Cells were 
pelleted by spinning at 1200rpm for 5 mins in a chilled (4ºC) benchtop centrifuge 
[Heraeus Labofuge 400R] and resuspended in FACS wash, before being counted 
using a haemacytometer. 
2.3.2. Antibody staining 
Cells in a suitable volume of FACS wash were incubated on ice with primary 
antibody for 20 min, in 5ml FACS tubes [Falcon].  Cells were washed in FACS wash 
and then incubated for 20 min with secondary antibody if required.  Where 
intracellular antigens were analysed, cells were fix d and permeabilised using Fix 
and Perm kit [Caltag Laboratories] prior to incubation with antibodies.  Following 
staining, cells were pelleted and resuspended in FACS wash, containing 1:25 7AAD 
[BD Bioscience] or 1:2000 ToPro3 [Molecular Probes] as viability markers if 
required.  All antibodies used are detailed in Table 2.1. 
2.3.3. Isotype controls 
Isotype controls were used where stated.  These are non-specific antibodies of the 
same class as the primary antibody used (e.g. IgM, G2a), and raised in the same 
species (e.g. rat, donkey), as listed in Table 2.1. Isotype controls correspond to 
whether a primary antibody/fluorophore direct conjugate, a biotinylated primary 
antibody, or an unlabelled primary antibody in combination with a fluorescently 
labelled secondary antibody were used.  All isotype control antibodies were 
purchased from BD Pharmingen, apart from Rabbit IgG [Zymed]. 
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2.3.4. Flow cytometric cell sorting and analysis 
Cell sorting was performed on a MoFlo [Dakocytomation] into ice-cold FACS wash, 
using isotonic sheath fluid.  Cell analysis data was acquired on a FACSCalibur [BD 
Bioscience] using CellQuest software [BD Bioscience]. Combinations of single-
stained and fluorescence-minus-one (FMO) controls were used to set up cross-
channel compensation.  Downstream sample analysis was performed using FlowJo 
software [Treestar Inc].  Where isotype controls are used to set positive/negative 
fluorescence thresholds, gates are set to give 1% positive staining on isotypes.   
2.4. Immunofluorescence 
2.4.1. Frozen section preparation 
Tissue was embedded in OCT compound [Tissue Tek, Miles Inc., USA], snap frozen 
on dry ice and stored at -80°C.  Prior to sectioning, frozen tissue in OCT blocks was 
placed in the cryostat chamber [Leica CM1900] and allowed to equilibrate to -20°C 
for 30 mins.  Sections were cut at 7µm and collected onto poly-L-lysine coated glass 
slides [VWR International].  Sections were air-drie at RT for 20 mins, fixed in 
100% acetone at -20°C for 2 mins and air-dried for a further 20 mins.  Slides were 
then stored at -80°C prior to use.   
2.4.2. Cytospin Preparation 
5-10,000 cells suspended in 100µl of PBS were loaded into a cytospin chamber 
including a poly-L-lysine coated glass slide [VWR International] and a filter card 
[Thermo].  Samples were centrifuged at 1,000rpm [Cytospin 3, Shandon] for 5 mins 
at RT.  Slides were removed from the cytospin chamber and air-dried for 2 mins, 
then fixed in 100% acetone at -20°C for 2 mins.  Following fixation, slides were air-
dried for a further 2 mins and stored at -80°C prior to use. 
2.4.3. Antibody staining of slides 
Frozen, fixed samples on slides were allowed to air-dry for 5 mins.  The area 
immediately surrounding each section was marked using a PAP pen [Daido Sangyo].  
Slides were then rinsed briefly in PBS, prior to blcking for 15 mins with 5% serum 
in PBS.  The species from which the serum was obtained was the same in which the 
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secondary antibody was raised, in order to minimise non-specific antibody binding.  
Slides were then incubated with primary antibody in PBS, for 1 hour at RT, followed 
by 3 x 5 minute washes in PBS containing 0.1% Tween 20 (PBST).  This was 
followed by incubation with fluorophore-conjugated secondary antibody and DAPI, 
in PBS, for 30 mins at RT in the dark.  A further 3 x 5 washes in PBST were 
performed, also in the dark, before rinsing with water and mounting in either 
glycerol/water or Vectashield Hardset mounting medium [Vector Labs].  To check 
for non-specific staining, isotype controls were usd (see section 2.3.3).  Sources and 
isotypes of antibodies used are detailed in Table 2.1. 
2.4.4. Imaging 
For immunofluorescence detection and image capture, slides were examined using a 
Leica AOBS confocal microscope under the excitation c ditions appropriate to the 
fluorophores used.  Images were subsequently processed with Adobe Photoshop CS. 
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Table 2.1 Antibody clones, isotype and source 
Name Source  Clone  Conjugate  Isotype  
Primary antibodies  
anti-β-gal 1 Cortex Biochem CR7001RP2 n Rabbit IgG 
anti-β-gal 2 Europa 1010702 n Mouse 

















anti-keratin 8 DSHB Troma1 n 
Rat 
IgG2a 










anti-EpCAM DSHB G8.8 n, biot* 
Rat 
IgG2a 
anti-PDGFRα BD PharMingen APA5 n Rat IgG2a 
anti-PDGFRβ BD PharMingen APB5 n, biot Rat IgG2a 




From R.L. Boyd, Monash 
University Medical School, 
Australia 
MTS20 n Rat IgM 
anti-Plet1 
From R.L. Boyd, Monash 






From W van Ewijk, 




UEA-1 Vector Labs - biot Lectin 
Secondary antibodies  
anti-Rat IgM BD PharMingen - PE  - 
anti-Rat IgG2a 
BD PharMingen - FITC, APC  - 
Invitrogen - A488, A647  - 
anti-Rat IgG2b 
BD PharMingen - FITC, APC  - 
Invitrogen - A488, A647  - 
Anti-Rabbit 
IgG 
Invitrogen - A488, A647 - 




List of primary and secondary antibodies used in this t esis, including source, 
isotype and clone identity (where relevant). ‘Conjugated’ column details 
fluorophores or other molecules used in antibody identification, abbreviations are as 
follows: n – non-conjugated; PE – phycoerythrin; FITC - fluorescein isothiocyanate; 
APC – allophycocyanin; Cy5 – cyanine 5; biot – biotinylated; A488 – Alexa Flour 
488; A647 – Alexa Flour 647.  * biotinylated using Molecular Probes FluoReporter 
kit. 
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2.5. S phase labelling with halogenated thymidine a nalogues 
BrdU labelling was performed using a BrdU Flow Kit [BD Pharmingen].  Mice were 
given 100-200 µl intraperitoneal injections of 10 mg/ml BrdU in Dulbecco’s 
phosphate buffered saline (DPBS) as supplied with th s kit, or DPBS alone. 
IdU and CldU labelling/staining protocols used were obtained from S. Tajbakhsh and 
P. Rocheteau, Pasteur Institute, Paris.  IdU [MP Biomedicals] was made up to a 
concentration of 10 mg/ml (in 9 g/L NaCl, 0.2N NaOH) and i.p. injected into mice to 
give a 57.5 mg/kg dose.  CldU [Sigma] was also made up to 10 mg/ml (in 9g/L 
NaCl), and injected to give a 42.5 mg/kg dose.  Doses were calculated to take into 
account differences in molecular weight of the two analogues. 
Following thymidine analogue pulses, mice were sacrificed and processed as 
described in sections 2.2 and 2.3.  Antibodies used to etect IdU and CldU were 
mouse anti-BrdU [BD Pharmingen, 34780] and rat anti-BrdU [Accurate, OBT-0030], 
respectively. 
2.6. X-gal staining 
2.6.1. Pre-stain tissue fixation 
The effects of three fixative solutions on X-gal staining were examined.  
1) 10% formalin (a 1:10 dilution of 37% formaldehyde solution [Fisher 
Chemicals] in PBS). 
2) 4% PFA (a 4% solution of paraformaldehyde in PBS, heated to 60oC for 1 
hour or until fully dissolved). 
3) ‘Old embryo fix’ (OEF). The following were used to make 10ml of OEF: 
250µl 37% formaldehyde solution [Fisher Chemicals], 80µl 25% 
glutaraldehyde [Sigma-Aldrich], 20µl 1M MgCl2 [Fisher Chemicals], 200µl 
250mM EGTA [Fisher Chemicals], 20µl 10% NP-40 [Fisher Bioreagents], 
9.4ml PBS. 
Following dissection and washing in PBS of tissue, fixatives were applied at 4oC for 
varying lengths of time as detailed in results chapter. 
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2.6.2. X-gal staining of intact tissue 
Fixed tissue was washed for 3 x 10 mins with X-gal-w sh at RT before being stained 
with X-gal-stain in an incubator (for 48 h at 25°C ± 1°C, or as described in results 
chapter).  It was washed again with PBS, in preparation for fixation (with X-gal-fix 
for 24 h at 4°C, or as detailed in results chapter).  Tissue was now washed once with 
PBS. 
2.6.3. Visualisation and recording of clones 
X-gal stained tissue was cleared using serial concentrations of glycerol [Sigma-
Aldrich] in PBS.  Tissue was left in 30%, 50% and 80% glycerol respectively, for 24 
hours in each at 4oC.  Tissue was stored in 80% glycerol at 4oC. 
Examination of stained tissue in 80% glycerol was performed under a light 
microscope.  Any resultant β-gal+ clones discovered were digitally photographed 
with a Zeiss Stemi SV11 microscope using Openlab v3.0 software [Improvision]. 
2.6.4. Tissue embedding for cryo-sectioning 
Fresh or fixed tissue was embedded either in OCT compound as described in section 
2.4.1, or in sucrose/gelatine. 
For sucrose/gelatine embedding, pre-fixed tissue was incubated in 15% sucrose 
[BDH AnalaR] for 4 hours at 37oC, as a cryo-protectant.  Tissue was subsequently 
placed in a mould containing 15% sucrose/7% gelatine [BDH Biochemicals] for 3 
hours at 37oC.  Tissue was then positioned in the orientation required for freezing 
and the mould was transferred to ice to allow the gelatine to set, followed by snap 
freezing in liquid nitrogen.  Frozen blocks were stored at -80oC prior to sectioning. 
2.6.5. Sectioning of tissue 
Tissues used in X-gal staining (either prior too or after sectioning) were cut at a 
thickness of 12-14µm on a cryostat [Leica CM1900], at -23oC.  These were thicker 
than normal cryosections (usually 6-7µm) - both in an attempt to show darker 
staining of β-gal+ cells, and to reduce the number of sections that would have to be 
cut in order to section through a complete thymus lobe.  Sections were placed on 
poly-L-lysine coated glass slides [VWR International], ir-dried for 20 minutes and 
stored at -80oC.  
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2.6.6. Alkaline treatment following X-gal incubation 
For intact thymus lobes, X-gal staining solution was removed from staining 
receptacle by pipette and replaced with 1M Na2CO3.  Lobes were incubated for 20 
minutes at room temperature, before being washed in PBS for 10 minutes and 
embedded in OCT for freezing and sectioning. 
Alkaline treatment was also performed on tissue sections stained by X-gal whilst on 
slides. X-gal was poured of slides, and 100µl of 1M Na2CO3 was immediately added 
to each tissue section.  After 20 minutes at room te perature, Na2CO3 was poured 
off and slides were washed for 10 min in PBS.  Slides were then mounted with 
glycerol/water and sealed with nail varnish. 
 
51 
Chapter 3. Results: Cellular composition of fetal t hymus 
between E12.5 and E17.5 
3.1. Introduction 
Prior to undertaking retrospective clonal analysis, it was important to select a thymic 
developmental stage that could provide sufficient information on epithelial cell 
lineage divergence, without a high likelihood of multiple clones occurring within the 
epithelial compartment of a single thymus lobe.  The developmental stages examined 
were at embryonic gestational day 12.5 (E12.5), E13.5, E14.5, E15.5, E16.5 and 
E17.5.   
In order for the number of potential epithelial clones in a single lobe from an embryo 
of a given developmental stage to be calculated, the number of TECs present at that 
age needed to be ascertained.  The number of somatic la cZ to lacZ recombination 
events expected could then be calculated within a population of a known size, since 
the expected recombination frequency of the laacZ allele is already known. 
Due to the lack of quantitative data on the composition of the embryonic thymus, all 
other major cell types known to be present during thymus ontogeny were also 
analysed. 
To do this, foetal thymic lobes were dissected from multiple litters of mice at the 
same embryonic stage, and pooled.  Thymus lobes then underwent enzymatic 
dissociation into a single cell suspension, whereupon they were incubated with 
various monoclonal antibodies in order to identify specific intrathymic cell 
populations.  Results were obtained using flow cytometry, which enabled the relative 
proportions of different cell types in the thymus to be found.  These figures were 
then applied to the total number of cells per thymus lobe, to enable calculation of the 
actual number of each of the major cell types present in the thymus at these stages, 
and are detailed in this chapter.   
Resultant calculations of clone frequency are detailed in Chapter 5. 
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3.2. Results 
3.2.1. Total thymus cellularity 
The total number of cells per thymus lobe was calcul ted for each time point.  To do 
this, a known number of age-matched thymus lobes (from several litters of mice) 
were pooled and dissociated.  The number of cells pr ml in the resultant 1ml single-
cell suspension was then counted using a haemocytometer.  The total number of cells 
present in the sample was then divided by the number of thymus lobes used, giving 
the mean number of cells in 1 thymus lobe (Figure 3.1, Table 3.1).  At E12.5, each 
lobe is comprised of 1.67x104 ±6.7x103 cells, although this may be an overestimate 
due to the difficulty in cleanly separating the E12.5 thymus from surrounding tissue 
when dissecting.  At E13.5, the thymus has a size of ar und 2.82x104 ±1.34x103 
cells, before undergoing a three-fold expansion to ar und 8.64x104 ±2.99x104 at 
E14.5.  Another three-fold increase in cell number to 2.36x105 ±9.26x104 occurs 
between E14.5 and E15.5, whereupon the thymus continues to increase by a factor of 
3.7 during the following 24 hours, giving a total cellularity at E16.5 of around 
9.79x105 ±2.60x105.  At the final point of study, E17.5, the total number of cells per 
lobe was found to be 2.24x106 ±4.72x105, 2.5 times the number of cells seen at 
E16.5.  
The remainder of this chapter uses immuno-staining in combination with flow 
cytometry to define cellular composition in terms of known cell types.  In all 
subsequent flow cytometric analyses shown, all events were gated to select only 
viable cells.  This was done in two steps; firstly as shown in Figure 3.2A, events 
corresponding to single cells were selected on the basis of size (using forward-scatter 
(FSC-H)) and density (side-scatter (SSC-H)).  These cells were then analysed in a 
second step, where the DNA-binding viability stain 7AAD was used as a marker of 
dead cells.  Only 7AAD-negative cells are selected, as shown in Figure 3.2B.  Any 
events passing these two criteria were regarded as viable cells, and it is these that are 
shown in all subsequent flow cytometric analysis in this thesis, unless stated 
otherwise. 
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Figure 3.1 Total thymus cellularity between E12.5 a nd E17.5 
After undergoing enzymatic dissociation, cells from pooled thymus lobes were 
counted by haemocytometer.  Data points represent th  mean and standard deviation 
of at least 5 independent experiments. 
 
 







12.5 1.67 0.67 
13.5 2.82 1.34 
14.5 8.64 2.99 
15.5 23.6 9.26 
16.5 97.9 26.0 
17.5 224.5 47.2 
Absolute number of cells per thymus lobe, values correspond to data points on graph 
in Figure 3.1 above. 
 
Chapter 3: Results: Cellular composition of fetal thymus between E12.5 and E17.5 
  54 
 
Figure 3.2 Flow cytometric gating strategy for live  cells 
Events regarded as cells were gated on the basis of forward-scatter (FSC-H), to 
determine size; and side-scatter (SSC-H), to determin  density (A).  Within this 
population, the intercalating dye 7-aminoactinomycin D (7AAD) was used as 
viability stain to identify dead cells (B).  Only 7AAD negative cells were included in 
any subsequent flow cytometric analysis shown in this thesis, unless stated 
otherwise. 
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3.2.2. Haematopoietic cells 
In the mature thymus, over 99% of thymic cellularity is composed of haematopoietic 
cells.  The cell surface marker CD45 can be used to i entify all haematopoietic cells 
apart from erythrocytes, which are a very minor presence in the embryonic thymus 
and were therefore not included.  To define the propo tion and number of CD45+ 
cells in the developing thymus, an anti-CD45 monoclona  antibody (mAb) was used 
to identify haematopoietic cells by flow cytometry, as shown in Figure 3.3.  At E12.5 
only around 20% of thymic cells were CD45+.  By E13.5 just over 40% of cells in 
the thymus are CD45+, 65% by E14.5 and by E15.5 this figure has increased to 80% 
of total cellularity.  Haematopoietic cells account for around 85% and 95% of total 
cells per thymus lobe by E16.5 and E17.5 respectively (Figure 3.3, Table 3.2). 
These data were applied to the total number of cells per lobe (individually for 
separate experiments) to give the actual number of haematopoietic cells per thymus 
lobe (Figure 3.4A).  At E12.5 approximately 4.26x103 ±1.64x103 CD45+ cells are 
present in a single lobe.  These have penetrated throug  the mesenchyme into the 
epithelium (Itoi et al., 2001), having been attracted by chemotactic factors, and 
represent the first ‘wave’ of colonisation.  At E13.5 the thymus was found to have an 
average of 1.37x104 ±2.35x103 CD45+ cells per lobe, representing a three-fold 
increase within 24 hours.  By E14.5 there were seen to be around 6.29x104 
±8.92x103 haematopoietic cells – an increase of 4.9x104 cells from the previous day.  
This influx represents the second wave of thymocytes that arrive at E13.5-E14.5, 
probably carried by the blood vessels that are now present around the outside of the 
thymus.  By E15.5 there are now on average 2.29x105 ± .97x104 CD45+ cells within 
the thymus, having increased by a factor of 3.5 since E14.5.  The establishment of 
intrathymic vasculature, which continues to supply rospective T-cell precursors, 
accounts for this ‘third wave’.  Thus, a 3.5-fold increase leads to a total of 7.86x105 
±2.96x104 CD45+ cells at E16.5, and by E17.5 there are now 2.25x106 ±3.38x104 
haematopoietic cells within the stroma of each thymus lobe, giving a population 
proportionally similar to that seen in the mature ogan. 
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The non-haematopoietic fraction of the thymic stroma also increases in terms of cell 
number during embryonic development, albeit at a rate that is not comparable to that 
of CD45+ cells (Figure 3.4B, Table 3.2).  At E12.5 around 1.54x104 ±2.16x103 
CD45- cells were shown to be present.  A large number of these would be expected 
to be extrathymic mesenchyme, due to difficulties in completely removing the tissue 
that surrounds the thymus at this stage.  The number of non-haematopoietic stromal 
cells increases to around 1.73x104 ±2.51x103 by E13.5, and this doubles by E14.5 to 
give approximately 3.66x104 ±7.44x103.  By E15.5, 6.17x104 ±1.47x104 cells that do 
not express CD45 are seen, by E16.5 this figure rises to 1.20x105 ±1.01x104, and by 
E17.5 there are around 1.65x105 ±3.19x104 CD45- cells within the thymic stroma – 
effectively showing a 2.5-fold increase during the final 48 hours investigated in this 
study. 
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Figure 3.3 Haematopoietic proportion of thymus betw een E12.5 and 
E17.5 
Dissected thymus lobes underwent enzymatic dissociati n, followed by incubation 
with anti-CD45 monoclonal antibody.  CD45+ haematopoietic cells were identified 
by flow cytometric analysis (A).  Histograms represent at least 5 independent 
experiments. 
Shown in B are the relative percentages of CD45+ (solid line) vs. CD45- (dotted line) 
cells within the developing thymus from day 12.5 to day 17.5.  Data points represent 
the mean and standard deviation from at least 5 independent experiments. 
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Figure 3.4 Actual numbers of haematopoietic and non -haematopoietic 
cells in the foetal thymus 
The percentage of total cells showing CD45+ staining by flow cytometry (Figure 3.3) 
was applied to the total number of cells per thymus lobe (Figure 3.1).  These 
parameters were calculated for each experiment individually.  Each data point 
represents the mean and standard deviation of at least 5 independent experiments. 
These data show an exponential increase in CD45+ haematopoietic cells (A).  A more 
modest, but still substantial increase is shown in the CD45- non-haematopoietic 
fraction of the thymus (B). 
 
 
Table 3.2 Proportion and number of haematopoietic v s. non-


















lobe (x10 3 ) 
±SD 
(x103 ) 
12.5 21.9 78.1 8.4 4.26 1.64 15.4 2.16 
13.5 43.7 56.3 8.1 13.7 2.35 17.3 2.51 
14.5 64.6 35.4 9.2 62.9 8.92 36.6 7.44 
15.5 79.4 20.6 6.0 229 19.7 61.7 14.7 
16.5 85.2 14.8 2.8 786 29.6 120 10.1 
17.5 93.8 6.2 1.4 2245 33.8 165 31.9 
Summary of flow cytometric analysis, counting the percentage and number of CD45+ 
haematopoietic cells within the developing thymus, from Figure 3.3 and Figure 3.4. 
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3.2.3. Thymic mesenchyme 
Mesenchymal cells are a major component of the non-haematopoietic thymic stroma, 
and can be identified by immunohistochemistry using the monoclonal antibody 
ERTR7 (Van Vliet et al., 1984).  However, ERTR7 recognises an unknown 
intracellular determinant of fibroblasts that has proved to be undetectable by flow 
cytometry, and therefore unsuitable for the purpose of quantifying mesenchymal cell 
numbers.  During embryogenesis, derivatives of neural c est (NC), including that 
which surrounds the thymus, have been shown to express platelet-derived growth 
factor receptor alpha (PDGFRα) (Takakura et al., 1997), as does mesoderm-derived 
mesenchyme in the trunk.  Ligands for PDGFRα are expressed on epithelial cells 
that are in close proximity to PDGFRα-expressing embryonic mesenchyme (Orr-
Urtreger and Lonai, 1992).  In patch (ph) mice - which are defective for PDGFRα 
expression - the proliferation, migration to within the thymus lobe, and provision of 
FGF growth factors by encapsulating mesenchyme appears to be substantially 
reduced (Itoi et al., 2007).  Examination of PDGFRα expression in the developing 
thymus was undertaken to assess its suitability as a marker of mesenchyme for flow 
cytometry.  Platelet-derived growth factor receptor beta (PDGFRβ) expression was 
also examined, in an attempt to identify the perivascular mesenchyme indicated by 
ERTR7 staining.  PDGFRβ is expressed on mesenchymal vascular smooth muscle 
(VSM) and pericytes in other organs.  These cells are recruited by endothelium 
expressing the ligand PDGFB during angiogenesis (Lindahl et al., 1997, Lindblom et 
al., 2003, Kaminski et al., 2001).  PDGFRβ is also expressed on mesenchyme in the 
craniofacial and urogenital regions (Betsholtz, 2003).  
At E13.5, shown in Figure 3.5, ERTR7+ mesenchyme can be seen to surround the 
thymus lobe in a thick layer, with some sections invading inward.  PDGFRβ is 
expressed in a very similar fashion at this stage.  In contrast, PDGFRα appears only 
to be expressed in the capsular area around the outside of the organ (Figure 3.5L).  
At E15.5, ERTR7+ cells are seen extensively within the interior of the thymus lobe, 
as shown in Figure 3.6.  Although (as shown in Figure 3.5) these cells are negative 
for PDGFRα, the staining pattern for PDGFRβ (Figure 3.6E-H) shows a high 
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similarity in both proportion and morphology to ERT7.  By E17.5, ERTR7+ cells 
are seen both in the capsule, albeit in a thinner layer than in earlier organogenesis, 
and as an extensive network throughout the organ (Figure 3.7A-D).  The ERTR7+ 
cells of the capsule are non-epithelial, shown by pan-cytokeratin staining in Figure 
3.7E-I, with the capsule and sub-capsular epithelium appearing to by separated by a 
continuous basement membrane (Figure 3.7I).  At this stage, PDGFRα expression 
appears to be further reduced even in the capsule (Figure 3.7J-M), with only 
infrequent PDGFRα+ cells appearing around the outside of the thymus (Figure 3.7M, 
white arrowheads). 
Following these immunofluorescence experiments, flow cytometry analysis was used 
to calculate the proportions of stromal cells expressing PDGFRα and/or PDGFRβ 
from E12.5 through to E17.5.  The results of this analysis are shown in Figure 3.8.  
In A, representative flow cytometry plots of NH cells show a shift over time from a 
predominantly PDGFRα+β+ mesenchymal phenotype at E12.5 to increased 
PDGFRα-β+ at E13.5 (correlating with the observation that inward migration of 
mesenchyme from the capsule has now begun, Figure 3.5).  This trend continues 
until, at E16.5, less than a tenth of the PDGFRβ+ cells continue to show PDGFRα 
expression. 
Just under half of all NH cells are mesenchymal at E12.5 (Figure 3.8B).  Between 
E12.5 and E14.5 there is a rapid decrease on the proportion of mesenchymal cells 
making up the non-haematopoietic stroma.  This matches the high rate of epithelial 
cell proliferation at this stage, addressed in the following chapter of this thesis.  
Between E14.5 and E17.5 the mesenchymal proportion of the NH thymus component 
appears to remain at between 10-15%, however the proportion of PDGFRα+ cells has 
significantly decreased to less than 1%. 
These data were applied to the total number of non-haematopoietic (NH) cells 
previously found to be in each thymus lobe (Figure 3.4).  Thus, the absolute number 
of mesenchymal cells present at each time point was calculated (Table 3.3, Figure 
3.9).  The large number of mesenchymal cells (specifically PDGFRα+β+ cells), and 
relatively large standard deviation observed at E12.5, may be explained by the fact 
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that, when dissecting large numbers of these early thymus lobes, it is difficult to 
completely trim off all surrounding pharyngeal mesenchyme.  It is interesting to note 
that the number of PDGFRα+β- and PDGFRα+β+ cells remains constant from E13.5 
to E17.5, whilst it is only PDGFRα-β+ cells that substantially increase in number 
during thymus development – particularly between E15.5 and E16.5.  This may be a 
result of proliferation induced by endothelial cells, with PDGFRβ+ perivascular VSM 
and pericytes undergoing recruitment by the nascent intrathymic vascular network as 
mentioned earlier in this section. 
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Figure 3.5 Staining of selected mesenchyme markers at E13.5 
Following page 
Immunofluorescence staining of E13.5 thymus, showing effectiveness of different 
markers in identifying thymic mesenchyme.  ERTR7 (panels A-D) is a general 
marker of thymic fibroblasts.  In D, fibroblasts invading the epithelial interior of the 
organ from the capsule can clearly be seen (white arrowheads), and there is a clear 
population fibroblast population already visible deep inside the lobe (white arrows).  
A very similar pattern is seen with PDGFRβ staining (panels E-H), upon staining a 
different section from the same E13.5 lobe, with PDGFRβ+ cells visible in the thymic 
interior (white arrows), and invading from the capsule (white arrowheads).  
Conversely, PDGFRα+ cells only appeared in the capsule (panels I-L).  Scale bars are 
100 µm. 
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Figure 3.5 Staining of selected mesenchyme markers at E13.5 
For legend, see previous page. 
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Figure 3.6 PDGFR β continues to mark mesenchyme during at E15.5 
Immunofluorescence staining of E15.5 thymus sections.  ERTR7 (A-D) shows 
mesenchyme surrounding the outside of the thymus, with extensive areas present 
within the interior of the lobe.  PDGFRβ (E-H) displays a similar pattern.  Scale bars 
are 200µm. 
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Figure 3.7 Non-epithelial, ERTR7 + mesenchymal cells are predominantly 
PDGFRα- by E17.5 
Following page 
Immunofluorescence staining of E17.5 thymus.  Thymic esenchyme, staining for 
ERTR7, (A-D) is observed in the capsule, and scattered throughout t e interior of the 
thymus.  These cells are non-epithelial, as they do not stain with PanK (E-I).  At 
E17.5 only a small number of cells, located in the capsule, appear to stain with 
PDGFRα (J-M, marked by arrowheads in M) Scale bars in A-D and J-M are 100µm, 
in E-I are 50µm. 
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Figure 3.7 Non-epithelial, ERTR7 + mesenchymal cells are predominantly 
PDGFRα- by E17.5 . For legend, see previous page. 
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Figure 3.8 Flow cytometric analysis of PDGFR α vs. PDGFRβ expression 
Data show proportions of non-haematopoietic cells from dissociated thymic lobes 
staining for PDGFRα and/or PDGFRβ. A, representative flow cytometric analyses of 
CD45-TER119- cells incubated with mAbs for PDGFRα and PDGFRβ.  Quadrants 
are set on isotype controls, also using CD45-TER119- cells.  Plots are representative 
of at least 3 independent experiments.   
In B, the percentage of CD45-TER119- cells that are PDGFRα+β- (blue) PDGFRα+β+ 
(yellow), or PDGFRα-β+ (red) at each time point is shown.  Data points represent the 
mean for at least 3 independent experiments. ±standard deviation is shown. 
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12.5 510 389 1,207 444 5,494 3,076 6,876 2,923 
13.5 314 233 2,069 1,145 1,408 195 3,712 855 
14.5 573 263 2,873 873 1,114 890 5,208 1,812 
15.5 609 239 4,439 944 1,080 653 8,071 3,446 
16.5 497 214 12,748 1,256 1,535 865 14,780 2,329 
17.5 820 570 15,365 5,697 1,442 511 17,628 5,945 
Flow cytometric data regarding proportions of CD45-TER119- cells expressing 
PDGFRα and/or PDGFRβ (Figure 3.8) were applied to the number of CD45-
TER119- cells present in a single thymus lobe, from E12.5 to E17.5, to calculate 
absolute mesenchymal cell numbers. Calculations were p rformed separately for 
each experimental replicate, with data here representing the mean and standard 
deviation for at least 3 independent experiments.   
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Figure 3.9 Actual numbers of mesenchyme cells in th e foetal thymus 
Flow cytometric data regarding proportions of CD45-TER119- cells expressing 
PDGFRα and/or PDGFRβ (Figure 3.8) were applied to the number of CD45- 
TER119- cells present in a single thymus lobe, from E12.5 to E17.5, to calculate 
absolute mesenchymal cell numbers.  Values are given in Table 3.3.  Blue bars 
represent PDGFRα+β-, yellow represents PDGFRα+β+, and PDGFRα-β+ cells are 
represented by red.  Data represents the mean and st ard deviation for at least 3 
independent experiments.  Calculations were performed separately for each 
experimental replicate. 
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3.2.4. Thymic endothelium 
In order to analyse thymic endothelial cells by flow cytometry, a MAb recognising 
platelet endothelial cell adhesion molecule-1 (PECAM-1, a.k.a. CD31) was used on 
dissociated thymus, as previously documented (Gray et al., 2002, Muller et al., 
2005).  At E12.5, just under 5% of all non-haematopoietic cells in the thymus 
showed CD31 expression, with this proportion very gradually decreasing to 
marginally over 3% at E17.5, as shown in Figure 3.10A and Table 3.4.  If these 
values are translated into actual numbers of CD31+ cells at each time point (Figure 
3.10B, Table 3.4), it becomes apparent that this population grows slowly between 
E12.5 and E15.5 – doubling from just under 750 to approximately 1500 cells.  
Between E15.5 and E16.5, however, the number of CD31+ cells present appears to 
double again, to almost 3400, and at E17.5 has increased to just over 5300 cells.  The 
sharp increase in number from E15.5 is mirrored by the observed increase in 
PDGFRβ+ mesenchyme – a cell type known to be associated with endothelium – 
pointing to an elevated generation of intrathymic vasculature at this stage.  It cannot 
be ruled out that CD31+ cells are still being recruited from outside the tymus at this 
stage.  However, this seems less likely due to the thymic capsule forming a barrier 
around the organ, and it is probable that the increase in CD31+ cells from E15.5 
marks an increase in proliferation of endothelial cel s or their precursors.  This may 
well be mediated by VEGF, an endothelial cell mitogen expressed by both TECs and 
thymic mesenchyme (Muller et al., 2005). 
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12.5 4.78 1.30 736 201 
13.5 4.59 0.52 796 90 
14.5 2.95 0.52 1,081 191 
15.5 2.48 0.23 1,530 140 
16.5 2.82 0.53 3,387 638 
17.5 3.23 1.24 5,335 2,044 
Number of CD31+ endothelial cells in the embryonic thymus between E12.5 and 
E17.5, calculated from flow cytometry results.  Number of cells calculated separately 
for each experimental replicate, values stated above are mean and standard deviation 
of at least 3 independent experiments. 
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Figure 3.10 Number of CD31 + endothelial cells from E12.5 to E17.5 
Flow cytometric analysis for CD31, on cells gated as being CD45-TER119- (A). 
Gates were set on isotype-matched controls, shown in grey.  Histogram plots are 
representative of at least 3 independent experiments.   
The absolute number of CD31+ cells per thymus lobe was calculated by multiplying 
the CD31+ percentage of the NH population by the number of NH cells per lobe at 
each time point (B), exact values are given in Table 3.4. 
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3.2.5. Thymic epithelium 
Thymic epithelial cells are keratin+, however the intracellular nature of keratin means 
that it cannot be used in conjunction with many other cell-surface markers.  In order 
to more easily identify TECs by flow cytometry, I used the extracellular marker 
EpCAM.   
EpCAM expression on TECs was confirmed by co-staining with a pan-cytokeratin 
antibody on cytospins (Figure 3.11).  To do this, di sociated cells were sorted by 
flow cytometry - excluding those positive for CD45, TER119, PDGFRα or CD31.  
Since low levels of EpCAM have also been observed on CD4-CD8- and CD4+CD8+ 
thymocytes, and also some dendritic cells, it must be used in conjunction with a 
means to distinguish haematopoietic versus non-haematopoietic cells (Borkowski et 
al., 1996, Nelson et al., 1996).  The remaining cells were collected and spun onto 
glass slides, fixed in acetone, and air-dried.  Labelling with anti-EpCAM and pan-
cytokeratin antibodies was then performed, and slide  were analysed by fluorescent 
confocal microscopy.  In all samples from E12.5 to E17.5, 99% (± 2%) of EpCAM+ 
cells were seen to show keratin+ staining (Figure 3.11), confirming EpCAM’s 
suitability as a marker of foetal thymic epithelium at the time points under 
investigation. 
Flow cytometric analysis of the epithelial proportin of the thymus during 
development was carried out, with the epithelial comp nent identified as being 
EpCAM+CD45-TER119- (Figure 3.12A).  As a fraction of total dissociated thymus, 
epithelial cells are around 40% at E12.5 and E13.5, dropping quickly as the 
haematopoietic cell population undergoes massive influx into, and proliferation 
within, the thymic primordium until only around 2.5% of cells in the organ are 
epithelial at E17.5 – close to the proportion observed in the mature organ.  As a 
proportion of NH cells, however, epithelial cells ri e from around 55% at E12.5 to 
80% at E13.5.  This increases to about 85% at E14.5, and appears to remain the case 
until at least E17.5 (Figure 3.12B, Table 3.5).   
When these data are translated into actual number of pithelial cells per lobe, a 
steady increase is apparent (Figure 3.12C, Table 3.5).  Roughly, a doubling in total 
Chapter 3: Results: Cellular composition of fetal thymus between E12.5 and E17.5 
  74 
epithelial cells present is observed in each 24-hour period between E12.5 and E14.5.  
The rate of increase of the epithelial population then falls slightly, showing a 1.5-fold 
increase between E14.5 and E15.5 to around 5.1x104.  The number of epithelial cells 
per lobe rises to 1x105 at E16.5 and about 1.4x105 at E17.5. 
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Figure 3.11 EpCAM marks all foetal thymic epithelia l cells 
Dissociated thymus was sorted by flow cytometry to remove any cells expressing 
CD45, TER119, PDGFRα or CD31.  Remaining cells were collected and spun onto 
glass slides and fixed with acetone.  Slides were stained with pan-cytokeratin (PanK) 
antibody and anti-EpCAM-1 antibody.  Results showed 99% (±2%) of PanK positive 
cells staining for EpCAM, at all time points from E12.5 to E17.5.  The above 
example is from E14.5 thymus, but representative of all time points examined.  Scale 
bars are 100µm. 
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Figure 3.12 Increase in EpCAM + thymic epithelium from E12.5 to E17.5 
See following page. 
A, representative flow cytometric analysis of total dissociated thymus shows a 
decrease of EpCAM+CD45-TER119- negative thymic epithelium as a proportion of 
the entire thymus.  B, EpCAM+ cells increase as a fraction of the non-haematopoietic 
component of the thymus.  C shows the total number of EpCAM+ cells per lobe, 
calculated as:  
(Number of NH cells per lobe) x (percentage of EpCAM+ cells in NH population) 
Values were calculated separately for each experimental replicate.  Values on graphs 
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Figure 3.12 Increase in EpCAM+ thymic epithelium fr om E12.5 to E17.5 
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Table 3.5 Proportion and number of TECs in the embr yonic thymus 





% of total 
cells  
±SD 









12.5 39.9 9.4 53.4 11.7 8.23 2.12 
13.5 40.4 11.0 79.2 9.1 13.7 3.24 
14.5 29.7 6.1 86.8 3.0 31.8 7.40 
15.5 16.2 4.1 83.4 1.0 51.4 12.8 
16.5 8.8 2.4 84.0 3.2 101.0 11.7 
17.5 2.5 0.7 85.2 1.4 140.7 29.2 
Summary of flow cytometric analysis from Figure 3.12.  Values were calculated 
separately for each experimental replicate.  Data here show the mean and ± standard 
deviation for at least 3 independent experiments. 
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3.3. Discussion 
These data provide a numerical picture of thymus ontogeny.  The major cell type 
present in the mature organ – the haematopoietic population – shows a phenomenal 
increase in number between E12.5 and E17.5 when compared to the non-lymphoid 
component, as shown in Figure 3.4.  When considered without haematopoietic cells, 
the largest change in total number is seen in the epithelial cell population, which 
shows a 17-fold increase in cell number between E12.5 and E17.5 as seen in Figure 
3.13.  Mesenchymal and vascular cell numbers increase between E12.5 and E17.5 by 
a factor of around 3 and 6 respectively (Figure 3.13).  By E17.5, the number of 
epithelial cells present in the thymus is approximately 6 times larger than the total 
number of mesenchymal cells and vascular cells combined (Figure 3.13). 
With regard to relative proportions of each cell type within the non-lymphoid stroma, 
mesenchyme appears to be the major cell type at E12.5 but is quickly overtaken by 
epithelium by E13.5, and by E14.5 then the relative contribution seems to be 
constant through to E17.5, as shown in Table 3.6.  Epithelial cells make up around 
85%, mesenchyme around 12%, and vascular cells 3%. 
Since this work was undertaken, a number of studies have been published that 
support some of the data in this chapter.  Work by Gray et al. shows comparative 
numbers of total cells per lobe, and numbers of CD45- cells, from E14 through to 
E18 (Gray et al., 2006).  Furthermore, data from Hamazaki and colleagues also 
provide a very close match to my assessment of CD45- cell numbers from E13.5 to 
E17.5 (Hamazaki et al., 2007).  A study by Jenkinson et al., examining PDGFRα+ 
thymic mesenchyme, supports my finding that this cell type reduces as a proportion 
of the non-haematopoietic population during thymus ontogeny (Jenkinson et al., 
2007).  A more recent study, analysing the expression of PDGFRα and PDGFRβ, 
supports my observation that whilst PDGFRα expression is reduced during thymus 
ontogeny, and becomes confined to the capsule, PDGFRβ+ cells remain throughout 
the organ during embryonic development (Foster et al., 2008).  This study also shows 
that by E13.5, neural crest-derived cells have begun to differentiate into cells of a 
perivascular phenotype, and that NC derived mesenchyme persists into the adult 
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thymus (Foster et al., 2008).  In addition, experimnts in which the size of the TEC 
population was calculated at E12 and E15 also give near-identical data those 
calculated in this chapter (Jenkinson et al., 2008). 
There are some caveats to this analysis, the first of which is cell dissociation 
technique.  The times used in enzymatic incubations are different for thymus lobes at 
different stages of embryonic development, with incubation times reduced to the 
minimum duration required to produce a single-cell suspension.  This was done in 
order to minimise exposure of cells to potentially harmful conditions, or enzymes 
that may have an effect on certain antigens expressed by the cell surface (i.e. 
trypsin).  As a result, in later embryonic stages, it may be that there is increased cell 
death in certain subsets, or reduced ability to detect certain antigens due to increased 
cleavage of specific cell-surface markers.  None of these issues have been obvious 
from my work, however this could be examined by increasing dissociation times for 
early embryonic tissue and examining relative frequency of specific cell types or 
detection levels of certain cellular markers. 
Secondly, dead cells are not accounted for in haemacytometer counts, which will 
have introduced some degree of error in the calculation of total cell numbers as 
relative cell frequencies have been assessed on viable, 7AAD negative cells.  A 
viability dye such as trypan blue could have added in order to visualise dead cells 
when counting by eye. 
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Figure 3.13 Summary of non-haematopoietic cell numb ers 
The above figure summarizes the number of cells preent at each time point for each 
of the major non-haematopoietic cell types - epithelial, mesenchymal and vascular. 
Their relative proportion in the non-lymphoid stroma is summarized in Table 3.6 
below. 
 
Table 3.6 Summary of contribution of major cell typ es to the non-




Non-CD45+ EpCAM + PDGFRα
+ and/ or 
PDGFRβ+ 
CD31+ 
















12.5 78.1 15.6 53.4 8.22 44.6 6.88 4.8 0.74 
13.5 56.3 17.3 79.2 13.7 21.4 3.71 4.6 0.80 
14.5 35.4 36.6 86.8 31.8 14.2 5.21 3.0 1.08 
15.5 20.6 61.6 83.4 51.4 13.1 8.07 2.5 1.53 
16.5 14.8 120.2 84.0 101.0 12.3 14.8 2.8 3.39 
17.5 6.2 165.1 85.2 140.7 10.7 17.6 3.2 5.34 
Compilation of data calculated in this chapter, giving the stromal (non-
haematopoietic) proportion of the embryonic thymus, the relative composition of the 
stroma, and the absolute numbers of the main non-haematopoietic cell types present 
from E12.5 until E17.5.  For standard deviation error values, refer to cell-specific 




Chapter 4. Results: Modelling of thymic epithelial 
proliferation 
4.1. Introduction 
Following the work described in Chapter Three, the t ymic epithelial compartment 
was analysed in more detail. 
The Plet1+ thymic epithelial progenitor cell (TEPC) population (identified with the 
monoclonal antibodies MTS20 and MTS24) can give ris to a properly organised and 
functional thymus equivalent, when isolated from E12.5 and E15.5 mouse thymi and 
ectopically transplanted in vivo (Bennett et al., 2002, Gill et al., 2002). 
In Chapter Four, I investigate the numbers of Plet1+ thymic epithelial cells present 
throughout E12.5 to E17.5 of fetal thymus development.  I also examine levels of 
apoptosis and participation in the cell cycle in Plet1+ vs. Plet1- cells, in order to look 
at possible models of TEC kinetics and proliferation. 
In combination with data from Chapter Three, these analyses would also assist in 
interpreting any data from TEC clones generated by the laacZ labelling system in 
Chapter Five. 
4.2. Results 
4.2.1. Proportion of thymic epithelial cells showing Plet1 staining 
between E12.5 and E17.5 
Flow cytometry was used to assess the proportion of Plet1+ vs. Plet1- thymic 
epithelial cells (TECs) present as thymus organogenesis proceeds from E12.5 to 
E17.5.   TECs were identified as being non-haematopoietic (negative for CD45 and 
TER119) but showing positive staining for EpCAM, as shown in Figure 4.1A.  The 
proportion of TECs showing staining with MTS20 antibody was then ascertained, 
with examples for each age of study shown in Figure 4.1B.  At E12.5, it was seen 
that almost 90% of TECs showed Plet1+ staining.  This proportion reduces to around 
66% at E13.5, and sharply decreases again to approximately 23% at E14.5.  A further 
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steady reduction in the proportion of Plet1+ TECs continued to E17.5, where an 
average of just 6.5% was seen.  These data are summarised in Table 4.1. 
4.2.2. Absolute numbers of Plet1+ and Plet1- thymic epithelial cells from 
E12.5 to E17.5 
In order to ascertain the changes in size of the Plet1+ and Plet1- populations during 
thymus development, absolute numbers of Plet1+ or Plet1- TECs were calculated.  
For each experiment, the number of TECs per lobe was first calculated – by 
multiplying the percentage of EpCAM+CD45-TER119- cells in the sample by the 
total number of cells per lobe known to be present at the particular age of study.  
This figure was then applied to the percentage of Plet1+ or Plet1- TECs already 
known to occur in that sample (from Figure 4.1), to give the absolute number of 
Plet1+ or Plet1- TECs present.  These data are summarised in Table 4.1, and 
represented graphically in Figure 4.2.  It can be se n that numbers of Plet1- TECs 
increase massively on a daily basis, effectively doubling every 24 hours.  
Conversely, no significant difference was observed in the size of the Plet1+ TEC 
population through all stages of organogenesis investigated here, numbering roughly 
6,000-7,000 cells throughout.  To ascertain whether variations in the number of 
Plet1+ TECs at different developmental stages were significant, a one-way ANOVA 
test was used.  This test is based on a Gaussian distribution of results, something that 
would be expected (but not proved, due to a small number of replicates, e.g. n=4 for 
each group of results).  The P-value was found to be 0.662, so it was therefore 
considered that the difference between the numbers of Plet1+ TEC was insignificant 
Table 4.2. 
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Figure 4.1 Proportion of TECs showing Plet1 + staining 
FACS analysis of antibody staining.  In A, an analysis of E15.5 thymus is used to 
demonstrate gating procedure.  Cells were selected on the basis of size and density 
(left), live cells were 7AAD- (centre), and TECs were identified as being 
EpCAM+/CD45-/TER119- (right) (A).  Panel B shows Plet1 (MTS20) staining for 
E12.5 to E17.5 TECs, compared to isotype-matched controls (shown in grey).  
Examples are representative of at least 3 independent experiments. 
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Table 4.1 Proportion and number of Plet1 + and Plet1 - thymic epithelial 











12.5 88.7 4.1 
+ 5.9 0.5 
- 1.1 0.1 
13.5 66.2 15.6 
+ 7.1 1.3 
- 6.5 0.7 
14.5 23.3 6.1 
+ 6.6 1.1 
- 20.0 4.7 
15.5 18.1 4.2 
+ 7.1 1.2 
- 35.8 2.8 
16.5 12.8 3.6 
+ 7.1 1.4 
- 65.2 9.7 
17.5 6.5 0.8 
+ 7.2 2.0 
- 121.8 5.8 
Dissociated thymus lobes were stained with antibodies against CD45, TER119, 
EpCAM and Plet1 (MTS20), and analysed by flow cytometry. For gating, see Figure 





Table 4.2 No significant difference in Plet1 + population size 
Source of 
Variation df SS MS F P-value 
Between Groups 5 5,129,907 1,025,981 0.655 0.662 
Within Groups 18 28,212,756 1,567,375   
Total 23 33,342,664       
One-way ANOVA analysis of Plet1+ TEC number between E12.5 and E17.5, using 
data summarised in Table 4.1.  df = degrees of freedom; SS = sum of squares; MS = 
mean square (SS/df); F = F ratio (MS between groups/MS within groups).  P-value = 
probability of significant difference between groups (<0.05 is significant).  
Calculated using Microsoft Excel. 
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Figure 4.2 Actual numbers of Plet1 + vs. Plet1 - TECS from E12.5 to E17.5 
Cell numbers were calculated by applying the percentage of Plet1+ or Plet1- TECs to 
the number of TECs (EpCAM+CD45-TER119-) per lobe for each separate 
experiment.  Plet1+ TECs represented by red circles, Plet1- TECs represented by 
green triangles.  Error bars represent standard deviation.   
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4.2.3. Analysis of apoptosis in foetal thymic epithelial cells 
Before an attempt at dissecting the kinetics of TEC proliferation could be made, 
levels of apoptosis needed to be examined.  This was necessary because an under-
estimate of cell proliferation would be made if significant apoptosis was present 
within the developing TEC population, but not taken into account. 
Fluorescently conjugated Annexin V (AV) protein was u ed, in combination with 
7AAD, to detect apoptotic cells.  Phosphatidylserin (PS), a negatively charged 
phospholipid, is normally present in the inner, cytoplasmic leaflet of the plasma 
membrane (Op den Kamp, 1979).  In dying cells, PS is translocated to the outer, 
external layer of the membrane (Fadok et al., 1992).  AV binds to PS, in a Ca2+-
dependent manner (Andree et al., 1990). 
Use of an intercalating dye (7AAD in this instance) enables distinction between 
apoptotic and necrotic cells.  Translocation of PS to the cell surface marks one of the 
first stages of apoptosis, during which time the plasma membrane is still intact and 
can exclude 7AAD.  Necrosis, however, involves an erly loss of integrity in the 
plasma membrane and results in the inability to exclude this dye.  Therefore, cells in 
early apoptosis are AV+7AAD-, whilst necrotic/dead cells are AV+7AAD+ (Vermes 
et al., 1995). 
The proportion of TECs involved in apoptosis was examined at 24h intervals from 
E12.5 until E17.5, as described in Figure 4.3.  Theresults are summarised in Table 
4.3.  It was seen that the level of apoptosis within e TEC population remained low 
throughout the period of thymus ontogeny.  Between 2.6% and 5.8% of TEC were 
seen to be in the early stages of apoptosis at each time point, with a mean of 4.3%.  
This degree of apoptosis was judged as insufficient to be taken into account when 
modelling the growth of the TEC compartment.  Necroti /dead cells were 
approximately the same between experiments, and were attributed to the enzymatic 
digestion and mechanical dissociation processes used here to give a single-cell 
suspension for flow cytometry. 
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Figure 4.3 Apoptosis within TEC population 
Flow cytometric analysis of epithelial cells undergoing apoptosis and necrosis.  This 
figure shows a typical experiment, using E15.5 thymus as an example.   
TEC were gated as EpCAM+CD45-TER119-.  7AAD is in the same detection channel 
as CD45/TER119, enabling necrotic/dead cells to be excluded at the same time as 
these markers (A, top panel).  Viable TEC were then examined for Annexin V (AV) 
staining (A, bottom panel). 
As a positive control to confirm the position of AV+ cells, EpCAM+CD45-TER119-
TECs were selected without the addition of 7AAD (B, top panel).  This allows the 
inclusion of AV+ necrotic/dead cells in the gated TEC population.  Consequently, a 
larger AV+ peak appears on the histogram in B - confirming that the gate in A is in 
the correct position to identify cells in early apopt sis. 
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% of TEC 
12.5 2 4.9 
13.5 2 2.6 
14.5 2 4.6 
15.5 2 3.6 
16.5 1 4.2 
17.5 1 5.8 
 Mean 4.3 
 ±SD 1.1 
Dissociated thymus lobes were stained with antibodies for EpCAM, CD45 and 
TER119.  Cell viability and apoptosis were detected using 7AAD and fluorescently 
conjugated Annexin V.  Cells analysed by flow cytometry, for gating procedure see 
Figure 4.3. 
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4.2.4. Analysis of DNA content to investigate proportions of Plet1+ and 
Plet1- TECs involved in proliferation 
In order to further examine the kinetics underlying thymic epithelial proliferation and 
expansion, it was decided to investigate the proportions of the Plet1+ TEC and Plet1- 
TEC populations that were actively involved in cell proliferation – achieved by 
analysing cellular DNA content.  Cells were sorted by flow cytometry, whereupon 
Plet1+ and Plet1- non-haematopoietic populations were separated and collected 
(Figure 4.4A-C).  Sorted cells were subsequently fixed and permeabilized.  Within 
these samples, epithelial cells were identified as tho e showing staining with a pan-
cytokeratin (PanK) antibody (Figure 4.4D).  Samples were incubated with 7AAD 
intercalating dye, in order to quantify the amount of DNA present in each cell.  Flow 
cytometric analysis then allowed an estimation of the proportion of cells in G1/G0 
phase, S phase, or G2/M phases of the cell cycle (Figure 4.5).  Cells found to be in 
either S phase or G2/M phases were grouped together as ‘S/G2/M’, i.e. actively 
proliferating.  These data are summarised in Table 4.4, and graphically in Figure 4.6.  
It was seen that the proportion of cells in S/G2/M phases (‘proliferating’) was 
significantly higher in the Plet1+ TEC population than in the Plet1- TEC population, 
from E12.5 to E15.5.  In Plet1+ TECs, around 40% of cells were seen to be in 
S/G2/M at E12.5.  This increased to a peak of 53% at E13.5, followed by a decrease 
to 50%, 35% then 18% at E14.5, E15.5 and E16.5 respectively.  In Plet1- TECs, the 
proportion of S/G2/M cells also peaked at E13.5 (around 44%) after an increase from 
30% at E12.5.  As in Plet1+ TECs, a decrease in the proportion of S/G2/M cells was 
observed – to 33% at E14.5 and 21% at E15.5.  By E16.5, the proportion of S/G2/M 
cells was equivalent in both Plet1+ and Plet1- TEC populations (around 17-18%).  
This continued to be the case at E17.5, where a similar proportion of S/G2/M cells 
were observed (16-17%). 
One caveat of this analysis is that cells in either G1 or G0 are indistinguishable from 
each other.  This means that any cells in G1 gap phase are not taken into account by 
these experiments.  Consequently, it can be considered that in every sample, by a 
similar degree, there is a higher proportion of cells in cycle than might be obvious 
from this assay.  However, the main point of this analysis was to allow differences 
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between samples to be detected – something that would n t be duly affected by this 
issue. 
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Figure 4.4 Strategy used to purify Plet1 + TECs and Plet1 - TECs by flow 
cytometric sorting 
See following page. 
Cells from dissociated whole thymus were stained with antibodies and sorted using 
flow cytometry.  Live cells were gated on the basis of size and 7AAD uptake; from 
these, non-haematopoietic (NH) cells were gated as being CD45-/TER119- (A).  
Gates were then set to separate NH cells into Plet1+ and Plet1- populations, using 
MTS20 antibody and an isotype matched control (B).  These NH Plet1+ and Plet1- 
populations were sorted and collected, then analysed to check purity was above 95% 
(C).  Collected cells were fixed and permeabilized, whereupon TECs were identified 
by further staining for pan-cytokeratin (PanK), in comparison to an isotype control 
(D).  E14.5 cells are used here as a demonstration of procedure.  
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Figure 4.4 Strategy used to purify Plet1 + TECs and Plet1 - TECs by flow 
cytometric sorting 
 
For legend, see previous page. 
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Figure 4.5 Cell-cycle analysis of purified Plet1 + and Plet1 - TECs using 
quantification of DNA content 
See following page. 
Sorted Plet1+ or Plet1- TECs (for sort criteria, see Figure 4.4) were fixed, 
permeabilized and incubated with 7AAD, so as to quantify DNA content by flow 
cytometry.  A cell cycle analysis platform in FlowJo (Treestar inc.) software was 
used to determine proportion of cells in G1/ 0, S, or G2/M phases of the cell cycle.   
Representative examples of at least 3 independent experiments are shown for each 
time point.  Red (Plet1+) or green (Plet1-) histograms indicate the actual levels of 
7AAD detected by flow cytometry.  Blue overlaid peaks on each graph represent 
different phases in the cell cycle, calculated by the software, as indicated in the top 
left panel (E12.5, Plet1+).  ‘%G1’ marks cells in G1/G0 phases, ‘%S’ marks cells in S 
phase and ‘%G2’ marks cells in G2/M phases. 
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Cell cycle analysis using quantification of DNA con tent 
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 Table 4.4 Proportion of Plet1 + and Plet1 - TECs in different phases of the 
cell cycle 
  Plet1+ TEC Plet1 - TEC  



















Mean 58.2 29.9 11.3 41.2 70.5 22.1 7.3 29.4 0.001 
SD± 2.1 1.3 1.1 2.1 3.1 3.0 1.3 3.2 ** 
13.5 Mean 44.2 35.6 19.6 53.4 55.5 32.2 11.5 43.7 0.003 
SD± 4.7 3.2 4.7 2.8 3.2 2.7 1.7 3.6 ** 
14.5 Mean 49.2 33.5 15.4 48.9 67.2 24.0 8.7 32.7 0.000 
SD± 3.3 3.7 1.3 2.8 2.7 1.8 1.7 1.6 ** 
15.5 Mean 65.4 24.6 10.8 35.4 79.4 15.5 5.6 21.1 0.000 
SD± 4.1 3.0 1.7 3.0 4.4 2.3 1.0 2.4 ** 
16.5 Mean 82.7 12.0 6.1 18.1 82.2 12.4 5.0 17.4 0.644 
SD± 1.6 0.8 1.4 2.0 1.0 1.3 0.2 1.3   
17.5 
Mean 80.6 10.9 5.9 16.8 83.4 11.4 4.5 15.9 0.601 
SD± 3.6 2.6 1.0 2.9 2.5 1.0 0.4 0.7   
Dissociated thymus lobes were stained with antibodies against CD45, TER119 and 
Plet1 (MTS20) and sorted by flow cytometry (Figure 4.4).  Sorted cells were stained 
with anti-pan-cytokeratin and 7AAD. DNA content of cells was ascertained by flow 
cytometry, cell cycle phase proportions calculated by FlowJo software (Figure 4.5).  
Data are representative of at least 3 independent experiments.  P values were 
calculated from the percentages of cells in S/G2/M, using a non-paired, 2-tailed t test.  
Values were expected to have a normal distribution, although small sample size (n=3 
to 7) prevented this from being proved.  Highly significant differences, where P<0.01 
are indicated by asterisks (**). 
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Figure 4.6 A consistently higher proportion of Plet 1+ than Plet1 - cells 
are involved in cell cycle from E12.5 until E15.5 
Compiled results of DNA content analysis, as described in Figure 4.5 and 
summarised in Table 4.4.  This graph displays the percentage of TECs that were 
calculated to be in the S, G2 or M phases of the cell cycle.  Plet1
+ TECs are 
represented by red circles, Plet1- TECs by green triangles.  Data points represent the 
mean of at least 4 independent experiments.  Error bars represent ± standard 
deviation. 
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4.2.5. Absolute numbers of S/G2/M Plet1+ and Plet1- thymic epithelial 
cells  
The data obtained from DNA content analysis was subequently used to ascertain the 
absolute numbers of Plet1+ or Plet1- TECs that were in S/G2/M or G1/G0.  To 
calculate these figures, the absolute numbers of Plet1+ or Plet1- TECs calculated to 
be in the thymus (Table 4.1) were applied to the propo tion of Plet1+ or Plet1- TECs 
that were adjudged to be in either G1/ 0 phase (‘non-proliferating’) or S/G2/M 
phases (‘proliferating’) (Table 4.4).  Results are summarised in Table 4.5, and 
represented graphically in Figure 4.7.  Strikingly, the number of S/G2/M Plet1
+ cells 
appears to reduce from a peak of around 4,000 per lob  at E13.5 to less than 1,300 at 
E16.5.  This is accompanied by an increase in the number of G1/G0 Plet1
+ TECs, 
from a basal level in the region of 3,300 ±160 cells at E12.5-E14.5 up to over 5,800 
by E16.5.  As expected, by far the greatest increase during the developmental stages 
examined was in G1/G0 Plet1
- TECs, most of which can be deemed as post-mitotic, 
and upon the path to terminal differentiation.  Interestingly, however, there was also 
a large increase in the number of Plet1- TECs in S/G2/M.  From initially only around 
300 at E12.5, the number of S/G2 M Plet1
- TECs sees a near ten-fold increase to just 
under 2,900 by E13.5.  This population doubles in the next 24 hours to over 6,500 
cells, and again in the next 48 hours to around 11,000.  By E17.5 there were seen to 
be approximately 20,000 S/G2/M Plet1
- epithelial cells in each thymus lobe – 
accounting for almost 94% of ‘proliferating’ TECs. 
As stated earlier in this chapter, due to the inability to distinguish between G1 and G0 
cells by this method, the number of ‘proliferating’ TECs will be an underestimate, 
and the number of ‘non-proliferating’ TECs will be an overestimate. 
 






















Absolute # TEC 
in G 1/G0 (x10




Absolute # TEC 






+ 58.2 2.1 41.2 2.1 5.90 0.50 3.43 0.36 2.43 0.26 
- 70.5 3.1 29.4 3.2 1.08 0.06 0.76 0.07 0.32 0.03 
13.5 
+ 44.2 4.7 53.4 2.8 7.11 1.26 3.14 0.70 3.79 0.78 
- 55.5 3.2 43.7 3.6 6.51 0.69 3.62 0.50 2.85 0.41 
14.5 
+ 49.2 3.3 48.9 2.8 6.61 1.06 3.25 0.63 3.23 0.61 
- 67.2 2.7 32.7 1.6 19.97 4.66 13.43 3.50 6.53 1.63 
15.5 
+ 65.4 4.1 35.4 3.0 7.12 1.17 4.65 0.96 2.52 0.49 
- 79.4 4.4 21.1 2.4 35.83 2.77 28.46 3.46 7.56 0.77 
16.5 
+ 82.7 1.6 18.1 2.0 7.08 1.40 5.85 1.25 1.28 0.28 
- 82.2 1.0 17.4 1.3 65.15 9.71 53.53 8.50 11.35 1.84 
17.5 
+ 80.6 3.6 16.8 2.9 7.23 2.04 5.83 1.86 1.22 0.38 
- 83.4 2.5 15.9 0.7 121.85 5.79 101.66 7.41 19.32 1.05 
Dissociated thymus lobes were stained with antibodies to identify numbers of Plet1+ and Plet1- thymic epithelial cells present at daily 
intervals from E12.5 to E17.5 (from Table 4.1).  These data were combined with DNA content analysis (from Table 4.4) to calculate the 
number of Plet1+ and Plet1- TECs that were either in the G1/ 0 or S/G2/M phases of the cell cycle, as indicated by column numbers in 
parenthesis.  Errors were calculated by adding the proportional standard deviations (±SD) from both sets of data. 
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Figure 4.7 Absolute numbers of Plet1 + vs. Plet1 - TECs involved in cell 
cycle between E12.5 and E15.5 
Graphs display values calculated in  
 
 
Table 4.5, where flow cytometric data for the absolute number of Plet1+ and Plet1- 
TECs were combined with data on the proportion of either population adjudged to be 
involved in the cell cycle.  
Graph B is a close-up of the boxed area of graph A, included in order to show a 
clearer view of the differences between the Plet1+ G1/G0, Plet1
+ S/G2/M and Plet1
- 
S/G2/M populations. 
Plet1+ cells in G1/G0 represented by red, filled circles and solid line.  Plet1
+ cells in 
S/G2/M represented by red, open circles and dotted line.  Plet1
- cells in G1/G0 
represented by green, filled triangles and solid line.  Plet1- cells in S/G2/M 
represented by green, open triangles and dotted line.  All data points are 
representative of at least 3 independent experiments.  Error bars represent ± standard 
deviation. 
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4.2.6. Possible modes of Plet1+ TEC proliferation and cell cycle kinetics 
Because it is known that the number of Plet1+ cells in the thymus remains constant 
between E12.5 and E17.5 (Figure 4.2), that at least a proportion of these are 
proliferating at any one time (Figure 4.6), and that apoptotic cell death is minimal 
(Figure 4.3), possible modes of Plet1+ TEC proliferation can be examined.  The basic 
choice to be made between models is whether a Plet1+ c ll divides in a symmetric or 
an asymmetric manner (Figure 4.8).  In symmetric division, a Plet1+ TEC would give 
two Plet1+ progeny.  If asymmetric division were to occur, one Plet1+ daughter and 
one Plet1- daughter would be produced.  The main difference between these models 
is how the fate of the two daughter cells is decided. 
Since the number of Plet1+ cells remains constant throughout the stages of 
development examined, it follows that an average of half of all Plet1+ daughter cells 
produced must switch to a Plet1- lineage for the symmetrically dividing model to be 
true (Figure 4.8A).  If both daughter cells are identical after mitosis of their parent, 
this lineage decision must be regulated by external factors – in effect, the ‘niche’ in 
which the cells now find themselves.  In a 3-dimensio al, unpolarized stroma such as 
the developing thymus, it is difficult to imagine how this phenotypic switch could be 
controlled with sufficient accuracy as to maintain  constant number of Plet1+ cells. 
Conversely, if Plet1+ TECs divide in an asymmetric fashion, then a mechanism to 
regulate the number of Plet1+ cells is already in place (Figure 4.8B).  The result of 
this model is self-renewal, whereby every dividing Plet1+ parent cell will produce 
one Plet1+ daughter identical to itself, and one Plet1- cell.   
Consequently, it seems much more likely that Plet1+ cells divide in an asymmetric, 
self-renewing manner as this provides the best explanation of how a consistently 
sized population of these TECs may be maintained. 
Assuming that asymmetrical Plet1+ TEC division does indeed occur, two different 
scenarios can be envisaged with respect to cell cycle kinetics.  These must fit with 
the data on proportions of Plet1+ TEC in S/G2/M (Figure 4.6). 
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In the first scenario, (Figure 4.9A), an increasing proportion of the Plet1+ population 
enters quiescence as thymus ontogeny proceeds - leaving  smaller and smaller 
number of actively proliferating Plet1+ cells (‘non-uniform’ proliferation).   
In a second scenario (Figure 4.9B), most Plet1+ cells continue to proliferate during 
thymus ontogeny, but the period between divisions increases such that a smaller 
proportion of cells are in S/G2/M at any one time (‘uniform’ proliferation).  
4.2.7. Analysis of embryonic TEC division using labelled nucleotides 
To distinguish between the two possible models of Plet1+ cell cycle kinetics 
mentioned above (i.e. uniform vs. non-uniform proliferation, Figure 4.9), an in vivo 
DNA double-labelling technique using pulses of halogenated thymidine analogues 
was attempted.  Pulse labelling allows identification of any cells undergoing DNA 
replication during a specific time window, in contrast to the ‘snapshot’ of 
proliferative activity provided by 7AAD staining alone in Section 4.2.4.   
In double labelling, a pulse of 5-iodo-2’deoxyuridine (IdU) is followed by a pulse of 
5-chloro-2’deoxyuridine (CldU).  IdU was used in the primary labelling since it is 
less genotoxic than CldU (S. Tajbakhsh and P. Rocheteau, Pasteur Institute, Paris; 
personal communication).  IdU and CldU can be distingu shed by two anti-BrdU 
antibodies; one of which also has high affinity forIdU but not CldU, and the other 
vice versa (Aten et al., 1992, Bakker et al., 1991). 
Double labelling occurs where a cell participates in S phase during the first (IdU) and 
the second (CldU) pulses.  In the non-uniform proliferation model, shown in Figure 
4.9A, a large number of Plet1+ cells bearing the first label but not the second would 
be expected, with these cells having entered quiescence.  A smaller number of Plet1+ 
TEC would continue to proliferate through to the second pulse, with these bearing 
both first and second labels. 
In the uniform proliferation model (Figure 4.9B), it would be expected that all or 
most Plet1+ TEC would be double-labelled.  However, this would be dependent on 
the second pulse being long enough to catch all cells of the proliferative 
compartment in S phase.  
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It was decided to time the first pulse to finish at E14.5, as the proportion of Plet1+ 
TEC proliferating at any one moment was seen to sharply decrease with time from 
thereon (Figure 4.6).  To find the optimum labelling duration (the minimum pulse 
time required to give the maximum proportion of labelled cells) leading up to E14.5, 
a series of 5-bromo-2’deoxyuridine (BrdU) pulses of differing lengths was examined 
(BrdU was used in place of IdU in this experiment, as it was cheaper, and already 
stocked in the lab).  BrdU was dissolved in DPBS (‘carrier’), and applied by in vivo 
injection to pregnant female mice.  Pregnant mice were given a series of 5 intra-
peritoneal (i.p.) injections, beginning at E12.5, of BrdU or carrier only at 12-hour 
intervals (see Table 4.6).  Mice were sacrificed 2 hours after the final injection.   
Analysis of embryos was carried out at E14.5.  In all c ses, embryonic thymi were 
dissociated and stained with antibodies, whereupon Plet1+ TECs and Plet1- TECs 
were collected using flow cytometric sorting (see Figure 4.4).  These were fixed, 
permeabilized and analysed for BrdU uptake (using an anti-BrdU antibody), and total 
DNA content (using 7AAD).  Optimum pulse duration was seen to be 26 hours (3 
BrdU injections), as shown in Figure 4.10, since longer pulses (38 or 50 hours, using 
4 or 5 BrdU injections respectively) did not appear to increase the fraction of labelled 
cells. 
I planned to follow up this work with IdU/CldU double labelling experiments.  
Unfortunately, repeated attempts to identify IdU+ or CldU+ cells with two anti-BrdU 
antibodies of different specificity, one reportedly IdU-specific (‘anti-IdU’) and one 
CldU-specific (‘anti-CldU’), were problematic. 
To test the specificity of these antibodies, equimolar concentrations of either IdU or 
CldU only, IdU and CldU together, or saline carrier only (negative control) were i.p. 
injected into pregnant wild type female mice.  These animals were sacrificed 4 hours 
post-injection, when embryos were at the E14.5 stage. 
Embryonic thymi were removed and cells dissociated, whereupon cells were fixed, 
permeabilized, and tested for reactivity with anti-IdU or anti-CldU antibodies by 
flow cytometry.  However, even after careful titration the former did not appear to 
bind to either, whilst the latter showed non-specific binding in all samples (including 
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carrier-only negative control samples).  Due to time constraints, it was decided not to 
proceed with these experiments. 
However, some inferences about the proliferative behaviour of Plet1+ TECs prior to 
E14.5 can still be made from Figure 4.10.  It appears from examining the proportion 
of cells in the BrdU- population that between 8.48% and 17.9% of E14.5 Plet1+ TEC 
have not proliferated since before E12.5, and remain in G0 through to E13.5 and 
E14.5.  In addition, it is apparent from the 26-hour BrdU pulse that around 90% of 
Plet1+ TEC have been involved in S phase between E13.5 and E14.5. 
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Figure 4.8 Symmetrical vs. asymmetrical division of  Plet1+ cells 
Cartoon depicting two contrasting types of Plet1+ TEC division.  Red circles 
represent Plet1+ TECs.  Green circles represent Plet1- TECs.  Thin black arrows 
show parent/daughter relationships of cells, thick white arrows represent a 
phenotypic change in a single cell. 
If symmetrical division of Plet1+ TECs were to occur (A), an average of half of all 
resulting daughter cells must switch to a Plet1- phenotype in order for the number of 
Plet1+ cells in the thymus to remain constant. 
If Plet1+ TECs divide asymmetrically (B), the number of Plet1+ cells would 
automatically be maintained in a self-renewing fashion. 
This figure does not speculate on the behaviour of Plet1- cells once Plet1 expression 
has been lost. 
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Figure 4.9 Uniform vs. non-uniform Plet1+ TEC proli ferative behaviour 
 
See following page 
 
Cartoon demonstrating two possible models of embryonic Plet1+ TEC proliferative 
behaviour change.  Either could explain the observation from Figure 4.6 that, as time 
(t) progresses from E12.5 to E17.5, a smaller proportion of Plet1+ TEC are in S, G2 
or M phases of the cell cycle at any one moment.   
Red circles indicate a representative random group of Plet1+ TEC, with the cell cycle 
status of each cell shown to proceed in the direction of arrows from E12.5 to E17.5.  
Blue arrows indicate S/G2/M phase, where cells would be identified by 7AAD 
analysis (Figure 4.6), black arrows indicate G1 phase and pink arrows indicate G0.  
All Plet1+ TEC are here assumed to divide by self-renewal, givin  rise to one Plet1+ 
daughter and one Plet1- daughter (Figure 4.8). 
In A, non-uniform proliferation is shown.  Initially most Plet1+ TEC are 
proliferating, but as thymus ontogeny proceeds a growing proportion enters 
quiescence. 
B demonstrates a uniform proliferation model.  Here, all Plet1+ begin to enter G0 
‘replication refractory’ periods.  These refractory periods lengthen as thymus 
ontogeny proceeds, resulting in individual cells proliferating less frequency. 
Coloured boxes represent timings of sequential IdU (green) and CldU (orange) 
pulses in thymidine analogue double-labelling experim nts.  Gap between pulses 
ensures no double labelling occurs during a single S phase. 
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Figure 4.9 Uniform vs. non-uniform Plet1 + TEC proliferative behaviour 
For legend, see previous page. 
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0 - 5 0 
2 14.5 4 1 
14 14.0 3 2 
26 13.5 2 3 
38 13.0 1 4 
50 12.5 0 5 
Groups of 3 or more pregnant mice were pulsed with BrdU for 0, 2, 14, 26, 38 or 50 
hours.  All groups received 5 intraperitoneal injections, beginning at E12.5 and then 
every 12 hours, of either carrier only, or carrier plus BrdU, as detailed above.  The 
age at which BrdU was consequently introduced is also stated.  Thymi from all 
embryos were harvested and processed 2 hours after final injection at E14.5.  Within 
each group, thymi were pooled and processed in a sigle sample. 
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Figure 4.10 Analysis of BrdU uptake 
To find the optimum pulse duration required for maximum labelling of E14.5 Plet1+ 
TEC, intra-peritoneal injections of BrdU were given to pregnant females as detailed 
in Table 4.6.  BrdU content was analysed in sorted Pl t1+ cells at E14.5. 
In A, BrdU analysis is displayed.  Cells are CD45-TER119-PanK+MTS20+ (see 
Figure 4.4).  Data in top row (0h, 2h, 14h) and bottom row (26h, 38h, 50h) were 
gathered on different days. 
Histogram (B) shows percentage of labelling achieved with each pulse duration.  
Black bars represent the proportion of Plet1+ TEC labelled with BrdU.  Grey bars 
indicate the proportion of Plet1+ TEC that were unlabelled and remained in G0.  N=1. 
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4.3. Discussion 
I analysed the proportion of TECs staining for Plet1, an extra-cellular antigen 
marking a population of foetal thymic epithelial progenitors, by flow cytometry 
(Figure 4.1). 
Plet1+ TECs were seen to comprise almost 90% of all TECs at E12.5. It had 
previously been reported that Plet1+ TECs comprised around 50% of total thymic 
epithelium at E12.5 (Bennett et al., 2002, Gill et al., 2002).  However, these studies 
did not take into account thymic mesenchyme, which makes up a substantial 
proportion of thymus cellularity at E12.5 (see Chapter Three of this thesis) and 
which would have been included in their ‘total epithelial’ populations.   
I found the Plet1+ proportion of TECs to steadily reduce on a daily basis, comprising 
around 18% at E15.5.  Gill and colleagues reported Pl t1+ cells to be 25% of the total 
CD45- population.  Although not an enormous difference, this discrepancy might be 
accounted for by improvements in dissociation technique.  It is likely that 
differentiated Plet1- TECs (especially delicate, stellate cTEC) were more prone to 
cell death than undifferentiated Plet1+ TEC during older, less refined methods of 
dissociation.  Current methods use additional enzymes, such as hyaluronidase, to 
break extracellular matrix attachments, and consequently are less reliant on 
potentially damaging mechanical force to separate cells.   
When proportional data were translated into actual n mbers of Plet1+ or Plet1- TECs 
present at each day of embryonic development from E12.5 until E17.5, it was 
striking to observe that the number of Plet1+ cells remained constant – at 
approximately 6,000 – 7,000 (Table 4.1, Table 4.2). 
Following this observation, I decided it was important to examine whether the Plet1+ 
TECs either continued to divide, or dropped out of he cell cycle.  TEC DNA was 
quantified by 7AAD staining, to ascertain the percentage of Plet1+ and Plet1- cells 
that were in S/G2/M phase at each time point.  This revealed the prolife ative peak in 
both Plet1+ and Plet1- TECs to be around E13.5.  In both Plet1+ and Plet1- TECs, a 
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steady decrease in the proportion of cells in S/G2/M was seen in each successive 24-
hour period after E13.5.   
It might have been expected that a higher proportion of cells would have been 
dividing at E12.5 than at E13.5.  One possible explanation for this result is the 
influence of intrathymic mesenchyme.  Mesenchyme-derived growth factors, FGF7 
and FGF10, are known to induce epithelial proliferation (Revest et al., 2001).  
Mesenchymal cells penetrate inward from the periphey of the thymus lobes from 
around E13, resulting in closer proximity to an increased number of TECs.  This 
could increase the proportion of the TEC population receiving proliferation-inducing 
signals, resulting in a larger percentage of TECs entering the cell cycle.   
A recent publication, using the proliferation marker Ki67 in keratin+ thymic cells, 
has backed up my findings on the proportion of TECs proliferating during different 
stages of thymus ontogeny with very similar data (Jenkinson et al., 2007). 
Since there were always some Plet1+ cells proliferating at each stage of 
organogenesis examined, and yet the Plet1+ population was found to be of a constant 
size, it was concluded that Plet1+ TECs must continually contribute to Plet1- TEC 
expansion throughout thymus ontogeny.  Examination of TEC apoptosis levels 
supported this conclusion.  Minimal TEC death was ob erved during these stages of 
ontogeny (Figure 4.3), indicating that all daughter c lls from Plet1+ TEC divisions 
were still present.  Taken together, these findings allowed the proposal of two 
contrasting modes of Plet1+ TEC division (Figure 4.8).   
The first model is symmetrical division, where two identical Plet1+ daughter cells are 
produced (Figure 4.8A).  In order to conform to the data showing a constant 
population size, a symmetric division model would require external factors to cause 
an average of only one daughter to remain Plet1+, whilst one became Plet1-.  This 
could be the case if parent cells were fixed in position, e.g. anchored to a basement 
membrane, and mitosis occurred in a polarised fashion (such that one daughter would 
move away whilst the other would remain in the ‘niche’ occupied by the parent cell).  
This concept could easily be applied in simple stratified epithelium.  In the three-
dimensional stroma of the embryonic thymus, however, it is not obvious how such a 
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mechanism may occur.  The second model is asymmetrical division, where the Plet1+ 
population is constantly maintained through self-renewal (Figure 4.8B). 
Thus, the asymmetric model provides the most logical means of maintaining Plet1+ 
TEC number.  If an asymmetrically dividing model were true, occasional 
symmetrical division may still occur in order for homeostatic maintenance of 
stem/progenitor cell numbers.  This has been proposed to occur in the intestinal 
epithelium, where mathematical modelling suggests that around 5% of stem cell 
divisions occur symmetrically, resulting in an ability to adjust the number of stem 
cells present in a single crypt (Loeffler et al., 1997). 
The data showing a proportional decrease in Plet1+ cell proliferation over time were 
applied to the corresponding absolute number of Plet1+ TEC present, for each time 
point.  From this, it is clear that as organogenesis proceeds, a smaller number of 
Plet1+ TECs are actively proliferating.  The following scenarios can here be 
envisaged:  
A) Non-uniform replicative behaviour.  A decreasing sub-population of Plet1+ cells 
continues to proliferate, whilst the remainder enter quiescence. 
B) Uniform replicative behaviour.  All/most Plet1+ cells remain in the cell cycle, but 
become increasingly slow-cycling. 
Scenario A involves a Plet1+ population with heterogeneous cell cycle kinetics 
(Figure 4.9).  Most will be actively proliferating during earlier stages of 
organogenesis, but over time an increased number become quiescent.  If this scenario 
is true, quiescence may be in response to presentation or withdrawal of certain 
undefined external mitogenic or anti-mitogenic factors.  It is likely that other cells in 
the thymus would provide such queues.  Changes in the immediate ‘niche’ of a 
Plet1+ TEC, or in its wider vicinity, during thymus development may activate the 
triggers involved in the decision between continued proliferation or entry into 
quiescence. 
If scenario B were true, it may be as a result of pr portional changes in length of one 
or more phases of the cell cycle.  M phase is generally consistent (around an hour) in 
most mammalian cell types.  However, G2 (normally 2 to 5 hours), and particularly 
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G1 and S phases can be more prone to durational variation.  For example, studies on 
the developing rat retina have indicated an increase in cell cycle length over the 
course of embryonic and early postnatal development, predominantly attributable to 
increased S phase duration (Alexiades and Cepko, 1996).  Cell cycle phase time can 
increase for a number of reasons.  For S phase, the number of replication origins and 
their timing can regulate duration (Holmquist, 1987).  In G1 or G2, cells must pass 
checkpoints, which are partly to ensure the cell is in a physiologically fit state and 
prepared to proceed with the subsequent stage.  If the nutritional or energetic 
requirements for carrying out these tasks were met with decreased efficiency, or in a 
less timely manner, some phases of the cell cycle may be progressively slowed (or 
vice versa).  In the thymus, the number of epithelial cells detected to be in S/G2/M at 
any one time was found to decrease as thymus ontogeny proceeds (Figure 4.6).  In 
the context of the cell cycle, it follows that this could result from an increased 
(G1/G0):(S/G2/M) ratio, i.e. prolonged G1/G0 or shortened S/G2/M phases. 
Another explanation for scenario B may be the existnce of an increasing refractory 
period between divisions (G0), as indicated in Figure 4.9B.  A study on β cell 
expansion in the mature mouse pancreas has shown such a mechanism (Teta et al., 
2007).  Here, the authors labelled proliferating cell DNA in vivo with sequential 
pulses of the halogenated thymidine analogues CldU and IdU.  Double labelled cells 
were only seen in substantial numbers following 1 month and 8 month pulses of the 
respective analogues, whereas 1 week of CldU followed by 4 weeks of IdU yielded 
very few.  The study concluded that most adult β cells are not postmitotic, and 
eventually divide more than once, but that these divisions are limited by a replication 
refractory period (Teta et al., 2007).  The cell cycle kinetics of Plet1+ TECs could be 
explained by an increase in replication refractory period as thymus development 
proceeds, resulting in an increasingly smaller fraction of cells being in S/G2/M at any 
one time. 
Double labelling with the halogenated thymidine analogues IdU and CldU was 
attempted, in order to distinguish between the two m dels from Figure 4.9.  
Unfortunately this proved unsuccessful due to detection problems.  However, 
labelling with BrdU alone was able to reveal some information.  A 26-hour pulse 
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from E13.5 to E14.5 showed almost 90% of Plet1+ TECs proliferated during this 
period, whilst longer pulses indicated between 8.5% and 17.9% of Plet1+ TECs had 
not proliferated since before E12.5 (Figure 4.10).   
4.3.1. Epithelial progenitor/stem cells in other tissues 
In addition to the thymus, a number of other organs exhibit epithelial turnover and 
renewal.  The nature of stem/progenitor cells that are involved in the creation and 
maintenance of these organs have been studied at various levels of depth and may be 
helpful in suggesting the models of proliferation and differentiation which occur in 
thymic epithelium.  Unfortunately with regards to thymus development, it is mainly 
observations on adult tissue stem cells that have been recorded in these studies and 
not progenitor/stem cells involved during initial embryonic organ development.  
However, I decided to examine whether any mechanisms documented within these 
other organs may assist in the dissection of events within thymus development. 
4.3.1.1. Mammary epithelium 
In the mammary gland a single stem cell is able to give rise to an entire new, 
functional mammary epithelial network (Shackleton et al., 2006).  There are two 
major mammary epithelial types – myoepithelial and luminal (with ductal and 
alveolar subtypes).  In the human, progenitor cells have been identified that are 
luminal-restricted, myoepithelial-restricted or bipotent when cultured in vitro (Eirew 
et al., 2008, Stingl et al., 2001).  Similarly, in the mouse, separate progenitor 
populations with varying proliferative abilities have been identified (Stingl et al., 
2006).  These cell types may represent a progressive restriction of epithelial lineage. 
4.3.1.2. Intestinal epithelium 
Similar to the steady-state mature thymus, constant epithelial turnover occurs in the 
intestine.  Intestinal stem cells inhabit invaginations known as crypts, with the lower 
part of each adult crypt holding 4-6 SC (Cai et al., 1997, Potten, 1998, Roberts and 
Potten, 1994).  These cells self-renew, and multipotent daughters produce a transit 
amplifying (TA) population.  Around 6 generations are produced from each first 
generation TA progenitor cell, culminating in terminal differentiation.  In the small 
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intestine, commitment to one of 4 epithelial lineags (enterocyte, Goblet cell, 
enteroendocrine cell or Paneth cell) occurs at around the third generation of the TA 
population (Marshman et al., 2002).  First and second generation TA cells have 
progressively improved DNA repair abilities, but inestinal SC preferentially undergo 
apoptosis rather than attempt to repair damaged DNA(Potten, 1977).  The number of 
SC present in a single crypt may subsequently be adjuste  – mathematical modelling 
suggests that around 5% of SC divisions occur in a symmetrical manner, producing 2 
SC or two TA cells, providing a means of homeostatic maintenance (Loeffler et al., 
1997).  Recent work has enabled the identification of an intestinal SC population as 
small, Lgr5+ cells interspersed between Paneth cells (Barker et al., 2007, Haegebarth 
and Clevers, 2009). 
4.3.1.3. Pancreatic epithelium 
The pancreas contains three types of epithelial-derived cells – those of the pancreatic 
ducts, endocrine (islet) cells, and exocrine (acinar) cells.  The pancreas develops 
initially as small buds from the endodermal epithelium, from E9.5 - at which point 
the epithelial cells are morphologically similar and show staining for the 
transcription factor Pdx1 (Offield et al., 1996).  These buds begin extending multiple 
branches into the surrounding mesenchyme at around E11.5.  The distal tips of the 
nascent branching epithelium contain Pdx1+Cpa1+ multipotent progenitor cells that 
leave endocrine and duct progeny in their wake (Zhou et al., 2007).  At 
approximately E14, these multipotent cells have been observed to undergo a 
phenotypic transition and become restricted to the exocrine lineage (Zhou et al., 
2007).  In contrast to medullary islets in the thymus, neither acini nor endocrine islets 
in the pancreas exhibit clonal growth from single cells (Percival and Slack, 1999). 
Islet β-cell mass expands continually but gradually throughout adulthood (Bock et 
al., 2003, Butler et al., 2003, Kushner et al., 2002).  Limited regeneration can occur 
following injury by partial pancreatectomy.  However, no new islets are formed, and 
it has been shown that although new β-cells can be created within existing islets, 
these occur by self-duplication of existing β-cells rather than differentiation from a 
pancreatic stem cell (Dor et al., 2004).  Interestingly, however, a recent study showed 
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that with a different injury model – partial duct ligation - a neurogenin3 (ngn3)+ β-
cell progenitor population appears (Xu et al., 2008).  This seems to be analogous to 
the transient ngn3+ progenitor population seen during embryonic development, 
suggesting the persistence of a β-cell stem/progenitor cell into adulthood that may be 
reactivated under certain conditions. 
4.3.1.4. Epidermal epithelium 
Patterns of epithelial stem cell growth and amplification have been reasonably well 
characterised in the skin.  Upon culture of skin keratinocytes, populations of varying 
proliferative ability can be identified (Barrandon a d Green, 1987).  The cells with 
the largest clonogenic potential, so-called ‘holoclones’, are found predominantly in 
the ‘bulge’ region of the hair follicle, below the s baceous glands – a region rich in 
label-retaining cells (LRC) (Kobayashi et al., 1993, Rochat et al., 1994, Cotsarelis et 
al., 1990).  This region contains multipotent stem cells; capable of producing not 
only hair follicle cells, but also giving rise to the intrafollicular epidermis (both in 
expanding newborn mouse skin, and in response to wounding in adult mouse skin) 
(Oshima et al., 2001, Taylor et al., 2000).  During homeostasis, however, continual 
epidermal replacement is generated solely from unipotent epidermal stem cells 
anchored in the innermost, basal, layer (Ito et al., 2005).  These have been shown to 
divide in an asymmetric manner, and it is thought that most or all basal layer 
epithelial cells may have unipotent SC abilities (Clayton et al., 2007, Lechler and 
Fuchs, 2005).  Sebaceous glands can also be maintained from their own resident 
progenitors during homeostasis (Horsley et al., 2006). 
Hair follicles undergo cycles of proliferation and downward expansion into the 
dermis (anagen), followed by degeneration (catagen) and a period of dormancy 
(telogen).  The lowest permanent section of the hair follicle is the bulge region.  
When anagen occurs, transient proliferation is seen amongst the otherwise quiescent 
cells of the bulge (Wilson et al., 1994b).  These slow-cycling cells are specified 
during early morphogenesis, giving rise to the adult bulge later during skin 
development (Nowak et al., 2008).   
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The existence of an additional population of Plet1+ (MTS24+) cells, displaying 
stem/progenitor–like clonogenic properties, has been r cently documented (Nijhof et 
al., 2006).  These reside directly above the bulge region of the hair follicle, in the 
upper isthmus, and transplant experiments suggest th y are also multipotent (Jensen 
et al., 2008).  Their relationship to bulge SC remains to be determined. 
Recent work has also identified a population of faster-cycling Lgr5+ bulge 
stem/progenitors (Jaks et al., 2008).  Although most bulge cells remain active but 
slow-cycling during anagen the bulge remains a constant size, as their progeny leave 
the bulge and contribute to the growing follicle (Blanpain et al., 2004, Oshima et al., 
2001).   
4.3.2. Models of TEC proliferation during ontogeny 
The idea of a constant sized, continually cycling population of stem/progenitor cells 
has been applied to intestinal crypts and to the bulge region of the hair follicle. 
Although developed mainly from observations in adult tissue, and not during organ 
development, I have tried to relate this concept to thymus ontogeny.  It is 
conceivable, and consistent with my experimental results, that a slowly cycling 
Plet1+ TEC population of constant size gives rise to more rapidly dividing transit 
amplifying (TA) Plet1- progeny.  The majority of Plet1+ cells would be expected to 
divide asymmetrically, allowing self-renewal of the stem/progenitor population.  In 
addition, there may be a mechanism for occasional symmetrical division – this would 
aid in homeostatic maintenance of stem/progenitor cell numbers, and has been noted 
to occur in intestinal SC (Loeffler et al., 1997). 
A continual increase in the total TEC population size, coupled with a continual 
decrease in the rate of Plet1+ proliferation, suggests that post-mitotic, fully 
differentiated TECs are produced from a dynamic population of Plet1- TA TECs that 
undergo several rounds of division.  
Decreased Plet1+ proliferation coincides with phenotypic changes in Plet1+ cells such 
as increased MHC class II expression, and a decreasing number of Plet1+ cells co-
expressing K5 and K8.  It may be that progressive lin age restriction accompanies 
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these phenotypic changes.  Alternatively, lineage restriction may occur after a 
number of rounds of TA cell division (as in the intestine). 
Clones generated by the laacZ system could potentially reveal the size of any Plet1- 
proliferative unit (i.e. from prospective first-generation TA cells until fully 




Chapter 5. Results: Retrospective clonal analysis u sing the 
laacZ system 
5.1. Introduction 
5.1.1. Application of the laacZ system in thymic epithelial cells 
It is known that all TECs originate from the endoderm of the 3rd pharyngeal pouch 
(Gordon et al., 2004).  However, at the start of this project there was no reliable 
information as to the relationship between mTECs and cTECs during embryonic 
development.  Do medullary and cortical lineages diverge at an early stage during 
thymus development, do they share a common progenitor cell until shortly before 
differentiation, or does a mixture of these mechanisms operate?  Compilation of a 
TEC clone library would definitively answer this question (Figure 5.1).  
It was decided to use the laacZ expression model under control of the ubiquitous 
ROSA26 promoter, resulting in detectable clones in all possible cell lineages.  
Antibody staining would be used to confirm the identity of any potential TEC clones. 
It is important to compile a saturated clone library s far as possible, where every 
potential size and variety of clone is represented at least once, and additional clones 
would not provide extra information.  In general, tissues will exhibit the longest 
clones (many labelled cells) rarely and shortest clones (i.e. one labelled cell) much 
more frequently, due to a smaller pool of ancestral cells being present at the time 
when longer clones would be initiated.  It might be thought that long clones would 
originate from more distant precursors, with smaller clones being born at a more 
recent point in history.  However, this is not necessarily the case.  Large clones may 
originate from a population of more recent, rapidly ividing cells.  Conversely, 
labelling of older cells that divide slowly, become dormant, or differentiate at an 
early stage can give rise to clones of a much smaller size.  In a saturated clone 
library, the ratio of different clone sizes that appear can aid in deducing the modes of 
cell division involved in construction of a tissue.   
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5.1.2. Strategies for TEC clone library analysis  
Firstly, modes of TEC division can be deduced by examining the frequency at which 
long (many labelled cells) and short (few labelled c lls) clones occur.  If cells divide 
in a symmetrical manner (Figure 5.2A), a small number of longer, older clones 
would be observed, with a higher frequency of shorter, younger clones (Figure 
5.2B&C).  Conversely, if cells were to divide in an symmetrical, self-renewing 
manner, only one extra cell is produced from each round of cell division (Figure 
5.2D.)  In this model, there would be an equal chane of observing a clone of any 
given size (apart from a single-cell clone, expected to occur in half of all labellings), 
as demonstrated in Figure 5.2D and E.  Upon grouping clones into classes of 
increasing exponential size however, an increase in occurrence would be observed 
for each size group (Figure 5.2F). 
The minimum/maximum sizes and scarcity at which clones consisting entirely of 
cTEC or of mTEC are seen would aid in identifying size, longevity, and proliferative 
potential of the putative common TEPC.  In order to ascertain the point in time at 
which common TEPCs make the transition to mTEPCs and cTEPCs (or indeed do 
not), the clone library can be subjected to a variety of analyses.  Two of which, 
crossing index and dual origin coefficient, are described below. 
Crossing index is a measure of clones appearing in multiple parts of a structure that 
has been “divided into units either arbitrarily or n the basis of morphological 
markers” (Petit et al., 2005).  In this case there ar  two units - cortex and medulla.  
Here, the crossing index would be created using groups of clones of the same size, 
i.e. those containing 4 cells, those containing 5 cells etc.  The crossing index would 
be expressed as the percentage of that clone size group crossing the medulla/cortex 
divide.  If a particular size group has a crossing index of 0%, one can imply that no 
common TEPCs were present at the stage where the ini ial labelling of clones of that 
size occurred.  The minimum clone size at which the crossing index is larger than 0% 
will point toward the most recent point in history at which a common progenitor 
existed.  A very high crossing index would be expected to occur at some point, in a 
clone size corresponding to an ancestral cell capable of giving rise to all TEC types, 
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even if it were to occur only at a very early stage prior to formation of the thymic 
rudiment. 
Dual origin coefficient can be calculated in order to assess proportional contribution 
to medulla and cortex from clones of different size.  I have adapted this method 
from the “coefficient of bilaterality” used in determining left/right contribution of 
clones along the mediolateral axis of the presomitic mesoderm (Eloy-Trinquet and 
Nicolas, 2002).  In the thymus, dual origin coefficient (DOC) would be defined as 
(nC-nM)/(nC+nM), where nC and nM are the number of labelled cTEC and mTEC 
cells respectively, in any given clone.  DOC values would range between -1 (a clone 
comprising solely of medullary epithelium) and 1 (a cortex-only clone).  Clones with 
a DOC of 0 would contribute an equal number of cells to both lineages.  DOC would 
be plotted against clone size, thus allowing comparison within a roughly equivalent 
precursor pool. 
Three hypothetical examples using imaginary clones are shown below to 
demonstrate the outcome of DOC analysis in different developmental models.  
Example 1 (Table 5.1, Figure 5.3A) shows a group of cl nes emanating from a 
precursor pool containing lineage-restricted TEPCs only.  DOC values of either 1 or 
-1 are present, ruling out a bipotent progenitor at the stage these clones were born.  In 
example 2 (Table 5.2, Figure 5.3B), all clones exhibit a dual cortical and medullary 
identity.  These would have originated from a pool f common TEPCs retaining the 
potential to give rise to both cTECs and mTECs and hence displaying DOC values 
anywhere between -1 and 1.  Example 3 (Table 5.3, Figure 5.3C) also represents 
clones from a bipotent precursor pool.  However, most of the precursors here gave 
rise exclusively to cortex, with only a small number producing medulla in addition.  
This bias would be seen if a default TEC phenotype existed (i.e. cortex), diverging 
only when induced to do so in certain cells.  I have included this model based partly 
on the finding that medullary areas are often present as “cuffs” surrounding 
intermediate-sized thymic vasculature (Anderson et al., 2000).  It is a possibility that 
these medullary areas originate by differentiating from an equipotent pool of TEPCs, 
upon receipt of molecular stimuli associated with certain vessels, i.e. fate choice 
could be ‘niche-dependent’.  The models described above are by no means the only 
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possible outcomes for DOC analysis of the thymus, however they are good examples 
to demonstrate the usefulness of this technique. 
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Figure 5.1 Possible outcomes of clonal analysis 
Compilation of a TEC clone library would reveal the relationship between cortex and 
medulla.  A basic example of retrospective clonal analysis is shown here.  At the top, 
the very early thymus is represented, showing a population of epithelial progenitor 
cells.  The developmental potential of these is unknown.  A single laacZ 
recombination event occurs, labelling one of these TEPCs.  Below are 
representations of two possible outcomes, following a alysis of this thymus lobe at a 
later time point.  The diagram on the left shows a clone consisting entirely of 
mTECs, indicating that the cell in which the laacZ recombination occurred was 
restricted to a medullary-only fate.  Conversely, the right-hand diagram represents a 
clone containing both mTECs and cTECs, showing thate initial labelled cell 
retained the potential to give rise to medullary and cortical lineages. 
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Figure 5.2 Frequency of clone sizes can indicate mo des of cell division 
In each of these models, imagine that a laacZ recombination has an equal chance of 
occurring in any cell.  Cells present at the time of cl ne observation are shown in 
yellow, precursors are shown in red to indicate mode f growth.  Graphs show the 
relative frequency expected for clones of a specifid size (or group of sizes) to occur, 
in a population of cells with the given growth mode. 
A population of progenitor cells may divide in a symmetric manner as shown in A.  
In this model, clones show a decrease in frequency as their size increases (B).  This 
is seen irrespective of whether or not clones are grouped according to exponential 
increases in size (C).   
In the asymmetrical model (D), clones comprised of one cell are most frequent; 
clones with more than one cell appear with lower, equal frequency (E).  Upon 
grouping these clones into classes of upward exponential size however, an 
exponential increase in their occurrence is observed (F). 
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Table 5.1 Single lineage contribution 
Table 5.2 Global dual lineage contribution 
Table 5.3 Biased, occasional dual lineage contribut ion 
See following page. 
Tables show imaginary data used to demonstrate 3 outcomes of dual origin 
coefficient (DOC) analysis.  Each table details thecomposition of 12 clones in a 
similar size group (A-L), indicating the number of cortex and medulla cells in each, 
and the total number of cells.   
DOC values were calculated as: (nC-nM)/(nC+nM), where nC is the number of 
labelled cortical cells and nM the number of labelled medullary cells in that 
particular clone. 
Table 5.1, Table 5.2, and Table 5.3 are illustrated by Graph A, Graph B and Graph C 
respectively in Figure 5.3. 
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For legend, see previous page. 
Table 5.1 Single lineage contribution 
Clone Cortex (nC) Medulla (nM) Total D.O.C. 
A 27 0 27 1.00 
B 18 0 18 1.00 
C 21 0 21 1.00 
D 0 16 16 -1.00 
E 30 0 30 1.00 
F 0 28 28 -1.00 
G 0 19 19 -1.00 
H 23 0 23 1.00 
I 0 25 25 -1.00 
J 0 22 22 -1.00 
K 25 0 25 1.00 
L 17 0 17 1.00 
 
Table 5.2 Global dual lineage contribution 
Clone Cortex (nC) Medulla (nM) Total D.O.C. 
A 12 8 20 0.20 
B 18 14 32 0.13 
C 20 10 30 0.33 
D 11 9 20 0.10 
E 14 16 30 -0.07 
F 9 16 25 -0.28 
G 10 16 26 -0.23 
H 16 9 25 0.28 
I 16 15 31 0.03 
J 10 12 22 -0.09 
K 7 10 17 -0.18 
L 12 12 24 0.00 
 
Table 5.3 Biased, occasional dual lineage contribut ion 
Clone Cortex (nC) Medulla (nM) Total D.O.C. 
A 12 8 20 0.20 
B 18 0 18 1.00 
C 26 0 26 1.00 
D 22 9 31 0.42 
E 22 0 22 1.00 
F 17 0 17 1.00 
G 32 0 32 1.00 
H 20 0 20 1.00 
I 16 15 31 0.03 
J 29 0 29 1.00 
K 24 0 24 1.00 
L 16 12 28 0.14 
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Figure 5.3 Dual origin coefficient showing three mo dels of TEC 
development 
A) A unipotent model is represented, using data from Table 5.1.  Separate progenitor 
pools exist for cortex or for medulla.  Clones are exclusively medullary or cortical, 
never both.   
B) Shows data from Table 5.2.  Here, clones originate from a common progenitor 
pool, which can and does give rise to both lineages.  All clones are therefore 
composed of both cortex and medulla. 
C) Represents Table 5.3.  The precursor cells in which these labelled clones 
originated primarily gave rise to cortex only.  However, a small number also show 
medullary progeny.  This model might be seen if progenitors had bipotent ability, but 
only a fraction received an induction signal to produce medulla. 
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5.2. Results 
5.2.1. Calculation of expected epithelial clone frequency 
Two variants of the laacZ gene, containing different duplication sizes and therefore 
different recombination frequencies, have been constructed.  The shorter, with an 
internal duplication of 289bp (R26laacZ0.3), shows laacZ recombination occurring 
at a rate of 1.66 x 10-6 per cell per generation in mouse embryonic stem (ES) cells in 
culture.  The larger 1,117bp duplication (R26laacZ1.1) displays a higher 
recombination rate of 8.15 x 10-6 per cell per generation in ES cells (E. Tzouanacou, 
unpublished results).  These two duplication sizes enable the selection of an 
appropriate clone generation frequency for TEC clone production.   
In order to choose the correct combination of embryo age and laacZ duplication size, 
a number of factors were taken into account.  Firstly, a thymus developmental stage 
at which sufficient numbers of differentiated cTECs and mTECs are present and 
identifiable was important, so that the lineage of labelled epithelial clones could be 
ascertained (E14 or above).  Secondly, an age should be identified at which the size 
of the epithelial population would allow the assumption of any labelled TECs being 
clonal, i.e. less than one TEC laacZ recombination event per thymus lobe. 
Recombination of laacZ can be analysed by the fluctuation test of Luria and 
Delbrück.  This test was originally developed in order to distinguish between random 
and bacteriophage-induced mutations in E. coli that resulted in resistance to phage 
attack (Luria and Delbruck, 1943).  The test predicts that for a spontaneous, random 
and heritably transmitted mutation (such as l acZ recombination), the number of 
genetic recombinations occurring follows a Poisson distribution, with parameter λ.  
Here, λ is the expected mean number of recombinations per thymus lobe and can be 
expressed as mNt (where m is the recombination frequency, measured as number of 
recombinations per cell per generation, and Nt is the number of TECs present per 
lobe as calculated in Chapter 3).  λ was calculated for each combination of laacZ 
duplication size and embryo age of study, as shown in Table 5.4.  If the expected 
mean number of occurrences of clones in a single lob is λ, then the probability of 
exactly N clones occurring in a single lobe is (λNe-λ)/(N!) according to Poisson.  This 
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enables the fraction of thymus lobes harbouring N independent clones to be 
calculated, and hence the percentage of all thymus lobes expected to carry N 
independent clones (Table 5.4).   
The recombination frequencies can be increased further if laacZ mice are mated 
together i.e. a homozygous R26laacZ1.1 cross, a homozygous R26laacZ0.3 cross, or 
a heterozygous cross involving one parent from each strain.  The expected 
recombination frequencies for these three additional ptions are shown in Table 5.5. 
It was initially decided to use R26laacZ0.3+/+ embryos, at the E16.5 stage, to perform 
the analysis.  At E16.5 the majority of TECs display a differentiated phenotype, 
enabling easier classification of potential clones.  This genotype would be expected 
to produce labelled TEC clones in approximately 26% of thymus lobes studied, 
providing a reasonable return for the number of lobes involved (Table 5.5).  The 
expected probability of >1 TEC labelling event occurring in a single lobe is 
calculated at 3.6%.  This might appear to be higher t an desired, but in reality a large 
number of clones would consist of one cell and would therefore be very rarely 
detected.  The likelihood of two epithelial clones of a detectable size arising in a 
single thymus lobe would consequently be an extremely rare event. 
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Table 5.4 Expected thymic epithelial recombination frequencies in 
heterozygous ( laacZ x wild-type) embryos 
Embryo age 17.5 16.5 15.5 14.5 13.5 12.5 
TEC # (Nt) 1.41x105 1.01x105 5.14x104 3.18x104 1.37x104 8.23x103 
Genotype R26laacZ1.1+/- 
Rec. rate (m) 8.15x10-6  
mNt (λ) 1.147 0.823 0.419 0.259 0.112 0.067 
% of thymus lobes displaying N independent clones 
N=0 31.8% 43.9% 65.8% 77.2% 89.4% 93.5% 
N=1 36.4% 36.1% 27.6% 20.0% 10.0% 6.3% 
N=2 20.9% 14.9% 5.8% 2.6% 0.6% 0.2% 
N=3 8.0% 4.1% 0.8% 0.2% 0.0% 0.0% 
N=4 2.3% 0.8% 0.1% 0.0% 0.0% 0.0% 
N=5 0.5% 0.1% 0.0% 0.0% 0.0% 0.0% 
Total labeled 
(fL) 68.2% 56.1% 34.2% 22.8% 10.6% 6.5% 
Genotype R26laacZ0.3+/- 
Rec. rate (m) 1.66x10-6 
mNt (λ) 0.234 0.168 0.085 0.053 0.023 0.014 
% of thymus lobes displaying N independent clones 
N=0 79.2% 84.6% 91.8% 94.9% 97.7% 98.6% 
N=1 18.5% 14.2% 7.8% 5.0% 2.2% 1.3% 
N=2 2.2% 1.2% 0.3% 0.1% 0.0% 0.0% 
N=3 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 
N=4 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
N=5 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Total labeled 
(fL) 20.8% 15.4% 8.2% 5.1% 2.3% 1.4% 
       
 0.0% = less than 0.05%    
Calculation of the proportion of thymus lobes expected to contain a given number 
(N) of epithelial clones.  To find the mean number of TEC clones per lobe (λ) at a 
specific embryo age, the number of epithelial cells at that age (Nt) was multiplied by 
the laacZ-LacZ recombination rate (m) known to occur for each genotype (in 
recombinations per cell per generation).  The calcul ted mean (λ) was then used as 
the parameter of a Poisson distribution, to work out the probability of ‘N’ 
independent clones arising in a single thymus lobe, using the formula (λNe-λ)/(N!).  
The total fraction of lobes labelled (fL) was calculated as (100% - N=0).  
Calculations were carried out using Microsoft Excel. 
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Table 5.5 Expected thymic epithelial recombination frequencies from 
different laacZ x laacZ cross embryos 
Embryo age 17.5 16.5 15.5 14.5 13.5 12.5 
TEC # (Nt) 1.41x105 1.01x105 5.14x104 3.18x104 1.37x104 8.23x103 
Genotype R26laacZ1.1+/+ 
Rec. Rate(m) 1.63x10-5 
mNt (λ) 2.294 1.646 0.838 0.518 0.224 0.134 
 % of thymus lobes displaying N independent clones 
N=0 10.1% 19.3% 43.2% 59.6% 79.9% 87.4% 
N=1 23.1% 31.7% 36.3% 30.9% 17.9% 11.7% 
N=2 26.5% 26.1% 15.2% 8.0% 2.0% 0.8% 
N=3 20.3% 14.3% 4.2% 1.4% 0.1% 0.0% 
N=4 11.6% 5.9% 0.9% 0.2% 0.0% 0.0% 
N=5 5.3% 1.9% 0.1% 0.0% 0.0% 0.0% 
Total labeled 
(fL) 89.9% 80.7% 56.8% 40.4% 20.1% 12.6% 
Genotype R26laacZ0.3+/+ 
Rec. Rate(m) 3.32x10-6 
mNt (λ) 0.467 0.335 0.171 0.106 0.046 0.027 
 % of thymus lobes displaying N independent clones 
N=0 62.7% 71.5% 84.3% 90.0% 95.5% 97.3% 
N=1 29.3% 24.0% 14.4% 9.5% 4.4% 2.7% 
N=2 6.8% 4.0% 1.2% 0.5% 0.1% 0.0% 
N=3 1.1% 0.4% 0.1% 0.0% 0.0% 0.0% 
N=4 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 
N=5 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Total labeled 
(fL) 37.3% 28.5% 15.7% 10.0% 4.5% 2.7% 
Genotype R26laacZ1.1/R26laacZ0.3 
Rec. Rate(m) 9.81x10-6 
mNt (λ) 1.380 0.990 0.505 0.312 0.135 0.081 
 % of thymus lobes displaying N independent clones 
N=0 25.1% 37.1% 60.4% 73.2% 87.4% 92.2% 
N=1 34.7% 36.8% 30.5% 22.8% 11.8% 7.4% 
N=2 24.0% 18.2% 7.7% 3.6% 0.8% 0.3% 
N=3 11.0% 6.0% 1.3% 0.4% 0.0% 0.0% 
N=4 3.8% 1.5% 0.2% 0.0% 0.0% 0.0% 
N=5 1.1% 0.3% 0.0% 0.0% 0.0% 0.0% 
Total labeled 
(fL) 74.9% 62.9% 39.6% 26.8% 12.6% 7.8% 
For explanation, see Table 5.4.  Recombination frequencies (m) for laacZ x laacZ 
crosses were obtained by adding the recombination frequencies of each parental 
genotype.  Data on the two combinations of genotype/developmental stage 
investigated in this thesis are outlined in red. 
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5.2.2. Detection of thymic epithelial clones 
5.2.2.1. β-galactosidase expression in the embryonic thymus under 
control of the ROSA26 promoter 
To demonstrate that cells in the E16.5 thymus were able to produce β-gal, by 
expression of lacZ under the control of the ROSA26 promoter, R26lacZ+/- mice that 
ubiquitously expressed β-gal were crossed with CBA/BL6 wild-type animals, 
resulting in both R26lacZ+/- and R26lacZ-/- embryos.  Thymus lobes were removed 
from embryos by microdissection, rinsed in cold PBS and fixed in ‘old embryo fix’ 
(OEF, see materials and methods) overnight at 4oC.   Lobes were subsequently 
washed with X-gal wash and stained at 37oC for 24 hours with X-gal (see materials 
and methods).  After fixing in X-gal-fix (XGF, see materials and methods) overnight 
at 4oC, lobes were examined.  Staining revealed blue cells throughout thymus lobes 
from R26lacZ+/- embryos, whereas wild-type littermates were negative for X-gal 
staining (Figure 5.4). 
5.2.2.2. Production of R26laacZ0.3+/+ E16.5 thymus lobes 
Initial R26laacZ0.3+/+ embryos were generated by homozygous R26laacZ0.3+/+ 
crosses.  This resulted in litters of a uniform R26laacZ0.3+/+ genotype.  In total 15 
litters were dissected, with 192 thymus lobes being removed from embryos at E16.5.  
Lobes were treated in the same manner as positive/negative controls (see section 
5.2.2.1).  After staining/fixation, lobes were put into 30%, 50% and 80% glycerol (in 
PBS) overnight at 4oC, sequentially.  This was done in order to clear the tissue, so 
that any β-gal+ cells present might show up more clearly.  Lobes wre then stored in 
80% glycerol at 4oC to await analysis. 
5.2.2.3. Detection and analysis of E16.5 β-gal+ clones 
X-gal stained E16.5 R26laacz0.3+/+ thymus lobes in 80% glycerol were examined 
under a light microscope, in order to look for blue β-gal+ cells resulting from any 
laacZ-lacZ recombination events that may have occurred.  Any observed clones were 
photographed.  The number of clones observed was well below the expected level.  
From predictions in Table 5.5, it was calculated that around 64 TEC clones would be 
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generated from a sample of 192 thymus lobes with this particular age/genotype 
combination (Table 5.6).  However, only 14 clones were observed, of any cell type.  
This seems even lower when the expected number of clones of any cell type is taken 
into account, with the total number of clones expected from this sample being around 
624 (Table 5.7).  This was calculated by the same means used in section 5.2, with a 
mean number of 3.25 clones of any type expected to occur in each E16.5 lobe (Table 
5.7).   
Clones detected here were all on or near the surface of the thymus.  Most β-gal+ cells 
occurred singly or in pairs.  Representative photographs of all E16.5 clone types are 
shown in Figure 5.5.  The location of clones in Figure 5.5 suggests either a capsular 
mesenchymal or subcapsular epithelial identity.  Panel C in particular appears to be 
of extrathymic mesenchymal origin.  The topology of these clones indicates a 
dispersive mode of growth and significant cell mixing, since individual cells are 
frequently separated by a long distance (particularly F and G).  In Figure 5.5B, 
several clusters of 2 cells can be seen.  This could indicate either recent cell division, 
or a switch from a dispersive to a coherent mode of gr wth (Figure 1.7). 
5.2.2.4. Production of R26laacZ1.1+/+ E15.5 thymus lobes 
Due to the lower than expected labelling frequencies observed using the homozygous 
R26laacZ0.3 embryos, it was decided to use the larger 1.1kb laacZ duplication.  
R26laacZ1.1+/+ embryos were expected to give an increased recombination 
frequency, resulting in an increase in the observed number of labelled clones.  E15.5 
R26laacZ1.1+/+ embryos were used in this analysis, because their smaller size would 
make it easier to see labelled cells in the interior of the thymus.  Also, the ratio of 
epithelial cells to non-epithelial cells is higher (16.2% ±4.1% of total thymus at 
E15.5 as opposed to 8.8% ±2.4% at E16.5, Figure 3.3.), boosting the epithelial 
proportion amongst total clones.  At E15.5, a mean number of 0.84 epithelial clones 
per lobe were calculated – 2.5 times as many as would be expected to occur in 
R26laacZ0.3+/+ thymus lobes (Table 5.5, Figure 5.5).  A total of 254 lobes were 
removed from R26laacZ1.1+/+ E15.5 embryos.  These were stained and cleared in the 
manner described for E16.5 thymus above. 
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Table 5.6 Expected/observed TEC clone numbers 
Embryo genotype  R26laacZ0.3+/+ R26laacZ1.1+/+ 
Embryo age  16.5 15.5 
Mean expected TEC 
clones per lobe ( λ) 0.34 0.84 
% of l obes expected with 
N>0 TEC clones ( fL)  28.5% 56.8% 
No. lobes examined ( S) 192 254 
No. lobes expected to 
contain TEC clones ( nL) 54.7 144.2 
Total no. TEC clones 
expected ( nC) 64.4 212.9 
No. clones observed 
(any lineage) 14 19 
The number of lobes expected to contain labelled TECs (nL), out of a total of ‘S’ 
lobes, was calculated by multiplying S by the percentage of lobes expected to have 
labelled TECs (fL).  fL was calculated as described in Table 5.4.   
The total number of TEC clones expected (nC) was calculated as S x λ.  (λ was 
calculated as described in Table 5.4).  Values for fL and λ taken from Table 5.5 
. 
Table 5.7 Expected number and frequency of total th ymus clones  
Embryo genotype R26laacZ0.3+/+ R26laacZ1.1+/+ 
Embryo age 16.5 15.5 
Recomb. Rate (m) 3.32x10-6 1.63x10-5 
Total cells (Nt) 9.79x105 2.36x105 
Mean expected total 
clones per lobe ( λ) 3.25 3.85 
% of lobes expected 
with N>0 clones ( fL) 96.1% 97.9% 
No. lobes expected to 
contain clones ( nL) 184.5 248.7 
Total no. clones 
expected (any lineage) 
(nC) 
624.0 977.9 
Here, the number of clones of any lineage expected to occur in the sample described 
in Table 5.6 was calculated.  λ was calculated as mNt, as described in Table 5.4.  The
total number of cells in the thymus (Nt) was calculated in Chapter Three.  Values for 
nL and nC were calculated as described for Table 5.6, above. 
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5.2.2.5. Detection and analysis of E15.5 β-gal+ clones 
E15.5 thymus lobes were analysed by the same method as E16.5 lobes, described in 
section 5.2.2.3.  From 254 E15.5 lobes, 19 clones were observed.  Once again, this is 
well below the expected number – from this sample a tot l of 144 TEC clones was 
calculated to have been present (Table 5.6).  This is particularly surprising when it is 
considered that almost 98% of these lobes were expected to harbour clones 
encompassing any type of cell.  A mean of 3.85 clones of any kind was calculated to 
occur per lobe, giving an expected total of 978 independent labelling events for this 
sample of 254 lobes.  In E16.5 and E15.5 lobes, the obs rved number of clones was 
2% and 3% respectively of the expected total number. 
Of the 19 E15.5 clones observed, the majority were v ry similar to those in Figure 
5.5.  These consisted of a very small number of cells, most frequently 1 or 2, located 
on the outside of the thymus.  Two larger clones were s en, however.  Clone 1.1/14 
was composed of around 40 cells, and was located as a region of extrathymic tissue 
on the outside of the lobe (Figure 5.6).  Clone 1.1/16 was composed of several 
hundred cells, and was immediately visible to the naked eye.  When examined under 
the microscope, blue patches both on the surface and within the interior of the lobe 
were obvious (Figure 5.7A).  This clone was cryo-sectioned, whereupon it was seen 
that labelled cells covered a large proportion of the lobe’s surface, particularly 
toward one pole.  Labelled cells also extended deep within the lobe, forming 
elongated clusters that often extended from the perimeter of the thymus (Figure 
5.7B-D).  The staining pattern correlates extremely closely with that seen when using 
the ER-TR7 monoclonal antibody to identify thymic mesenchyme (Figure 5.7E).  
Unfortunately, direct staining of tissue from this clone with the ER-TR7 antibody 
was not possible, since the antibody appears sensitive to the X-gal staining process. 
It was decided to section a number of R26laacZ1.1+/+ lobes, in case there were β-gal+ 
cells within the thymus that could not be visualized when examining an intact lobe – 
a distinct possibility since the vast majority of labelled cells observed were on the 
periphery of the organ.  A total of 64 E15.5, X-gal stained thymus lobes were fully 
sectioned, with the sections captured on glass slides.  Sections were all carefully 
Chapter 5: Results: Retrospective clonal analysis using the laacZ system 
  136 
examined under a light microscope.  From a sample of 64 E15.5 lobes, a total of 
approximately 246 clones of any cell type would be expected, due to a calculated 
mean of 3.85 laacZ recombination events occurring per lobe.  Upon examining the 
sections, 17 lobes were found to have labelled cells, representative examples of 
which are shown in Figure 5.8 and Figure 5.9.  Most of these had only one or two β-
gal+ cells, located in the thymic capsule (Figure 5.8).  One lobe contained a large 
clone consisting of 23 cells, found on multiple adjacent sections (Figure 5.9).  This 
clone was also located on the periphery of the thymus, appearing to be either extra-
thymic connective tissue, or part of the capsule that ad lifted away during the 
staining process.  Lobes were also hemisected in order to increase the chances of 
locating clones within the interior of the thymus, but this did not lead to extra clones 
being discovered.  None of the sectioned lobes reveal d any clones within the thymic 
parenchyma that could be considered as epithelial, and therefore of further interest in 
this project. 
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Figure 5.4 R26lacZ+/- thymus lobe showing X-gal staining 
Panel A shows negative control R26lacZ-/- E16.5 thymus after staining with X-gal.  
Panel B shows positive control E16.5 thymus from R26lacZ+/- littermate.  In panel C, 
a positively stained lobe was teased apart to show stain penetration into interior of 
thymus.  Lobes were stained for 24 hours at 37oC.  Scale bars: A, B – 400 µm; C – 
100 µm. 
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Figure 5.5 Examples of β-gal+ cells from R26laacZ0.3+/+ E16.5 thymus 
See following page 
Shown here are representative examples of β-gal+ clones seen in R26laacZ0.3+/+ 
E16.5 thymus lobes.  Black arrowheads indicate labelled cells.  Where clones are 
large and spread over a wide area, the outer extents of clone boundaries are marked 
by a black dotted line (B and C).  The numbers of labelled cells shown in each 
example are as follows: A-1, B-29, C-11, D-4, E-3, F-6, and G-8.  In Fa and Fb, 
multiple images represent changes in depth of focus required to visualise labelled 
cells in different areas of the same thymus lobe.  Ga, Gb and Gc also represent one 
lobe.  Scale bars are 200µm. 
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Figure 5.5 Examples of β-gal+ cells from R26laacZ0.3+/+ E16.5 thymus  
For legend, see previous page. 
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Figure 5.6 Clone 1.1/14 – a large clone in capsular /extrathymic tissue 
A) Whole-mount X-gal stain of E15.5 R26laacZ1.1+/+ thymus lobe, showing clone 
1.1/14.   
B) Cryo-section through clone 1.1/14, showing blue X-gal-stained nuclei.  Scale bars 
– in A is 200µm, in B is 100µm. 
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Figure 5.7 Clone 1.1/16 – a large clone of apparent  mesenchymal origin 
See following page. 
(A) Whole-mount X-gal stain of E15.5 R26laacZ1.1+/+  thymus lobe showing clone 
1.1/16.  Hundreds of labelled cells were observed, an  were concentrated toward one 
pole of the lobe.  In a horizontal progression towards the opposite pole the number of 
labelled cells decreased, and the final 30-40% was completely unlabelled.  White 
dashed line indicates approximate orientation of tissue sections.  (B) Greyscale 
image of frozen section through clone 1.1/16.  (C, D) Magnified view of panel B, 
showing detail of labelled cells.  Red, dotted lines show clustered nature of labelled 
cells, both in the thymus interior (C) and in the outer capsule (D).  Green colour 
shows DAPI stain, giving position of cell nuclei.  (E) ER-TR7 stain of E15.5 thymus 
for comparison, demonstrating similarity between distribution of ER-TR7+ 
mesenchyme and β-gal+ cells in clone 1.1/16.  Scale bars - A is 200µm; B and E are 
100µm. 
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Figure 5.7 Clone 1.1/16 – a large clone of apparent  mesenchymal origin 
For legend, see previous page. 
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Figure 5.8 Sections through R26laacZ1.1+/+ lobes showing examples of 
β-gal+ labelled cells 
See following page. 
(A-H) 8 representative examples of clones observed after sectioning a sample of 64 
E15.5 thymus lobes.  Nearly all clones observed in this analysis were located on the 
outside of the thymus.  Some were obviously in the capsule (A, C, G), while others 
may have originated from extrathymic tissue (D, E, H).  Two cells were observed 
that may be subcapsular (B, F).  Red arrowheads point to blue cells.  Scale barsare 
100µm. 
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Figure 5.8 Sections through R26laacZ1.1+/+ lobes showing examples of 
β-gal+ labelled cells 
For legend, see previous page. 
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Figure 5.9 Sections through a 23-cell clone 
(A-D) Adjacent sections through a single E15.5 thymus lobe, showing a clone 
comprised of 23 cells.  Red arrowheads point to blue cells.  Scale bars are 100µm. 
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5.2.2.6. Weak staining in R26lacZ+/- control thymus sections 
Since the vast majority of labelled lobes exhibited β-gal+ cells only on or near the 
surface of the thymus, it was considered whether or not reagents used in the X-gal 
staining process were able to penetrate into the interior of the thymus successfully.  
To investigate this, R26lacZ+/- positive control lobes were stained with X-gal as in 
section 5.2.2.1.  These were then frozen in OCT and sectioned using a cryostat (see 
materials and methods).  It was seen that although whole X-gal-stained lobes were 
dark blue in appearance, the β-gal+ cells were much paler when observed in section, 
and individual nuclei were not well defined (Figure 5.10).  However, it was 
concluded that this was not due to poor tissue penetration of the staining process, 
since cells on the periphery of the thymus stained with the same intensity as those in 
the centre of the organ (Figure 5.10).  In a large number of cells, a single tiny area of 
intense staining was visible in the form of a small dot.  These dots appeared to be 
either perinuclear or just outside the cell nucleus adjacent to the outer membrane 
(Figure 5.10C,D).  Some cells did display the expected X-gal staining morphology, 
with the whole nucleus appearing as dark blue.  These occurred predominantly in 
clusters, mostly at the edge of the thymus but alsoin the interior of the lobe (Figure 
5.10A).  Often, the areas of strongest staining appe red in extrathymic tissue that had 
remained attached to the thymus following dissection (Figure 5.10B).  
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Figure 5.10 Cross-section of β-gal+ control thymus reveals weak 
staining 
See following Page 
A) Cross section through an E16.5 R26lacZ+/- thymus lobe, showing poor resolution 
of nuclear X-gal staining. Cells that show an obvious, darkly stained nucleus are 
infrequent, occurring individually (black arrowheads), or in clusters (marked by 
dotted black lines). Staining appears in most cells as a single, intense dot (red 
arrowheads).   
B) Prominent, darkly stained nuclei are most frequently observed around the edge of 
the thymus (black arrowheads), or in extrathymic tissue still attached to lobes after 
dissection (within black dotted line).   
C) The size of the dots of X-gal staining (left panel) is demonstrated in comparison 
to the nucleus by a DAPI stain (pale blue in left panel, dark blue in right panel).  
Only small numbers of nuclei appear to be completely X-gal stained as expected 
(white arrowheads).   
D) Magnified view, showing the position of the ‘dot’ staining to be on the edge of 
the nucleus (black arrowheads).  Left panel shows brightfield only, right panel shows 
brightfield plus DAPI overlay. 
Scale bars in A and B are 200µm, scale bars in C and D are 50µm. 
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Figure 5.10 Cross-section of β-gal+ control thymus reveals weak 
staining  
For legend, see previous page 
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5.2.3. Optimisation of X-gal staining 
5.2.3.1. Pre-stain tissue fixation 
It was decided to optimise the X-gal staining process, in order to achieve the 
maximum possible staining intensity and give a better chance of locating the 
presumptively substantial number of β-gal+ clones that were not detected.  
Optimisation of X-gal staining was investigated using R26lacZ+/- mice constitutively 
expressing β-galactosidase. 
The first variable investigated was the method of tissue fixation.  Fixatives are used 
in order to preserve morphology within the tissue, and to prevent its degradation by 
microbes.  However, since X-gal staining relies on the enzymatic activity of β-
galactosidase produced within the cell, it was important not to over-fix the tissue.  
OEF (which utilises glutaraldehyde and formaldehyde as fixatives, see materials and 
methods) and two sources of formaldehyde - one made as a 4% solution of 
paraformaldehyde (PFA) in PBS, the other as a 10% dilution of formalin - were used 
for varying durations, as summarised in Table 5.8.  Both sources of formaldehyde 
resulted in a similar working concentration.  
 
Table 5.8 Effects of fixative variation on X-gal st aining 




overnight original condition 
3 hours no improvement 
1 hour no improvement 




3 hours no improvement 
1 hour no improvement 
10 min slight improvement 
3.7% formaldehyde 
(10 % formalin) 
overnight worse 
3 hours no improvement 
1 hour no improvement 
10 min no improvement 
 
A brief 10-minute fixation with 4% PFA appeared to result in a slightly stronger 
stain than the original OEF overnight fixation (not pictured).  The prominent ‘dot’ 
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morphology described in section 5.2.2.3 was still present.  Fixation in 10% formalin 
for an identical time did not result in a similar improvement, possibly due to the 
presence of methanol.  Methanol is added to formalin in small amounts by the 
manufacturer as a stabilising agent, but may cause conformational changes to 
proteins and hence affect the enzymatic activity of β-galactosidase.  This is not an 
issue with freshly dissolved PFA.   
Although both glutaraldehyde and formaldehyde operate in a similar manner by 
cross-linking protein molecules, glutaraldehyde has a higher molecular weight.  This 
can limit its ability to diffuse into tissues, and likewise may affect the penetration of 
X-gal substrate into cells.  Glutaraldehyde fixation can also cause significant auto-
fluorescence in tissue.  This would likely pose problems in this analysis, where cell 
types would be identified by confocal microscopy in conjunction with fluorescently 
tagged antibodies. 
In conclusion, it was decided to use 4% PFA for 10 minutes in all future tissue 
fixation prior to X-gal staining. 
5.2.3.2. Duration and temperature of X-gal staining 
Next, the conditions of the X-gal staining step were investigated.  One of the most 
obvious parameters that could be adjusted was the length of time for which the tissue 
was in contact with the X-gal staining reagent.  Since enzymatic reactions such as 
processing of X-gal substrate by β-galactosidase can also be sensitive to temperature, 
it was decided to investigate the effect of staining duration at two temperatures.  All 
tissues have endogenous β-galactosidase activity due to lysosomes, which can result 
in non-specific background staining - the stain wasperformed out 25oC to reduce this 
phenomenon.  Staining was also carried out at 37oC, as performed previously in this 
chapter.  Results are summarised in Table 5.9. 
 It was seen that a 48-hour stain gave marginally better results than a 24-hour stain.  
This difference is imperceptible when looking at photographs, and hence not shown 
here.  Increasing the stain time to 72 hours did not give any further improvement.  
There did not appear to be any difference between stai ing the tissue at 37oC or 
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25oC.  It was decided that future X-gal staining would take place for 48 hours, at 
25oC (for reasons of practical convenience). 
 
Table 5.9 Effects of time and temperature on X-gal staining 
Temperature Duration Result 
37 oC 
24h original condition 
48h Slight improvement 
72h Slight improvement 
25 oC 
24h no improvement 
48h Slight improvement 
72h Slight improvement 
 
 
5.2.4.    X-gal staining of whole-mount vs. sectioned tissue 
Previous results in section 5.2.2.3 showed uniform staining between cells both deep 
in the centre of the thymus and on its periphery, indicating there were no problems 
involving penetration of staining reagents into theint rior of the organ.  To confirm 
that diffusion of reagents through the outer capsule of the organ was not an issue, X-
gal staining of tissue sections was investigated. 
Freshly dissected E16.5 R26lacZ+/- thymus lobes were embedded in either OCT 
compound or 15% sucrose/7% gelatine and snap-frozen, before being sectioned onto 
glass microscope slides (see Chapter Two: Materials and Methods).   
Frozen sections from each embedding medium were firstly subject to variations in 
fixative (OEF or 4% PFA) and in fixation time, as summarised in Table 5.10.  These 
samples all underwent an X-gal stain of 24 hours at 25oC.  Little or no improvement 
was observed between any of these conditions and the X-gal staining pattern seen on 
sections of whole-mount-stained thymus. 
Variations in X-gal staining temperature and duration on slides were also 
investigated.  Sections from both OCT-frozen and sucrose/gelatine-frozen tissue 
were briefly fixed in 4% PFA, before undergoing the X-gal staining process.  
Conditions were varied in the same manner as in whole-m unt thymus staining, seen 
in Table 5.9.  Once again, no differences were observed compared to the whole-
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mount stained thymus.  Thus, it can be concluded that the poor X-gal staining seen 
here in the embryonic thymus is definitely not due to difficulties encountered by the 
fixation/staining reagents in penetrating through the hymic capsule into the interior 
of the organ. 
 
Table 5.10 Effects of embedding medium, type of fix ative and duration 
of fixation upon X-gal staining of frozen thymus se ctions 
Embedded Fixative Duration 




2 min No change 
10 min No change 
30 min No change 
4% PFA 
2 min No change 
10 min No change 




2 min No change 
10 min No change 
30 min No change 
4% PFA 
2 min No change 
10 min No change 
30 min No change 
 
 
5.2.4.1. Attempted sensitivity increase by alkaline treatment  
It has been noted that in some cases X-gal staining ca  be enhanced by following the 
staining step with alkaline treatment (Tanahashi and Tabira, 2000).  In the staining 
reaction, the X-gal substrate (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) is 
hydrolysed by β-galactosidase to produce galactose and 5-bromo-4-chloro-3-
hydroxyindole (Figure 5.11).  The latter product self-couples following oxidation, to 
give the insoluble blue precipitate required to visualise the result of the reaction 
(Pearson et al., 1963).  Alkaline treatment immediat ly following incubation with X-
gal increases oxidation of any residual 5-bromo-4-chloro-3-hydroxyindole from the 
hydrolysis step, increasing levels of the blue preci itate and therefore giving 
increased sensitivity to the assay.   
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Addition of 1M sodium carbonate (Na2CO3) for 20 minutes was tried after X-gal 
staining of whole lobes, and also on frozen sections f llowing X-gal staining upon 
slides (for details, see materials and methods).  Upon subsequent examination of 
alkaline-treated tissue, however, it was clear that no improvement in staining 
sensitivity had occurred (not shown).   
5.2.4.2. Detection of β-gal+ cells by confocal microscopy 
Anti-β-galactosidase antibody was investigated as an altern tive means of detecting 
β-gal+ cells.  Three antibodies from different manufacturers were tried on frozen 
E15.5 R26lacZ+/- positive control thymus sections, with both fresh and 
formaldehyde-fixed tissue.  The most successful of these antibodies showed a similar 
staining pattern to the X-gal stain.  Once again, small positively stained dots were 
visible, occurring just outside the nucleus (Figure 5.12).  This result provides 
additional support for the conclusion that the X-gal st ining results obtained above 
are a true reflection of the pattern of β-gal expression, and not a result of a sub-
standard staining protocol/technique.   
 
5.2.5. Staining of E10.5 R26laacZ1.1+/+ embryos 
E10.5 R26laacZ1.1+/+ embryos were examined for the presence of clones, to confirm 
that there were no inherent problems with my staining technique or with the intrinsic 
ability of the mice to produce detectable clones p r se.  199 E10.5 embryos were 
collected (fixed in 4% PFA at 4°C for 10 mins, X-gal stained at RT for 48h) and 
examined.  Most embryos contained multiple clones, as expected due to the high 
laacZ recombination rate seen in these homozygous R26laacZ1.1 embryos (1.63x10-5 
recombinations per cell per generation).  Clones of all sizes from <10 cells to several 
hundred cells were easily detected, both on the surface and within embryos, in all 
three germ layers.  It was therefore concluded that t ere are no inherent problems 
with the methods of histology and detection I have used in this chapter.
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Figure 5.11 Reaction of X-gal to produce an insolub le blue precipitate 
The above reaction shows the two-step process involved in the X-gal staining 
reaction.  The first step involves hydrolysis of X-gal by β-galactosidase, the product 
of which dimerises following a second oxidation step.  This produces the insoluble 
blue precipitate that enables detection of β-gal+ cells. 
(Picture from http://upload.wikimedia.org/wikipedia/en/5/5b/X-gal_reaction.png) 
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Figure 5.12 Anti- β-galactosidase antibody shows a similar pattern to X-
gal staining 
(A) Immunostaining of R26lacZ+/- positive control E15.5 thymus shows similar 
results to X-gal staining.  When compared to DAPI staining, it can once again be 
seen that a single, small localisation of β-gal is present on the outer edge of the 
nucleus (B and D). (C) Rabbit IgG isotype control was negative, when used with the 
same secondary antibody as in A.  Wild-type E15.5 thymus also showed negative 
when treated with anti-β gal.  Scale bars are 20µm. 
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5.3. Discussion 
From these experiments, it was concluded that the laacZ system, under the control of 
the ROSA26 promoter, is unsuitable for undertaking clonal analysis of the thymic 
epithelium at E15.5 or E16.5. 
The observed numbers of thymus clones were far below what was expected (around 
2% of the calculated number).  The vast majority of cl nes discovered were tiny (1 
or 2 cells), and nearly always within the thymic capsule or extrathymic.  Although a 
prevalence of small clones would be expected, theirspatial distribution was not.  By 
definition, the ubiquitous expression of R26laacZ should produce labelled cells in all 
lineages, occurring throughout the organ.  There is, however, anecdotal evidence that 
ROSA26 is not well expressed in CD45+ cells - the most numerous thymic 
component at E15.5 and E16.5, and therefore the population within which the 
majority of clones were expected to occur.  There may be a possibility that thymic 
epithelial cells may also express ROSA26 poorly.  This would leave thymic 
mesenchyme as the major cell type able to produce detectable clones (as documented 
in Chapter Three), and may account for the observation of a disproportionate number 
of labelled cells belonging to this population.  The greatest concentration of thymic 
mesenchyme occurs around the outside of the organ, in the capsule.  Together, these 
factors may explain why most labelled cells were observed in this part of the thymus.   
A weak staining pattern was observed in thymus lobes constitutively expressing β-
gal, with staining apparent only as a single, intense, dot in most cells.  This may 
indicate low levels of β-galactosidase protein expression, since staining wth an anti-
β-gal antibody showed a similar morphology.  The dots of staining were localized on 
the edge of cell nuclei.  If β-gal was expressed in a similar fashion in laacZ-lacZ 
cells, it may account for the difficulty in locating clones, since small groups of cells 
exhibiting this staining pattern would be extremely difficult to detect.  A similar 
‘prominent blue spot’ pattern has been described in pancreatic β-cells from 
R26lacZ+/+ embryos (Percival and Slack, 1999).  In addition, studies of primordial 
germ cells in R26lacZ embryos also report a ‘cyan perinuclear dot of X-gal 
precipitate’ (Adams and McLaren, 2002, Bielinska et l., 2007). 
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One possible explanation behind the problems in detecting βgal+ cells is epigenetic 
silencing, due to cytosine methylation at CpG dinucleotides.  CpG dinucleotides are 
not uniformly distributed, averaging only 1% of the v rtebrate genome (Takai and 
Jones, 2002).  However, CpG ‘islands’ of 300 – 3,000 base pairs, containing a higher 
frequency of CpG dinucleotides, are found in or near approximately 40% of 
mammalian gene promoters; frequently in those of widely expressed genes, and 
rarely in those exhibiting strict expression patterns (Fatemi et al., 2005, Saxonov et 
al., 2006, Gardiner-Garden and Frommer, 1987).  CpG dinucleotides are prone to 
methylation by methyltransferases, leading to recruitment of chromatin proteins and 
silencing – 70% to 80% of mammalian CpG cytosines ar  methylated (Jabbari and 
Bernardi, 2004).  However, CpG islands are somehow protected from 
hypermethylation under normal circumstances.   
Bacterial DNA tends to have a higher proportion of CpG dinucleotides than is found 
in most vertebrates.  These sequences can cause probl ms when introduced to the 
mammalian genome – CpG rich reporter transgenes can a t as foci for de novo 
methylation, which can spread in cis by means that are poorly understood.  This can 
result in the aberrant methylation and consequent inactivation of some promoters that 
are located in CpG islands.  An experiment in transge ic mice where the CpG 
content of an introduced lacZ reporter was reduced demonstrated this (Chevalier-
Mariette et al., 2003).  The lacZ reporter was placed under the control of a transgeic 
human promoter of the α-subunit of the elongation factor 1 of translation (EF1α), a 
widely expressed gene included in a CpG island with a igh (6.2%) CpG content.  
Three variants of the lacZ reporter with varying CpG content were used.  The 
original lacZ had a CpG content of 9.24%.  Two mutant alleles, lagZ and lagoZ, were 
engineered and had CpG contents of 1.6% and 0.06% respectively.  These used 
alternate codons to encode the same amino acids as the original lacZ sequence.  
Histological studies using X-gal showed very poor β-galactosidase expression in 
lacZ mice.  In lagZ mice expression was poor in most tissues, although levels were 
varied.  In lagoZ mice, with the lowest CpG content, stronger expression of β-
galactosidase was observed.  Methylation studies reveal d that, in the mice with the 
weakest transgene expression (EF1αlacZ), the CpG island where the EF1α promoter 
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was located had been hypermethylated, and consequently expression was silenced.  
Conversely, the promoter in the EF1αlagoZ mice escaped methylation, allowing 
transgene expression in most tissues examined (Chevalier-Mariette et al., 2003). 
Furthermore, a recent study examining expression of lacZ under the control of the 
ubiquitous β-actin promoter also reported widespread silencing of the transgene 
(Strathdee et al., 2008).  In ES cells and early embryonic (E9.5) tissue, lacZ 
expression was widespread, although a broad variation in expression levels was 
observed.  As mice aged, lacZ expression became restricted to certain tissues, and 
within those was seen to be patchy.  The β-actin promoter, located in a CpG island, 
was seen to be hypermethylated, particularly in differentiated cells (Strathdee et al., 
2008). 
To examine whether a similar mechanism of epigenetic silencing may be possible in 
the R26lacZ transgene used in my clonal analysis experiments in this chapter, I 
looked at the CpG content of the ROSA26 promoter (Figure 5.13).  From a total of 
534 base pairs in this sequence, there are 62 CpG dinucleotides.  At 11.6%, this 
confirms that the ROSA26 promoter is contained within a CpG island.  It is therefore 
entirely possible that, when placed adjacent to the CpG-rich lacZ reporter gene, de 
novo methylation spreads in cis from the reporter to the CpG-rich ROSA26 promoter 
sequence and results in silencing of the transgene in c rtain tissues. 
Since I have shown, using E10.5 embryos, that the transgenic mice used in this 
chapter can produce β-gal+ clones, and that my histological and detection techniques 
are able to display labelled cells at that age, it is likely that there are age-specific or 
tissue-specific problems with R26lacZ expression in these mouse lines. 
It is possible to test the hypothesis of genetic silenc ng in specific thymus 
components.  One could sort and collect the different thymic components by flow 
cytometry.  RNA isolation and RT-PCR would then provide an answer as to whether 
RNA transcripts for β-galactosidase were being produced in any particular cell 
subsets. 
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  1 ctcgagttag gcccaacgcg gcgccacggc gtttcctggc cgggaatggc ccgtacccgt 
 61 gaggtggggg tggggggcag aaaaggcgga gcgagcccga ggcggggagg gggagggcca 
121 ggggcggagg gggccggcac tactgtgttg gcggactggc gggactaggg ctgcgtgagt 
181 ctctgagcgc aggcgggcgg cggccgcccc tcccccggcg gcggcagcgg cggcagcggc 
241 ggcagctcac tcagcccgct gcccgagcgg aaacgccact gaccgcacgg ggattcccag 
301 tgccggcgcc aggggcacgc gggacacgcc ccctcccgcc gcgccattgg cctctccgcc 
361 caccgcccca cacttattgg ccggtgcgcc gccaatcagc ggaggctgcc ggggccgcct 
421 aaagaagagg ctgtgctttg gggctccggc tcctcagaga gcctcggcta ggtaggggat 
481 cgggactctg gcgggagggc ggcttggtgc gtttgcgggg atgggcggcc gcgg 
 
Figure 5.13 CpG dinucleotides within ROSA26 promote r sequence 
Mus Musculus ROSA26 region 534 bp promoter sequence DNA (GenBank: 
U83173). Position of CpG dinucleotides is highlighted in blue.  From a possible 533 
dinucleotide pairings, 62 (11.6%) are CpG.   
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Chapter 6. Concluding remarks 
The work detailed in this thesis aimed to assess the lineage potential of fetal thymic 
epithelial progenitor cells, with regards to their ability to give rise to cortex and/or 
medulla, as thymus ontogeny proceeds. 
I used a ROSA26laacZ non-invasive clonal labelling system to generate a libr ry of 
clones for retrospective analysis.  Since the laacZ-lacZ recombination rate had 
already been ascertained in ES cells (for two variants of the transgene, R26laacZ0.3 
and R26laacZ1.1), the theoretical average number of independent thymic epithelial 
cell clones in a thymus lobe of a given age could be calculated if the number of TECs 
present at that age were known. 
Therefore, I began in Chapter Three by analysing the number of TECs present within 
a single developing thymus lobe from early until late organogenesis (E12.5 – E17.5).  
Due to the lack of detailed quantitative data on all thymic fetal cell populations, I 
also quantified haematopoietic, mesenchymal and endothelial populations at these 
time points.  Consequently a defined data set now exists of thymic cell population 
sizes changes through thymus ontogeny, which will be of value to future studies of 
thymic developmental composition and kinetics.   
In Chapter Four, I examined the Plet1+ content of the TEC population.  Here, I 
discovered that there is no significant change in the absolute number of Plet1+ TECs 
between E12.5 and E17.5.  Furthermore, I used DNA quantification to demonstrate 
that the proportion (and thus the absolute number) of Plet1+ TECs undergoing 
proliferation at any one time decreases as thymus ontogeny proceeds. 
My experimental results from Chapter Four are consistent with a developmental 
model in which Plet1- transit amplifying (TA) cells are produced from the Plet1+ 
population.  A continual increase in the total TEC population size, coupled with a 
continual decrease in the rate of Plet1+ proliferation, suggests that fully differentiated 
TECs are produced from a dynamic population of Plet1- TA TECs with high 
proliferative capabilities.   
Recently, some doubt has been cast over the nature nd identity of TEPCs.  A recent 
investigation compared the ability of Plet1+ and Plet1- TECs to generate a functional 
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thymic microenvironment.  The authors stated there w re no differences in 
proliferative potential, organisational abilities, and T-cell maturation, between Plet1+ 
and Plet1- TECs from E14, E16 or E18 mouse embryos (Rossi et al., 2007a).  
Expression of genes associated with epithelial progenitor status in other tissues, such 
as p63 and BCRP-1, was also seen to occur at comparable levels in both TEC 
subsets.   
Discrepancies between these results and those of earlier work in E15.5 TECs by Gill 
et al, where Plet1- TECs did not form a functional thymic microenvironment, may be 
due to a larger number of TECs (2,500 vs. 100,000) being reaggregated in this 
instance (Rossi et al., 2007a, Gill et al., 2002).  In addition, the earlier study allowed 
grafted tissue to develop for 8 weeks as opposed to a 4-week time window in the 
Rossi et al paper.  It may be that the maintenance and survival of 100,000 cells for 4 
weeks is more feasible than that of only 2,500 cells for twice that period.   
However, it can also be seen from the work done in Chapter Four of this thesis that 
the Plet1- population contains a large number of proliferating cells.  It is likely that 
these are a transit amplifying population that can go on to produce differentiated, 
functional thymic epithelium. 
In an attempt to track the proliferative behaviour f individual cells over time, I 
attempted an ultimately unsuccessful in vitro double-labelling of TECs with 
halogenated thymidine analogues.  However, some preliminary work using BrdU 
labelling showed 90% of cells proliferating in the 26 hours prior to E14.5, 
confirming Plet1+ TECs to be highly active during early thymus organogenesis.   
As a follow-up experiment, a set of 26-hour BrdU pulses beginning at different time 
points during organogenesis (similar to those in Figure 4.10), would be interesting.  
Starting with E12.5 and progressing in 12-hour intervals until E17.5, these additional 
experiments would indicate which of the two proliferation models shown in Figure 
2.9 was more likely.  BrdU has been used previously to examine TEC proliferation 
from E15 to E18, but on the epithelial population as a whole and not the Plet1+ 
population specifically (Anderson et al., 1998). 
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Future work could also follow up the BrdU labelling with a chase period, where it 
could be seen whether the BrdU was retained by Plet1+ c lls.  Retention of BrdU in 
some cells but not in others would indicate non-uniform division, where as the loss 
of BrdU in all Plet1+ cells would indicate the uniform division model where all cells 
continue to proliferate, but at a reduced rate. 
In Chapter Five, I used the data on TEC number from Chapter Three to calculate the 
mean number of independent epithelial clones potentially occurring in a single 
thymus lobe.  This information was calculated for each 24-hour time point from 
E12.5 until E17.5, resulting in data for each heterozygous and homozygous 
combination of wild-type, R26laacZ0.3 and R26laacZ1.1 genotypes.  These findings 
resulted in selection and analysis of E16.5 R26laacZ0.3+/+ embryos.   
Upon subsequent collection, processing and analysis of thymus lobes, I observed a 
far lower than expected number of clones - none of which could be classified as 
epithelial.  Consequently, I analysed thymus lobes from E15.5 R26laacZ1.1+/+ 
embryos, in an attempt to increase the level of clone generation and observation.  
However, similar results were observed, with no epithelial clones seen.  I extensively 
analysed and optimised the histological techniques involved in embryo fixation, X-
gal staining and clone visualisation, and concluded that the problem lay in expression 
of the ROSA26lacZ transgene.  My analysis of the ROSA26 promoter revealed a high 
CpG dinucleotide content which, in combination with the high CpG content of the 
lacZ reporter sequence, has in theory a high likelihood f undergoing methylation-
induced silencing. 
In retrospect, if I repeated this work, I would address the problems of this transgene 
as a reporter of genetic recombination by re-engineer g the laacZ sequence.  Point 
mutations altering CpG dinucleotides could be introduced, enabling alternate codons 
for the appropriate amino acids to be used.   
In an ideal situation, I would use a mouse where the laacZ gene was expressed in a 
thymic epithelial-specific manner.  This could be achieved by creating a Foxn1laacZ 
mouse, as Foxn1Cre paired with a R26laacZ reporter would probably inherit the 
same silenced expression pattern as I found during my work.   
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